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ABSTRACT 
Gram-negative bacteria contain a double membrane system which is made up of the 
inner membrane (IM) and the outer membrane (OM). The OM, the asymmetric 
membrane, is an important contributor towards resistance against various toxic 
molecules which provides extensive protection of cell viability. The OM consists of 
lipopolysaccharides (LPS) at the outer leaflet and glycerophospholipid (GPL) at the 
inner leaflet. LPS is a large amphipathic molecule that is essential for most Gram-
negative bacteria and is composed of three moieties: lipid A, core oligosaccharide and 
O-antigen. Precursors of LPS, the rough LPS and O-antigen units, are synthesized at 
the inner leaflet of the IM and are assembled into mature LPS at the outer leaflet of the 
IM. Seven proteins, lipopolysaccharide transporters (LptA-G), form a periplasmic 
bridge and transport mature LPS from the IM to the outer leaflet of the OM, where LPS 
functions as an impermeable barrier. The inner leaflet of the OM is also an obligate 
component for the stability and functionality of OM. GPL molecules consist of 
phosphatidylethanolamine (PE), phosphatidylglycerols (PG) and cardiolipin (CL) in an 
approximately 75: 20: 5 ratio in most bacterial membranes. The biogenesis and 
transport of LPS and GPL are often the highlights of novel drug development; however 
little is known about the mechanisms of the actions of the proteins involved in these 
processes.  
Protein X-ray crystallography is a technique that determines the molecular structure of 
a protein or a protein complex from the diffraction data of a protein crystal generated 
under X-ray beam. Knowing a protein’s molecular structure provides us with the 
information which may include possible molecular motion and conformational changes 
or interactions between residues, substrates and domains. These important details may 
provide hints into how to perform further studies on broad-ranged specific targets. 
This thesis includes four Chapters related to the X-ray crystal determination of proteins 
involved in biosynthesis, modification and transport of LPS and the transport of CL. In 
Chapter 1 I have included the successful cloning, expression and structure 
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determination of the ABC transporter LptB2FG, which is responsible for LPS extraction 
from the inner membrane. Also, the corresponding in vivo and in vitro assays are 
reported to support the LPS extraction and transportation functionality of LptB2FG. 
Chapter 2 contains the successful expression of glycosyl transferase WaaB and the 
determination of its structure. Mutagenesis and enzyme activity assays have also been 
performed to determine the galactosyl transferase activity site of WaaB (work by Gareth 
James Asheworth). Chapter 3 describes the successful cloning and structural 
determination of LapB, which may control an intermediated step of lipid A biosynthesis 
via balancing the level of LpxC & FtsH, Finally, Chapter 4 reveals the protein 
expression and structural determination of the globular domain of PbgA. PbgA is 
regarded as the cardiolipin transportation protein and we have also performed in vivo 
mutagenesis functional assays to identify the important residues for its functionality. 
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1 CHAPTER 1 Lipopolysaccharide inner membrane ABC transporter LptB2FG 
1.1 INTRODUCTION  
1.1.1 The Gram-negative bacteria outer membrane  
Gram-negative bacteria contains a double membrane system, the outer membrane (OM) 
and the inner membrane (IM). There is a water-filled periplasm between the two 
membranes and the cytoplasm is surrounded by the inner membrane. The periplasm 
contains peptidoglycan, a polymer network that helps determine the cell`s shape and 
protects it from osmotic stress (2,3). The asymmetric OM, a unique membrane of Gram-
negative bacteria, faces the extracellular environment acting as a strong barrier which 
protects the cells from some antibiotics and hydrophobic small molecules, providing 
heightened resistance to antibiotics compared to Gram-positive bacteria (4,5). The 
asymmetry of OM is caused by the component difference between the outer leaflet and 
the inner leaflet of the OM. The periplasm facing inner leaflet is comprised of 
phospholipid while the extracellular facing outer leaflet is comprised of 
lipopolysaccharide (LPS). LPS, an essential polyglyco-lipid in most Gram-negative 
species, is generally described as the source of the OM`s relative impermeability (4,5).  
This double membrane system carefully protects Gram-negative bacterial from harsh 
environments and allows bacterial cells to survive under severe circumstances (6-9). 
The two membranes have an entirely different structure and composition. Additionally, 
these membranes differ with respect to the structure of the integral membrane proteins. 
The IM typically contains α-helical transmembrane proteins, while the integral OM 
proteins (OMPs) generally consist of anti-parallel amphipathic β-strands that adopts the 
cylindrical β-barrels with hydrophilic interior channel and hydrophobic surface. The  
hydrophobic surface around the barrel structure to help be anchored in the OM (10). 
The OM also contains lipoproteins anchored into the periplasmic leaflet of the OM via 
an N-terminal N-acyl-diacylglycerylcysteine, in most cases, facing into periplasm. 
Unlike the IM, the OM is not energized by a proton gradient and ATP is no available in 
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the periplasm (11). Nutrients usually pass through the OM passively by diffusion via 
porins formed by the OMPs (12). Porins form water-filled channels that allow the entry 
of small hydrophilic molecules with molecular weights up to ∼600 Da. All the 
components of the OM are synthesized in the cytoplasm or at the cytoplasmic face of 
the IM, and they have to be transported across the IM and through the periplasm to 
reach their destination and to be assembled into the OM (11) (Figure 2). For the OMPs, 
they are synthesized in the cytoplasm as precursors with an N-terminal signal sequence. 
The N-terminal signal sequence is recognized by the Sec system, which is a Sec protein 
complex machinery that translocate the unfolded proteins from the cytoplasm to the 
periplasm (13). After reaching the periplasm, chaperons immediately interacts with the 
OMPs helping stabilize and fold of the OMPs (14). With the help of the chaperons, 
OMPs are folded and inserted into the OM by BamA-E protein complex machinery 
(15-18) (Figure 2). Similar to OMPs, lipoprotein precursors are synthesized at the 
cytoplasm and translocate to the periplasm via Sec machinery. Then, Lgt (19), LspA 
(20) and Lnt (21) worked together to maturate the lipoproteins (Figure 3). The mature 
lipoproteins are sorted to determine that whether they should stay in the IM or be 
translocated into the OM by LolCDE machinery (22). If a lipoprotein is sorted to be 
transported to the OM, the LolCDE machinery transport this lipoprotein to a 
periplasmic chaperon LolA (23). Then the lipoprotein is delivered to LolB, an outer 
membrane receptor, and finally being inserted into the OM by LolB (24) (Figure 3). 
The majority of OM phospholipids of E. coli are phosphatidylethanolamine and 
phosphatidylglycerol. Phospholipids are synthesized at the cytoplasmic side of the IM 
(25,26). The phospholipids needs to be flipped to the periplasmic leaflet first before 
being transported to the OM. The flipping process may not require a specific transporter 
but require the help of typical α-helical fold transmembrane segments of some IM 
proteins (11). The transport of phospholipids may be achieved via spheroplasts in a 
different way of lipoproteins (described above) or LPS (discussed in the section 1.1.7). 
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A PEZ candy dispenser model of LPS transportation and assembly system. The 
model is proposed by Prof. D. Kahne (1). In this model, LPS transport from the 
IM to the OM in a similar way as the PEZ candy dispenser. After flipped by 
MsbA (27) and matured in the periplasmic leaflet of the IM, LPS is extracted 
from the IM and transported to LptC by IM ABC transporter LptB2FG. Then 
LptC, LptA and the N-terminal of LptD form a trans-periplasm bridge and LPS 
is delivered along this path. The sharing of the similar β-jelly-roll folds of LptC, 
LptA and the N-terminal of LptD indicate this possibility and further evidence 
are from the crosslinking assays (28). Finally, LptD/E outer membrane 
complexes would receive LPS from LptA, then insert and assembly LPS into 
the outer leaflet of the OM (29). 
 
 
Figure 1 PEZ model describing LPS transport path (1).  
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Figure 2 Outer membrane protein folding and insertion pathway (30). 
Gram-negative bacteria contain both an inner membrane and an outer 
membrane, of which the inner membrane partitions the cytoplasm, periplasm 
and peptidoglycan. For the transmembrane proteins, the inner membrane 
contains almost α-helical membrane proteins, whereas the outer membrane 
contains almost β-barrel outer membrane proteins. The biogenesis of an OMP 
begins in the cytoplasm, where it is translated with a signal peptide (green). It 
is then translocated across the inner membrane into the periplasm by Sec 
machinery (31). The periplasmic chaperones SurA or Skp (24) then stabilize 
and further escort the OMP to the β-barrel assembly machinery (BAM) complex 
for final insertion into the outer membrane (17). Once OMPs become wrongly 
folded and cannot be rescued by Skp, they will be degraded by DegP to prevent 
damaging to the cell. In E. coli, the BAM complex consists of five components: 
the essential core component BamA, which is an OMP itself, and four 
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accessory lipoproteins named BamB, BamC, BamD and BamE, which are 
anchored into the OM. 
 
 
Figure 3 Lipoprotein maturation and transportation (32) 
(a) Maturation of lipoproteins. Lgt turns the lipoprotein precursor into a 
diacylated prolipoprotein. LspA cleave the product of Lgt at the arrow indicated 
the cleavage position. Lnt then mature the lipoprotein by adding another pair of 
fatty acid chains on to the LspA product. Same as OMPs, lipoprotein precursors 
are translocated across the IM via the Sec (Secretion machinery) (31) or Tat 
(twin-arginine translocation) (33) pathway. (b) The Lol system consists of an 
ABC transporter LolCDE complex; a periplasmic molecular chaperone, LolA; 
and an OM receptor, LolB. The OM specific lipoproteins released from the IM 
by LolCDE form a hydrophilic complex with LolA and then cross the periplasm. 
Lipoproteins are transferred from LolA to LolB and are then incorporated into 
the OM.  
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1.1.2 LPS is made up of lipid A, core oligosaccharide and O-antigen 
The biogenesis of LPS starts with the synthesis of precursors in the inner leaflet of the 
IM and followed by their flipping across the IM into outer leaflet of the IM, 
subsequently maturing into LPS in the periplasmic leaflet of the IM, and transported 
from the IM across the periplasm into the outer leaflet of the OM (Figure 1). LPS 
contains three moieties, lipid A, core oligosaccharide and O-antigen. lipid A, a β-1,6 
glucosamine disaccharide that is phosphorylated at positions 1 and 4` and hexa-acylated 
via modifications at positions 2, 3, 2`, and 3`, forms the lipidic part of LPS that anchors 
it into the membranes. There are ~106 lipid A residues and ~107 glycerophospholipids 
in one cell of E. coli (34). Two monomers of Kdo (3-deoxy-D-manno-oct-2-ulosonic 
acid) are attached to lipid A forming the minimum essential viability unit of LPS 
(Figure 4) (35-37). The core oligosaccharide of LPS contains two regions, the inner 
core region and outer core region. The inner core region is composed of several 
glycosyls. An essential double Kdo, together with lipid A is called Re-LPS. Connecting 
to the inner core is an outer core which is also made up of glycosyls as those of the 
inner core. The rough LPS containing all core regions with a lipid A is called Ra-LPS. 
The most extracellular part of LPS is the highly varied O-antigen (made up of repeat 
polysaccharide units) which provides extra protection for Gram-negative bacterial cells, 
and accounts for immune evasion and antigenicity when the bacteria infects mammals. 
In wild-type strains, additional core and O-antigen glycosyl residues may be present, 
although they are not essential for growth in laboratory conditions. 
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A rough LPS can be divided into two parts the lipid A and the core 
oligosaccharides. The Kdo2-lipid A is called Re-LPS, the whole core with lipid A 
is called Ra-LPS. The polar head in the image refers to the core region of the 
LPS, the fatty acyl chain refers to the lipid A. A Ra-LPS is about 28 Å and 12 Å 
in length and width, and about 32 Å in height overall. The core size is smaller 
than lipid A with 16 Å in length. LPS is in ball-and-stick model [O atom (red), N 
atom (blue)] 
 
1.1.3 The biogenesis of lipid A of LPS  
Many Gram-negative bacteria synthesize lipid A and the lipid A product resembles the 
one found in E. coli (35-37). The enzymes that participated in the steps of lipid A 
biosynthesis have been characterized well in E. coli (38,39) (Figure 5). All these 
enzymes worked individually to finish their own steps. The details of the biosynthesis 
of lipid A are further discussed in section 3.1 in Chapter 3. LpxA is the enzyme for the 
first step of lipid A synthesis. The next step is the deacetylation of the product by zinc 
metalloenzyme LpxC. Following deacetylation, a second β-hydroxymyristate moiety is 
 
Figure 4 A rough LPS model.  
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incorporated by LpxD to generate UDP-2,3-diacylglucosamine (40). UDP-2,3-
diacylglucosamine is cleaved at its pyrophosphate bond by the highly selective 
pyrophosphatase LpxH to form 2,3-diacylglucosamine-1-phosphate (lipid X) (41). A 
specific kinase next phosphorylates the 4’ position of the disaccharide to form lipid IVA 
(42). E. coli LPS contains two Kdo glycosyl residues that are transferred to lipid IVA 
by a bifunctional enzyme, WaaA (43). The last steps of E. coli lipid A biosynthesis 
involve the addition of lauroyl and myristoyl residues to the distal glucosamine unit, 
generating acyloxyacyl moieties (44). These steps are shown in Figure 5. 
 
 
Figure 5 Structure and biosynthesis of Kdo2-lipid A in K-12 E. coli. (5) 
The enzymes committing each step of Kdo2-lipid A synthesis. (39). A single 
enzyme catalyses each single reactions. In almost all cases, as illustrated by 
E. coli as an example, the genes encoding the enzymes of lipid A biosynthesis 
are present in single copy in the genome (45). At the protein level, LpxA and 
LpxC are the most highly conserved among bacteria. KdtA is also named as 
WaaA.  
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1.1.4 Lipid A and rough LPS flipping by MsbA 
MsbA is an essential ABC transporter, resembling eukaryotic multi-drug resistance 
(MDR) proteins. The recent Cryo-EM structure of MsbA in complex with a Ra-LPS 
molecule elucidates the mechanism of lipid A and rough-LPS flipping (27,46). The 
structure demonstrates that LPS binds deep inside MsbA through extensive hydrophilic 
and hydrophobic interactions, and reaches the level of the target leaflet without flipping 
(27). As reported in the latest paper, LPS enters MsbA and is lifted to the periplasmic 
leaflet. The flipping then happens after LPS reaches the periplasmic leaflet and LPS is 
inserted into the periplasmic leaflet finally (27).  
 
Figure 6 The ABC transporter MsbA dimer crystal structure (3B60) (46) .  
Trans-membrane helices 1-6 of MsbA are coloured in purple, blue, yellow, 
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green, red, and orange, respectively. The transmembrane domain (TMD) is 
brown, and the nucleotide-binding domain (NBD) is cyan (5). 
 
1.1.5 The importance and biosynthesis of the core oligosaccharide of LPS 
The LPS contains a core oligosaccharides in the middle of its structure. The structure 
of core oligosaccharides of LPS from a broad range of species has been identified 
(Figure 7) (5), but studies mainly focused on those from E. coli and S. typhimurium 
(Figure 7). The core oligosaccharides are theoretically divided into two regions: inner 
core and outer core. The LPS that lacks O polysaccharides are called rough LPS. Within 
a bacterial family, the glycosyl sequence is usually conserved and the conservation can 
sometimes expand to the distantly related bacteria, suggesting the importance of the 
glycosyl residues of the inner core for the outer membrane functionality (5). In E. coli 
and several close species, the inner core typically contains three essential glycosyl 
residues, two Kdo and one Hep. The base structure of inner core is often decorated with 
sugars and with phosphate, pyrophosphorylethanolamine (2-aminoethanol; PPEtN), or 
phos-phorylcholine (PCho) residues (5). The variety of these modifications contributes 
to the heterogeneity of LPS. In many cases, we could only identify the carbohydrate 
backbone of a core oligosaccharide structure even in known species, and the details 
modifications of the core oligosaccharide are hard to identify. In contrast, the outer core 
structure is less conserved, because the outer core is sometimes expected to expose 
under selective environmental pressures. However, this variation is still limited, such 
as the E. coli. In E. coli there are five known core types (R1, R2, R3, R4 and K-12) 
(Figure 7). They have different infection specification and endotoxin level (47-50). The 
two known cores from Salmonella are quite similar to those of E. coli (Figure 7). In K. 
pneumonia only one major core structure has been discovered (Figure 7), and this is 
distributed among different serotypes. The limited structural variation in the core 
oligosaccharide within a genus is in striking contrast to the highly variable O 
polysaccharides and has stimulated interest in the possibility of targeting the core 
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oligosaccharides to generate immunotherapeutic antibodies (51-54). The deep-rough 
phenotype is displayed by E. coli and S. typhimurium that lack the Hep region of the 
inner core. The phenotype is actually a series of characteristics that collectively reflect 
changes in both structure and composition of the outer membrane leading to its 
instability (36). These deficiency mainly includes the surface hydrophilicity, resulting 
in the increasing in the sensitivity to hydrophobic dyes, detergents, hydrophobic 
antibiotics and polycyclic hydrocarbons (5). Also, the deep-rough mutants would 
release periplasmic enzymes into the medium unless sufficient amount of Mg2+ are 
added. The outer membrane of the deep-rough mutants show a decreased protein to 
lipid concentration and would influence biofilm formation (5,55). These previous 
studies has explained the importance of the cores. 
The biosynthesis of core oligosaccharide starts from the Kdo2-lipid A as the first 
receptor of glycosyl transferase. A sequential glycosyl transferases uses UDP-glycosyl 
as sugar residue donor and transfer the sugar on to Kdo2-lipid A to synthases the core 
oligosaccharide of LPS. It is assumed that rapid and efficient core oligosaccharide 
synthesis reflects a coordinated complex of membrane-associated glycosyl transferases, 
although the existence of such a complex was only based on various predictions and 
computer analysis (56). The chromosomal waa region (formerly rfa) contains the major 
core oligosaccharide assembly operons, and E. coli K-12 provided the first waa region 
sequenced (5).  
In E. coli, the enzymes that participated in core oligosaccharide synthesis are shown in 
Figure 8. Besides the glycosyl transferases that add sugar residues onto the core 
oligosaccharide, the modifications of the core region are also important. In E. coli and 
S. typhimurium, the modification of the core region requires three enzymes WaaP, 
WaaY and WaaQ (Figure 8). The WaaP is a LPS kinase and is the most important one 
because the modification process must happen in WaaPQY order (57). The waaP mutant 
exhibit deep-rough phenotype in E. coli and S. typhimurium and this mutant is even 
lethal in P. aeruginosa (58). However WaaP protein sequence share extensively high 
similarity in these three species (5). All of the E. coli and S. typhimurium cores have a 
glucose residue as the first sugar in the outer core. Previous biochemistry data showed 
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that WaaG was identified as the UDP-glucose:(heptosyl) LPS α1,3-glucosyltransferase 
in E. coli (59) and S. typhimurium (60). The following enzymes worked in sequence to 
add residues onto the outer core of LPS (Figure 8).  
 
 
Figure 7 Structure of core oligosacchrides of several species (5). 
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In E. coli and S. typhimurium species, the outer cores are shown, together with 
one Hep residue of the inner core. O-PS refers to O polysaccharides (O-
antigen) (60-62). The figure shows the conserved base structure of the inner 
core, and type-specific nonstoichiometric additions to the inner core are 
identified by dotted lines. Residues and linkages that are conserved in each of 
the core oligosaccharides are shown in red colour. The K. pneumoniae O1 and 
P. aeruginosa O5 core oligosaccharide are reported in previous literatures 
(63,64). In K. pneumoniae O1 and P. aeruginosa, the boxed regions of the core 
structures are those that differ between S-LPS (smooth LPS) and R-LPS (rough 
LPS). 
 
 
Figure 8 Structure and biosynthesis of the E. coli R1 core. (5) 
Glycosyl transferases that form the inner core backbone are in yellow boxes, 
and enzymes that modify the structure are in blue boxes. Green boxes identify 
outer core glycosyl transferases, and the ligase enzyme is in pink.  
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1.1.6 The functionality and the biosynthesis of the O-antigen of LPS 
Smooth LPS are produced by lots of Gram-negative bacteria species. The structure 
diversity of O antigens is huge; more than 60 monosaccharaides and 30 different 
noncarbohydrate components have been identified (65). The O polysaccharide repeat 
unit structures can differ in monomer sugars, the position and the stereochemistry of 
the linkage manner (5). LPS extracted from S-LPS strain shows a strain specific ladder 
pattern in the SDS-PAGE, suggesting that the O antigen units differs from single LPS 
molecules in one cell (5). The synthesis of O antigen units are also little conserved with 
some species encoding the O antigen from chromosome and some from mobile plasmid 
(66,67). The location of O polysaccharide at the cell surface where the bacteria contact 
the environment directly. The primary role of O-antigen appears to be protective. In 
animal pathogens. O-antigen may contribute to bacterial evasions and the evasion could 
be affected by the component and the length of O-antigen (68,69). With some 
exceptions, the enzymes involved in O polysaccharide assembly are encoded by genes 
at the locus historically known as rfb. These loci encode enzymes for the synthesis of 
sugar nucleotide precursors, glycosyl transferases that synthesize the O polysaccharide, 
and enzymes required for export processes (5). The diversity of the O-antigens also 
comes from the diversity of the rfb loci. Unlike biosynthesis of the core oligosaccharide, 
the repeating unit structures of O polysaccharides are assembled on the membrane-
bound carrier, undecaprenyl phosphate (und-P) (5). O polysaccharides are synthesized 
from sugar nucleotides by glycosyltransferase enzymes that are often soluble or 
periplasmic membrane proteins, indicating that assembly of lipid-linked O-repeat units 
occurs at the inner face of the cytoplasmic membrane (5). However, O polysaccharides 
are transferred from the carrier lipid and ligated to lipid A-core at the periplasmic leaflet 
of the inner membrane (70). There are three known pathways for O polysaccharide 
biosynthesis: Wzy-dependent (71), ABC-transporter dependent, and synthase-
dependent (5). In S. typhimurium and several other species, the biosynthesis of O 
oligosaccharide is Wzy-dependent pathway (Figure 9). The corresponding gene and 
gene products have been identified in the process (72). The synthesized O-antigen 
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repeat units are flipped by Wzx and polymerized by Wzy, with the length controlled by 
Wzz (Figure 9). The ABC-Transporter-Dependent pathway is confined to linear O 
polysaccharide structures and involves chain extension by processive addition of 
glycosyl residues to the nonreducing terminus of the und-PP-linked growing chain (5). 
The O polysaccharides biosynthesis process is initiated by WecA resulting in und-PP-
GlcNAc product as a primer for chain extension (5). The involvement of WecA is well 
established for the polymannose O polymers of E. coli O8, O9, and O9a and their 
structural counterparts in K. pneumonia O5 and O3 (5). In the next step in biosynthesis, 
an O polysaccharide specific glycosyl transferase adds the adaptor between the und-
PP-GlcNAc primer and the repeat unit domain and commits the lipid intermediate to 
the chain extension pathway (5). As with the WecA-mediated transfer, this reaction 
occurs only once per chain, and the residue is confirmed in the linkage regions for K. 
pneumonia O3 and O5 LPS (73). In the biosynthesis of D-galactan I, the corresponding 
process is mediated by the double-functional galactosyl transferase, WbbO. Both 
activities of WbbO are involved in formation of the adaptor, but one also participates 
in subsequent chain extension reactions (74,75). In the chain extension step, the repeat 
unit is assembled by transfer of residues to the nonreducing terminus of the und-PP-
linked acceptor in sequence (76,77). Following polymerization, surface assembly 
requires an ABC transporter (Wzm and Wzt complex) encoded by the O polysaccharide 
biosynthesis cluster Figure 10. The ABC-transport-dependent pathway does not have a 
Wzz chain-length determinant, yet S-LPS in bacteria with this pathway do exhibit 
strain-specific model distributions, which requires a termination mechanism to control 
the chain length (78).  
For the synthase dependent O polysaccharide biosynthesis, synthases are glycosyl 
transferases that have the capacity to synthesize polymers within a single polypeptide 
(5). The plasmid-encoded O:54 antigen of S. typhimurium Borreze is currently the only 
known example of a synthase-dependent O polysaccharide (67,79,80). Synthesis of the 
poly-N-acetylmannosamine homopolymer that comprises the O:54 antigen is initiated 
by WecA (Figure 11). The first ManNAc residue commits the und-PP-GlcNAc primer 
to O:54 biosynthesis and is transferred by the nonprocessive ManNAc transferase 
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WbbE (81). These first two steps resembles those of the ABC-transporter-dependent 
process. The second transferase, WbbF, is a member of the HasA family of enzymes, 
and it is proposed that this enzyme performs the chain-extension steps. Similar to the 
ABC-transporter– dependent pathway, the product of the synthase pathway is ligated 
to rough LPS by ligase (67).  
The impact of nonstoichiometric substitutions on O antigenicity is widely recognized. 
The phenomenon is well studied in S. typhimurium and S. flexneri, where additions of 
acetyl groups or glucose residues create novel O factors. The oafA gene product 
encodes the O-acetyltransferase conferring O:5 specificity in S. typhimurium(82). Other 
well-characterized O-acetyltransferases include Oac, encoded by the S. flexneri 
seroconverting bacteriophage SF6 (83), and the O-acetyltransferase carried by P. 
aeruginosa bacteriophage D3 (84). The modifications on the O antigens usually 
involves in Wzy-dependent pathway, but there is evidence for similar and often 
nonstoichiometric glycosylation and O-acetylation modifications in ABC-transporter 
pathways too (85-89). 
 
Figure 9 Biosynthesis and assembly of O-antigen in a Wzy-dependent pathway (5) 
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Upper panel shows the sequence of reactions involved in the formation of the 
O-antigen repeat units and their polymerization in S. typhimurium. The 
individual glycosyl transferase enzymes are identified in green boxes. Lower 
panel shows a model for the polymerization of O-antigen. Individual repeat units 
are flipped across the membrane by a process involving Wzx (yellow). These 
intermediates provide the substrates for the putative polymerase, Wzy (blue), 
acting in the periplasm. Chain extension occurs at the reducing terminus with 
the nascent chain being transferred from its undecaprenyl carrier to the 
nonreducing terminus of the “new” O-antigen repeat unit. The chain length is 
determined by Wzz (blue). The polymer is then ligated to lipid A-core and 
mature LPS is translocated to the outer membrane by LptB2FG. 
 
Figure 10 Biosynthesis and assembly of O-antigen in an ABC-transporter-dependent 
pathway (5). 
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Upper panel shows the predicted structures of undecaprenyl-linked 
intermediates in the biosynthesis of the O9 O-antigen of E. coli and the D-
galactan I polymer found in several serotypes of K. pneumoniae. The glycosyl 
transferase enzymes involved in each step are indicated below the structures. 
Biosynthesis is broken down into the formation of a common primer (shown in 
red), addition of an adaptor region, chain extension of the repeat unit, and 
addition of a chain terminator. In the O9 O-antigen structure, the chain is 
thought to be terminated by addition of 3-O-methylmannose, but the enzyme 
responsible has not been identified. Chain elongation occurs by glycosyl 
transfer to the nonreducing terminus. Several enzymes in these pathways are 
bifunctional. In the case of the galactosyl transferase WbbO, both of its activities 
are required for adaptor synthesis, but only one (WbbO2) participates in chain 
extension. The lower panel provides a model for the transmembrane assembly 
system. The glycosyl transferases are shown in green. The ABC-transporter 
formed by Wzm and Wzt is required for transfer of the undecaprenyl-linked 
polymer to the periplasmic face of the membrane, where it is ligated to lipid A-
core and translocated to the outer membrane. Within the nascent polymer, the 
primer/adaptor is identified by the red hexagon, the residues of the repeating-
unit domain by black circles, and the chain terminator by the blank hexagon. 
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Figure 11 Biosynthesis and assembly of O polysaccharides in a synthase-dependent 
Pathway (5) 
The only current example is the plasmid-encoded O:54 O-antigen of S. 
typhimurium Borreze. Upper panel shows the predicted structure of the 
undecaprenyl-linked intermediate. The primer is made by WecA. The WbbE 
enzyme then adds a single ManNAc residue as an adaptor. The synthase 
(WbbF) is then required for chain extension, generating a repeat unit domain 
with alternating β(1,3) and β(1,4) linkages. Growth is at the nonreducing 
terminus. Lower panel shows a model for the transmembrane assembly 
process, with glycosyl transferases identified in green and putative transport 
functions in yellow. The intermediate polymer is then ligated to lipid A-core 
oligosaccharide and translocated to the outer membrane. 
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1.1.7 The translocation of LPS from inner membrane to outer membrane 
After the biosynthesis of the core oligosaccharide, the lipid A-core ( called rough LPS 
in the following text) would be flipped from the cytoplasmic leaflet to the periplasmic 
leaflet by MsbA as described above (27,46). The completion of the S-LPS molecule 
involves the addition of O-antigen to the rough LPS, where it happened at the 
periplasmic face of the cytoplasmic membrane by the putative ligase WaaL (60).  
Seven proteins, lipopolysaccharide transporter (Lpt) A-G, have been identified to form 
an LPS transport pathway to transport LPS from the periplasmic leaflet of the IM to the 
OM outer leaflet (29,90-94). And the translocation process does not discriminate 
between LPS with different O antigen composition or length (95). Firstly, the LPS is 
extracted by LptB2FGC complex from the periplasmic leaflet of the IM with the energy 
from ATP hydrolysis by LptB and is then transported to LptA, an oligomerised 
periplasmic chaperon (28,96). There is evidence that LptA interacts with LptC in a head 
to tail fashion (97), which suggests that LPS is passed by LptC to LptA then passed to 
the LptD/E complex and finally inserted into OM outer leaflet (98-103). Structural and 
functional studies of LptD/E have been completed previously (29,90,104-108). The 
LptA and LptC periplasm bridge has been thoroughly studied during 2008-2014 
(97,109-112). Until today, the whole LPS transporting system still keeps one unsolved 
mystery that is LptB2FGC machinery (113). Works at Harvard University and 
University of Tokyo have already identified and purified by the inner membrane 
LptB2FGC complex in 2008 and 2009 (114,115). In this study, we have generated new 
constructs that produce better protein than them, which greatly helped with the 
crystallography studies.  
However the mechanism of LPS extraction and transporting to LptA by the LptB2FGC 
complex remains unknown. More importantly, different from other ABC (ATP Binding 
Cassette) transporters, the IM protein ABC transporter complex LptB2FGC does not 
transport substrate across the membrane, instead, it extracts the substrate laterally from 
the periplasmic side of the IM and transport it to the periplasmic chaperon LptA (28). 
This unusual transporting path indicates that the LptB2FGC may adopt a special 
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machinery to laterally extract and vertically transport LPS. This project mainly focused 
on the structural and functional studies of the mechanism of how LPS is laterally 
extracted by LptB2FGC complex and further delivered to LptA. It has been reported 
that LptB is an ATPase from the ATP-binding cassette protein (ABC) LptB2FG 
(28,115). LptB2FGC consist of LptB: LptF: LptG: LptC at molar ratio 2:1:1:1 (115). 
Within LptB2FGC, LptC is an inner membrane anchored protein, which binds to 
LptB2FG (a typical ABC transporter) forming LptB2FGC complex. 
 
1.1.8 Bacterial ATP-binding cassette (ABC) transporter 
The ATP-binding cassette (ABC) transporters form a superfamily in both prokaryotes 
and eukaryotes, which couples the energy from ATP hydrolysis to the translocation of 
substrates across a membrane (116). Their substrates include polypeptides, sugars, 
lipids, other hydrophobic compounds, and amino acids (116). All known eukaryotic 
ABC transporters are exporters while the majority of prokaryotic ABC transporters act 
as importers. In this Chapter, the LptB2FGC protein complex transports LPS from the 
lateral periplasmic leaflet of the IM to the periplasmic LptA protein, representing a 
different type of ABC exporter indicative of a novel subfamily. 
The archetypal ABC transporter is made up of four core domains: two hydrophobic 
transmembrane domains (TMDs), and two nucleotide-binding domains (NBDs). These 
can be arranged in a variety of topologies (117). The TMDs consist of multiple 
transmembrane α-helices which span across the lipid bilayer and form the binding 
site/path for substrates. It is speculated that the TMDs may possess one or more pairs 
of high affinity and low affinity binding sites, with substrate transferring from one to 
the other after entering the transporter (118). There are 48 ABC transporters in humans 
and 80 in the E. coli (119). The ABC transporter family is currently further divided into 
22 subfamilies of prokaryotic importers, 24 subfamily of prokaryotic exporters, and 10 
subfamilies of eukaryotic proteins. Despite the relatively high diversity in the TMDs, 
25%-30% sequence identity is shared through most of the NBDs in ABC transporter 
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superfamily, suggesting a similar mechanism for utilising of ATP power to drive the 
machinery.  
In the bacterial uptake systems, the TMDs of bacterial ABC importers typically interact 
with a periplasmic binding domain/protein, which delivers the substrate afterwards and 
ensures specificity. These binding protein-dependent transporters take up a wide variety 
of substrates, range from small sugars, amino acids, anions, iron chelatros vitamin B12 
and etc. In Gram-negative bacteria, small substrates enter the periplasm via diffusion 
through the outer membrane OMP porins (120). Large compounds, such as vitamin B12 
and iron-siderophore complexes, are transported across the outer membrane through 
high-affinity transporters by consuming energy from electrochemical gradient across 
the cytoplasmic membrane (121). A typical example of this kind of domain/protein is 
in the MalFGK2 transporter which transport maltose from the periplasm to cytoplasm 
(122). The periplasmic protein MBP usually had low affinity with MalFGK2 
transporter, however when the binding affinity of MBP with MalFGK2 transporter 
increased significantly when ADP vanadate (a kind of ATP mimic) was trapped inside 
the NBDs of MalFGK2 transporter (122). This kind of mechanism allow the periplasmic 
protein to search for substrate and promotes the efficiency of substrate transporting. 
ABC transporters also functions in efflux mode in some cases, including surface 
components of the bacterial cell (such as capsular polysaccharides, 
lipopolysaccharides, and techoic acid), proteins involved in bacterial pathogenesis 
(such as hemolysin, heme-binding protein, and alkaline protease), peptide antibiotics, 
heme, drugs and siderophores (123). In this cases periplasmic protein/domain usually 
fuse with the TMDs. As an example, the inner membrane ABC tranporter HlyB secret 
HlyA with an inner membrane protein HlyD (124) and an outer membrane facilitator 
TolC (125). TolC forms a channel spanning both outer membrane and the periplasm of 
E. coli (126,127). Both TMDs and NBDs of HlyB and HylD are responsible for 
substrate recognition. Following the recognition, ABC transporter HlyB presumably 
transport the unfolded HlyA across the inner membrane (128-131) and into the tunnel 
formed by TolC.  
The NBDs are intracellular, water soluble subunits which drive the whole machinery 
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transporting substrate by binding and hydrolysing of ATP. ATP hydrolysis is thought to 
drive a conformational change in the NBDs which propagate to the TMDs resulting in 
an energy consumable substrate translocation. Unlike TMDs, the NBDs are highly 
conserved, suggesting their universal role in powering the transport process. The 
structure of a NBD monomer can be divided into two subdomains: a larger RecA-like 
subdomain consisting of two β-sheets and six α-helices and a smaller helical subdomain 
formed by three to four α-helices (119). They are comprised of an ATP binding cassette 
domain, which contains a Walker A and Walker B motif, the Signature sequence (C 
motif) and several possible functional sites which together defines the ABC transporter. 
The Walker A and B motifs are supposed to bind phosphates of ATP and the Mg2+ ion 
when ATP binds in the NBDs (Figure 12, Figure 24 and Table 1). The Walker A motif, 
also known as the P loop, follows β-strand 3 and forms a loop that binds to the 
phosphates of ATP or ADP. The aspartic acid residue in Walker B coordinates the Mg2+ 
ion in the nucleotide binding through H2O (132-134). A glutamic acid residue binds to 
the attacking water molecule and the Mg2+ ion (135,136). This glutamic acid residue is 
the catalytic base for hydrolysis functionality. In LptB E163 is the catalytic site. The Q 
loop, also known as the lid (137), contains a glutamine residue that binds to the Mg2+ 
ion and attacking water (134,135). The structure of the Q loop is part of the Rec-like 
domain and appears to be highly flexible (119). The H loop following the β-strand 8 is 
referred to as a switch and also contains conserved histidine residue that interact with 
γ-phosphate of ATP (135,138)  (Figure 2). The signature motif is also named as 
LSGGQ motif, linker peptide or C motif. It has been used to identify ABC transporter 
and is the only major highly conserved motif that does not have direct interaction with 
nucleotides in the monomer structure (119).  
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Figure 12 E. coli MalK structure in ATP bound form (119). 
MalK is the NBD domain of the MalFGK2 ABC transporter that is responsible 
for maltose transport (a) Stereo view of the monomer E. coli MalK in ATP bound 
form. (b) The homodimer of MalK, viewed down the local twofold axis. The 
RecA-like subdomain is green, and the helical subdomain is cyan. Different 
colors further distinguish the conserved segments: Walker A motif (red), 
LSGGQ motif (magenta), Walker B motif (blue), and the Q loop (yellow). The 
ATP is represented in ball-and-stick model [O atom (red), N atom (blue)]. (c) 
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Schematic diagram of the interaction between one of the two ATPs bound to 
the homodimer. Black lines represent van der Waals contacts, and blue lines 
correspond to hydrogen bonds and salt bridges. (138).  
 
 
Motif 
Consensus 
sequence 
 
Function 
 
Referencing structures 
Walker A or P loop GXXGXGKST ATP binding HisP, MJ0789, MJ1267, 
Rad50, TAP1, GlcV, MalK 
Q loop or lid Q a. TM subunit 
interacion 
a. BtuCD 
  b. Q H-bond to 
Mg2+ 
b. MJ0796 (E171Q), GlcV-
ADP 
  c. Binding to the 
attacking water 
c. MJ0796 (E171Q) 
LSGGQ or linker peptide 
or signature motif 
LSGGQXQR ATP binding  Rad50, MJ0796 (E171Q), 
MalK 
Walker B hhhhD D makes a water-
bridged contact 
with Mg2+ 
GlcV (Mg2+ADP, 
Mg2+AMP-PNP), MJ1267 
(Mg2+ADP) MJ0796 
(Mg2+ADP) 
 E following 
Walker B 
a.Binds to 
attacking 
water 
a. MJ0796 (E171Q) 
  b.Binds to Mg2+ 
through a water 
b. GlcV (Mg2+ADP, 
Mg2+AMP-PNP) 
H motif or switch 
region 
H His H-bond to γ-
phosphate 
MJ0796 (E171Q), MalK 
Table 1 Function of conserved motifs in the nucleotide-binding domain NBDs 
This table described the conserved motifs in the NBDs of the ABC transporter, 
references for the structure mentioned above are: HisP (139) , MJ0796 (132), 
MJ1267 (133), Rad50 (138), TAP1 (140), GlcV (141), MalK (138), BtuCD (142), 
MJ0796 (E171Q) (135). 
 
40 
 
1.2 METHODS AND MATERIALS  
1.2.1 LptB2FG/LpB2FGC complex plasmids generation 
In order to screen for the best expression level and stability of LptB2FG/LptB2FGC 
from different strains, I have generated constructs for 9 species LptB2FGC in total, 
including E. coli K12, Salmonella typhimurium LT2, Shigella flexneri 2a, Klebsiella 
pneumoniae, Enterobacter aerogenes, Vibrio cholera, Acinetobacter baumannii, 
Neisseria gonorrhoeae, Citrobacter freundii during these 3 years using different 
methods and vectors. We finally focused on Shigella flexneri 2a and Klebsiella 
pneumoniae LptB2FG/LptB2FGC, of which one had the highest expression level and 
the other one had a unique SDS-PAGE pattern, respectively. To generate the most 
simplified, modified and expression-level qualified constructs, we amplified E. coli, S. 
flexneri 2a and K. pneumoniae lptCAB and lptFG fragments respectively using primers 
(see Table 11) with restriction enzyme sites EcoR I/ Kpn I for lptCAB fragments and 
Kpn I/ Xba I for lptFG fragments. PCR reaction mixtures were prepared as per Table 2 
and PCR program was set according to Table 3 
 
Component for 25 µl reaction system 
5× Q5 Reaction Buffer 5 µl 
10 mM dNTPs 0.5 µl 
10 µM Forward Primer 1.25 µl 
10 µM Reverse Primer 1.25 µl 
Template DNA variable 
Q5 High-Fidelity DNA Polymerase 0.25 µl 
Nuclease-Free Water to 25 µl 
Table 2 PCR reaction component 
This is a general PCR reaction mixture preparation recipe. All the PCR 
reactions throughout this thesis resemble this one with slight changes on the 
volumes of some components. For multi-sample PCR, a Master Mix (a mixture 
of shared component of all reactions) would usually be prepared and divided 
into separated tubes to speed up the preparation procedure. dNTPs are bought 
from ThermoFisher Scientifc. Q5 DNA polymerases and related buffers are 
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bought from NEB Company.  
 
Step Temperature Time 
Initial denaturation 98°C 30 seconds 
 
35 Cycles 
98°C 10 seconds 
68(Tm-5)°C 10 seconds 
72°C 30 seconds/kb 
Final Extension 72°C 10 minutes 
Hold 12°C ∞ 
Table 3 PCR program  
This is the PCR program used here. All the other PCR programs resemble this 
one, and may have some changes on the cycles or annealing temperatures 
depending on different cases. The PCRs are all run on Bio-Rad PCR machine. 
 
The PCR products were loaded into 1% agarose gels supplemented with 0.1% EtBr 
dye, which were run for 30 min at 100 V to check purity and yields. The PCR products 
agarose bands were excised and purified using GeneJET Gel Extraction Kit (Life 
Technologies). 25 µl of purified lptCAB PCR products and 0.5 µg pTRC99a plasmids 
were digested with EcoR I and Kpn I (FD digestion enzyme with Green Buffer) for 25 
min at 37°C. The digested lptCAB fragment and plasmids were purified by 1% agarose 
gel with 0.1% EtBr. The final ligations were performed as Table 4 (Thermo Scientific 
T4 DNA ligase, 5U/µl). 
 
Linear vector DNA 8 ng 
Insert DNA 3 times of vector in molar  
10× T4 DNA Ligase Buffer 1 µl 
T4 DNA Ligase 1 µl 
Nuclease-free Water to 10 µl 
Reaction temperature: room temperature 
Table 4 Ligation mixture component 
This is the ligation mixture recipe for this experiment, other ligations resemble 
this one and may have some changes at the DNA amount or total volume. The 
ligation can happen both at room temperature or 16°C for 3 to 16h. T4 ligase is 
purchased from ThermoFisher Scientifc Company. 
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The ligation reactions were performed at room temperature for 3-4 h or at 4°C 
overnight. 5 µl of the ligation mixture was added into 100µl high efficiency competent 
cell (Home-made Top10) for transformation. The transformation mixture was gently 
tapped in the tube and incubated on ice for 30 min followed by heat shock for 90s at 
42°C using a water bath. 500µl sterilized SOC (Super Optimal broth with Catabolite 
repression) medium was added into the transformation mixture and rocked at 200rpm 
and 37°C for 1 hour. 200µl transformed cells were plated on to LB medium plates that 
contained appropriate antibiotics. Single colonies were picked and inoculated into 10 
ml of LB with 100µg/ml ampicillin, at 37°C 200 rpm overnight shaking. The plasmids 
pTRC99a-lptCAB were purified using GeneJET Plasmid mini prepare Kit (Life 
Technologies) and the clones were verified by double restriction enzymtic digestion 
and DNA sequencing. After the lptCAB fragment was inserted into the pTRC99a vector, 
lptFG was subsequently inserted in the same way and confirmed by sequencing, 
generating pTRC99a-lptBCFG plasmid (LptA was a soluble protein and would not 
affect the membrane protein LptB2FGC complex purification since we separate and 
extract proteins from the membrane fractions, which is insoluble before detergent 
extraction). To generate pTRC99a-lptBFG constructs, deletion mutation method(143) 
was used to delete lptCA fragment off the original pTRC99a-lptBCFG plasmid. Finally, 
lptBCFG/lptBFG genes were cloned into single plasmid, transcribed and expressed into 
a single mRNA polycistron, which was common in prokaryotic cells and could magnify 
the expression level of complexed protein expression. 
 
1.2.2 Functional assay plasmids generation and site direct mutagenesis 
The E.coli LptFG deletion NR1113 strain contains ampicillin resistance and our 
lptBFG-pTRC99C also contains ampicillin resistance gene. In order to select the 
transformtants, I performed resistance gene modification on pTRC99a plasmid and 
related plasmids. The pTRC99a-E.coli-lptBFGC plasmid ampicillin resistant gene was 
replaced by kanamycin resistance gene to generate pTRC99a-KanR-E.coli-lptBFGC 
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using GeneArt® Seamless PLUS Cloning and Assembly Kit with primers listed in 
Table 11. A Flag tag at position 230 for LptF (LptF-230-Flag), plus a c-Myc tag at 228 
for LptG (LptG-228-Myc) or a Flag tag at position 138 for LptF (LptF-138-Flag), plus 
c-Myc tag at 144 for LptG (LptG-144-Myc) were inserted to generate two tagged 
plasmids named lptBF230G228C and lptBF138G144C respectively. This was so that 
the expressed protein LptF and LptG could be detected by appropriate antibodies during 
Western Blotting. These two plasmids and the plasmid pTRC99a-KanR-E.coli-lptBFGC 
were all confirmed to be able to rescue the lethal phenotype of NR1113 strain. The 
lptBF230G228C and lptBF138G144C were later used as the template to generate all 
the mutations. All single or double mutations were generated following Liu`s 
protocol(143). Primers for all the mutations are listed in Table 11 Table 11 Primers used 
in this thesis. All mutations have been confirmed by DNA sequencing. 
 
1.2.3 Expression and purification of lptB2FG/lptB2FGC complex 
Recombinant plasmids pTRC99a-lptBFG/lptBFGC from different species were 
transformed into C43 (DE3) strain (Novagen) respectively for protein complex 
expression. Single colonies of all the transformations were inoculated in 10ml overnight 
culture which was then prepared into 10% glycerol stock for further experiments. The 
glycerol stock was first inoculated into 500 ml LB overnight culture with antibiotic 
(ampicillin 100µg/ml). Then the bacterial cell culture was amplified into 12L LB 
supplemented with antibiotic (ampicillin 100µg/ml) at 37 °C until the optical density 
of the culture measured at a wavelength of 600nm (OD600) reached 0.6-0.8. The co-
expression of LptB, LptF and LptG was induced with 0.1mM isopropyl β-d- 
thiogalactopyranoside (IPTG) for 16 hours at 20°C. Cells were harvested into pellets at 
5,000rpm (JLA8.1000 Beckman) for 15min centrifugation the next day, and re-
suspended in buffer (20 mM Tris-Cl, pH 7.8, and 150 mM NaCl) supplemented with 
cOmplete EDTA-free protease inhibitor tablet (Roche), 1 µg/ml DNase (Sigma-
Aldrich) 100µg/ml lysosome. The cells were broken by passing twice through a cell 
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disrupter at 30,000psi (Constant Systems Ltd). Unbroken cells and cell debris were 
removed by centrifugation at 18,000g for 15 min at 4°C. The cell membrane was then 
pelleted with ultracentrifugation at 100,000g for 1h at 4°C. The membrane pellet was 
solubilized with Extraction Buffer (20 mM Tris-Cl, pH 7.8, 300 mM NaCl and 10 mM 
imidazole) supplemented with 1% (w/v) n-Dodecyl-β-D-Maltopyranoside (DDM) 
(Anatrace) supplemented with cOmplete protease inhibitor(Roche) at room temperature 
for 20 min. The suspension was then ultracentrifuged at 100,000g for 30 min before 
being loaded onto a 5 ml HP HisTrap column (GE HealthCare) and washed with Wash 
Buffer (20 mM Tris-Cl pH 7.8 300 mM NaCl and 60 mM imidazole) supplemented 
with 0.6% (w/v) 5-cyclohexyl-1-pentyl-β-d-maltoside (Cymal-5) (Anatrace), 0.03% 
(w/v) DDM and 0.4% n-nonyl-b-D-maltopyranoside (NM) mixed detergent. The 
LptB2FG/LptB2FGC complex protein were eluted with Elution Buffer (20 mM Tris-Cl, 
pH 7.8, 300 mM NaCl and 300 mM imidazole) with 0.6% (w/v) Cymal-5, 0.03% DDM 
and 0.4% NM. The protein was further purified using size exclusion chromatography 
with a HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare) in 20 mM Tris-
Cl, pH 7.8, 150 mM NaCl, 0.6% (w/v) Cymal-5, 0.03% DDM and 0.04% NM. Protein 
fractions of highest purity were collected and concentrated to 10 - 15 mg/ml using 
100kDa concentrator. 
 
1.2.4 Appropriate detergents screening and selecting of LptB2FG 
From the preview experience and literature reviewing, inner membrane protein 
crystallization relied heavily on a correct choice of detergents. To select the best 
detergents, 1 L of S. flexneri LptB2FG was cultured, whose membrane pellet was 
solubilized in 10 ml Extraction Buffer followed by ultra-centrifugation again to remove 
insoluble debris. Instead of loading all of the supernatant into a single Ni-NTA column, 
the supernatant was evenly distributed into 10 aliquots. One ml aliquots were incubated 
with 50 µl Ni-NTA beads for 15 min and loaded to a spin column. After centrifugation 
at 15,000rpm (12,000g) for 1min at bench top centrifuge to remove the non-binding 
45 
 
supernatant, the 10 columns that contained the Ni-NTA beads, were washed with 
Washing Buffer supplemented with various single detergents of certain concentration 
(see results for details), achieving a detergent-exchange screening. Finally the 10 
samples were eluted with Elution buffer containing their own certain detergent. The 
eluted samples were checked by visible precipitation degree first, then analysed on 
SDS-PAGE. The detergent that could successfully elute LptB2FG and protect the 
complex from precipitation for at least 6 hours were identified as a suitable detergent.  
 
1.2.5 LptB2FG crystallization, optimization and crystal soaking 
LptB2FG complex was successfully purified and crystallized using 1-3 kinds of suitable 
detergent or detergents mixture from all the possible combination. The best crystals 
from the screening were found from (0.1 M Sodium chloride 0.1 M MES 6.5 36 % v/v 
PEG 300) and (0.2 M Sodium acetate trihydrate 0.1 M MES 6.5 28 % v/v PEG 400). 
Crystallization was performed by sitting drop vapour diffusion method using 1 µl 
protein with 1 µl reservoir solution. Less than 3 kinds of single detergent were suitable 
for crystal forming. After the crystals appeared, the crystals optimisation and 
reproducing were attempted by designing and preparing 2-dimension expansions of pH 
and PEG concentration of crystallization conditions. The prepared optimization 
solutions were arrayed in deep well block for storage. The crystallization trails were 
performed at room temperature, 22°C. 
Nucleotides (ATP, ADP, AMP or AMP-PNP) were attempted for co-crystallization with 
the LptB2FG complex. The nucleotides and MgCl2 were prepared into 200mM stock 
solution in ddH2O respectively. Before setting onto crystallization, the LptB2FG 
complex were incubated with nucleotides and MgCl2 at the final concentration of 2.5-
10mM for both of the chemicals for 40-60min on ice.   
For the crystals that had promising resolution for structure determination, the 
anomalous signal data, which was required to determine the substructure, could only 
be collected on crystals containing anomalous signal scattering element. To obtain 
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anomalous signal scattering element incorporated crystals, we soaked crystals in 
different kinds of solutions that contained heavy metal ion or bromide/iodide ion. The 
soaking was performed at a broad range of conditions, from durations of 10 s to 4 h; 
from concentrations of 1mM to 100mM.  
 
1.2.6 LptB2FG Data collection and structure determination 
All datasets were collected at beamline I03, Diamond Light Source, UK. High 
redundancy platinum (potassium tetranitroplatinate (II) K2Pt(NO2)4 soaked crystals) 
SAD data were collected at the platinum L3 edge (1.07226Å) using parameter 
oscillation 0.1°, transmission 10% and image number 7,200 or 9999 for each anomalous 
signal scattering crystal and processed using XIA2 (144) with DIALS (145). XIA2 is 
an expert system for macromolecular crystallography data reduction, which recruit 
existing software to automatically complete data reduction process from images to 
merged structure factor amplitudes. This can automatically identify multi-wedge, multi-
pass and multi-wavelength data sets and includes specific procedures to test for 
crystallographic special cases. With the push towards high efficient crystallography at 
synchrotron beamlines and automation of structure determination, the ability to reduce 
data with auto input fills and without manual operation is an important gap in the 
pipeline (144). DIALS (Diffraction Integration for Advanced Light Sources) is a new 
software project aiming at analysis of crystallographic diffraction images. DIALS 
mainly focuses on versatility and modularity, making best use of CPU and GPU to 
increase speed and accuracy analysis based on a comprehensive physical model (145). 
Several Hg-derivative data were combined together and scaled using AIMLESS (146) 
to amplify anomalous scattering signal (147). AIMLESS is a program scales together 
multiple observations of reflections, and merges multiple observations into an average 
intensities and it is a successor program to SCALA (147). In this case, we put several 
unmerged data processed by XIA2 (144) into AIMLESS (146), which were then 
analysed and merged into a single reflection file (.mtz file). The reason why for merging 
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data from same crystal and even several different crystals was to trying to increase 
anomalous redundancy to increase the anomalous signal to noise ratio. In total, about 
60000 images were merged together to maximum the anomalous signal. SAD data of 
Hg-derivative crystals were collected at its peak wavelength 1.00068Å, using parameter 
oscillation 0.1°, transmission 10% and image number 7,200 or 9999 for each anomalous 
signal scattering crystal and processed using XIA2 (144) with DIALS (145). SAD data 
of selenomethionine incorporated crystals were collected at its peak wavelength 
0.9795Å, using parameter oscillation 0.1°, transmission 10% and image number 7,200 
or 9999 for each anomalous signal scattering crystal and processed using XIA2 (3) with 
DIALS (162). Native data were collected at the wavelength 0.976 Å.  
We observed severe anisotropic problem during X-ray diffraction and data collection 
and was characterized as largely affecting the short axis of the cell with data extending 
to approximately 2.5 Å less along this direction. Anisotropy correction of the raw 
dataset was performed using the STARANISO webserver 
(http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi) with a surface threshold of 
1.2I/σI and approximate vector 0.1a* + 0.6b* + 0.8c*. The selenomethionine crystals 
from S. flexneri belonged to space group I212121 with unit-cell dimensions: a = 105.5 
Å, b = 210.8 Å, c = 258.9 Å and α = β = γ = 90° (the unit cell dimensions may vary a 
little bit between different crystals). All crystals from K. pneumoniae belonged to space 
group P212121 with unit-cell dimensions: a = 110.15 Å, b = 124.53 Å, c = 398.09 Å and 
α = β = γ = 90°. The platinum positions in the Pt-derived K. pneumoniae crystal of the 
I212121 space group were determined by the SAD method using the SHELX (148) suite 
that were successful in locating platinum sites but did not result in a readily 
interpretable map.  
The phase determination of protein crystal X-ray diffraction contains several common 
ways: molecular replacement, experimental phase and density extension. 
In recent experimental phase determination methods, MAD (Multi-wavelength 
Anomalous Diffraction/Dispersion) and SAD (Single-wavelength Anomalous 
Diffraction/Dispersion) are the most widely used and helpful ways to solve phases. The 
atomic scattering factor contains three components: a normal scattering term f0 that is 
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dependent on the Bragg angle and two terms f ’ and f’’ that are not dependent on the 
scattering angle but on wavelength. The f ’ and f’’ of an element represent the anomalous 
scattering that happens at the absorption edge during X-ray crystal diffraction.  
In the MAD method, data were usually collected from a single crystal or crystals at 
several wavelengths (2-4 kinds wavelength) (149), in order to maximize the absorption 
and dispersive effects. Usually, wavelengths are chosen at the absorption peak (γ1), at 
the point of inflection (γ2) on the absorption curve and two remote wavelength (γ3 and 
γ4) (remote data are optional) (Figure 13).  
Single-wavelength anomalous diffraction/dispersion (SAD) is a technique used in X-
ray crystallography that facilitates the determination of the structure of proteins by 
allowing the solution of the phase problem. In contrast to MAD, SAD uses a single 
dataset at a single appropriate wavelength. One advantage of the technique is the 
minimization of time spent in the beam by the crystal, thus reducing potential radiation 
damage to the molecule. Although SAD is called as single-wavelength anomalous 
dispersion, but no dispersive differences are used in this technique since the data are 
collected at a single wavelength. The SAD experiment only provides measurements of 
the anomalous, or Bijvoet, differences ΔF± = |FPH(+)| - | FPH(-)|. These are then used as 
estimates of the heavy-atom contribution to the scattering and enable direct or Patterson 
methods to be used to derive the positions of the heavy-atom substructure (149).  
It is rare that experimental determined phases are sufficiently accurate to give a ready 
to use electron density map. Experimental phase are usually requires further phase 
improvement by density modification. The common techniques used in the density 
modifications contains solvent flattening, solvent flipping, histogram matching and 
noncrystallographic averaging. These methods are encoded into various programs, such 
as DM (150) RESOLVE (151) and CNS (152). The program ARP/wARP is particularly 
useful and performing the placing of atoms into electron density maps followed by 
refinements, model building and update (153). These method requires the data to be at 
least 2.7 Å resolution for extensive automatic interpretation, particularly in side chain 
assignment. Programs like BUCCANEER can work at lower resolution (154). 
SHELXE uses a novel approach on density modification (148). Density modification 
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is a cyclic procedure, involving the back-transformation of the modified electron 
density map to produce the improved phases (149). If native data have been collected 
at higher resolution, the density modification can work beyond the resolution limit of 
the experimental phase data and during cycles in the density modification. The phase 
information can be finally transfer to high resolution data (149). 
In this LptB2FG cases, six data sets from three isomorphous crystals were combined to 
increase the anomalous multiplicity to around 60-fold with a diffraction limit 3.7 Å. 
These steps helped to produce a map where transmembrane helices were visible as well 
as broken density for the LptB domains. Phasing and density modification from this 
modified dataset with PHENIX (155) resulted in a significantly more interpretable map. 
The S. flexneri selenomethionine incorporated crystal LptB2FG data was collected and 
the structure was solved using molecular replacement using the K. pneumoniae 
LptB2FG model. And the anomalous difference Fourier map was calculated with this 
model for registering and validating the amino acids sequence.  
 
 
Figure 13 MAD phasing (149) 
(a) A typical absorption curve for an anomalous scatter element. This kind of 
information can be gained by the Fluoresces Scan on a certain element at the 
Synchrotron before data collection (b) Phase diagram. |FP| is not measured, so 
one of the data sets is chosen as the ‘native’. 
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Two copies of the high resolution structures of LptB (PDB 4QC2) (156) were placed 
into the density at the base of the transmembrane region and adjusted to fit by COOT 
(157). The transmembrane region of LptF and LptG were built using standard helices. 
In addition, the platinum sites are found adjacent to methionine, arginine and histidine 
residues which follows the property for this element. For the sequence registry, we have 
collected sulphur anomalous and mercury-derived crystal anomalous data trying to 
register the amino acids sequence, but they are too noisy to give a good registry. We 
then tried extensively to produce several selenomethionine incorporated crystals of 
LptB2FG from S. flexneri to register amino sequence of LpB2FG structures.  
Final refinement of the model was performed using REFMAC5 rigid body and 
restrained refinement(158). REFMAC5 utilizes different likelihood functions 
depending on the diffraction data, the presence of twinning and the availability of SAD 
experimental diffraction data. To ensure chemical and structural integrity in the refined 
model, REFMAC5 offers several classes of model parameterization. Low resolution 
data refinement can be achieved thanks to low resolution refinement tools such as 
secondary structure restraints, restraints to known homologous structures, automatic 
global and local NCS restraints, ‘jelly-body’ restraints and the use of novel long-range 
restraints on atomic displacement parameters (ADPs). When high-resolution data are 
available, REFMAC5 additionally offers TLS parameterization, fast refinement of 
anisotropic ADPs (Atomic Displacement Parameters). Refinement in the presence of 
twinning is performed in a fully automated fashion. REFMAC5 is a flexible and highly 
optimized refinement package that is ideally suited for refinement across the entire 
resolution spectrum encountered in macromolecular crystallography (159).  
To improve the agreement of the protein structure model with the electron density map, 
refinements are needed which is an important step to adjusting the coordinate of atoms 
that refines the model to fitting better with the diffraction data. After refinement the 
electron density map will be improved and more details can be observed so that a more 
accurate model can be then build. After several rounds of this process, a model that fits 
with the original data best will be generated. 
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The R-factor is a measure of agreement within a structural refinement by measuring the 
difference between current model structure factor amplitude |Fcal| and the observed 
structure factor amplitude |Fobs| from the dataset. 
The R-free is used as an important model quality control and measures the quality of 
the current model according to the entire dataset. It is calculated with a randomly 
selected 5-10% data set, which is not used during refinement.  
Coot (Crystallographic Object-Oriented Toolkit) is for macromolecular model building, 
model completion and validation, particularly suitable for protein modelling using X-
ray data. Coot displays maps and models and allows model manipulations such as 
idealization, real space refinement, manual rotation/translation, rigid-body fitting, 
ligand search, solvation, mutations, rotamers, Ramachandran plots, skeletonization, 
non-crystallographic symmetry and more (157).  
For LptB2FG structure determination, COOT was used at last to fix the errors and adjust 
bond angles to improve Ramachandran plots.  
 
1.2.7 Functional assays and Western blotting analysis 
All single or double mutants were transformed into the E. coli lptFG deletion NR1113 
(114) strain by electroporation. The transformed E. coli cells were grown on LB agar 
plates supplemented with antibiotics (kanamycin 50 µg/ml) and 0.2% L-arabinose at 
37C for 12 h. Single colonies of each transformation were inoculated into 5 ml LB 
medium supplemented with above antibiotics and 0.2% (w/v) L-arabinose and 
incubated by shaking at 200 rpm at 37C for 12 h. Subculture cells were used for 
functional assays. E. coli NR1113 with the empty plasmid pTRC99a-Kan was used as 
a negative control while plasmids lptBF230G228C and lptBF138G144C were used as 
positive controls. For functional assays, NR1113 cells harbouring mutation plasmids or 
control plasmids were harvested, washed 2 times and diluted with sterile LB medium 
to an absorbance OD600 = 0.08 and streaked onto LB agar plates supplemented with 
52 
 
kanamycin 50 µg/ml. Cell growth was recorded after overnight incubation at 37 C. All 
the assays were repeated in triplicate. 
Western blotting was performed to examine the LptB2FG leaky expression levels of 
mutants and controls during the functional assay experiments. 0.5 ml of overnight 
cultures of transformed NR1113 cells with respective control or mutation plasmid were 
inoculated in 50 ml LB supplemented with antibiotics (kanamycin 50 µg/ml) and 0.2% 
L-arabinose at 37C for 6 h and pelleted. The cells were re-suspended in 1 ml buffer 
(20 mM Tris-Cl, pH 7.8, and 150 mM NaCl) supplemented with cOmplete (Roche), 1 
µg/ml DNase (Sigma-Aldrich). The cells were lysed by sonication for 1 min on ice. The 
lysed samples containing whole cell membranes were further solubilized with 
Extraction Buffer supplemented with DDM to a final concentration of 2% using 
rotation for 20 minutes at room temperature. The undissolved debris was removed with 
desktop centrifugation at 13,000g for 10 minutes at 4°C. The supernatant was loaded 
into Ni-NTA agarose beads spin column, washed with 0.05% DDM Wash Buffer and 
eluted with 0.05% DDM Elution Buffer to further purify and concentrate samples. The 
eluted samples were supplemented with 4×SDS–PAGE loading buffer before been 
heating for 10 min at 98 °C. After being centrifuged for 1 min at 13,000g, 10 µl of each 
sample were loaded into 4–12% Bis-Tris Plus Gel (Invitrogen) for SDS–PAGE. The 
proteins were transferred to PVDF membrane using Trans-Blot Turbo Transfer Starter 
System (Bio-Rad) at 20 V for 20 min. The PVDF membranes were blocked in 10 ml 
protein-free T20 (TBS) blocking buffer (Thermo Fisher Scientific) at 4 °C for 1 h. The 
membranes were incubated with 10 mL anti-Flag or anti-Myc monoclonal antibody 
(diluted, 1:300) (Sigma) at room temperature for 1 hour followed by washing with 
PBST (Thermo Fisher Scientific) four times and incubated with IRDye 800CW goat 
anti-mouse IgG (diluted, 1:20,000) (LI-COR) for 30 min. The membrane was washed 
with PBST four times and PBS twice. Images were acquired using LI-COR Odyssey 
(LI-COR).  
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1.2.8 ATPase activity assay 
ATPase activity was performed using ATPase/GTPase Activity Assay Kit (Sigma). C43 
(DE3) cells harbouring lptBFG (or lptBFG mutant) plasmid or LolCDE plasmid were 
cultured in 1L LB medium. The protein over-expression and the cell collection were 
performed using the same protocol as method section 1.2.3 described. Cells were twice 
disrupted by passing through a cell disruptor at 30,000 psi. The membrane fraction was 
harvested by ultra-centrifugation at 100,000g for 30 min and solubilized in 1% DDM 
followed by another ultra-centrifugation. The supernatants of each sample were loaded 
onto a gravity column containing pre-balanced 100µl of Ni2+-NTA beads. The LptB2FG 
or LolCDE complex was washed with 15 column volumes of wash buffer (40mM 
imidazole 20mM Tris-Cl pH8.0 300mM NaCl and 0.05% DDM), and eluted using the 
elution buffer (250mM imidazole, 20mM Tris-Cl pH8.0,300mM NaCl and 0.05% 
DDM).  
The protein concentration of all samples were determined with detergent compatible 
Pierce BCA Protein Assay Kit (Thermo Scientific) according to the manufacture’s 
instruction. Briefly, 2.5µl of purified protein was diluted to 25 µl for the BCA assay. 
Albumin (BSA) was used as standard. 200µl of Working Reagent (made by mixing 
Reagent A and Reagent B at 50:1 volume ratio) was added to each sample and 
incubation at 37°C for 30min. The absorbance at the 562nm was measured and the 
protein concentration of each sample was determined. 
The ATPase activity assay was performed in 96 well plates. 1µl of each sample was 
mixed with 4µl 0.5% DDM TBS (20mM Tris-Cl pH7.8, 150mM NaCl) and 5µl Assay 
buffer (ATPase/GTPase Activity Assay Kit) to make 10µl of ATPase activity assay 
sample. The phosphate standards and blank control for colorimetric detection was 
prepared according to the manufacturer’s instructions of ATPase/GTPase Activity 
Assay Kit (Sigma). 30µl reaction mix (made by 20µl Assay buffer plus 10µl 4mM ATP 
solution) was added into each ATPase activity assay sample. After incubation at room 
temperature for 15min, 200µl reagent (ATPase/GTPase Activity Assay Kit) was added 
into each sample to terminate the reaction and all samples were incubated for additional 
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30min. The absorbance at 600nm was measured. All assays were repeated 6 times. 
ATPase activities of all samples were determined using the mean value of the samples 
according to the linear regression of standards. 
 
1.3 RESULTS  
1.3.1 The LptB2FG and LptB2FGC proteins form stable complexes 
The LptB2FG/LptB2FGC were co-expressed in their own single plasmid in polycistron 
as method described in 1.2.3. LptB2FGC of 9 species were included in the expression 
test during my PhD period. In all the expression plasmids, LptB contained 8×His-tag at 
its C terminus, which was used to purify the whole complex during Ni-NTA 
purification. The detergent DDM was chosen to protect complexes in the species 
expression screening. According to the result of LptB2FGC species screening, LptB 
from all the species could be purified after Ni-NTA purification but only samples of K. 
pneumoniae and S. flexneri had LptF/G bands on SDS-PAGE, compared to the E.coli 
sample control. Based on the screening result, both complexes were successfully 
purified from two species (K. pneumoniae and S. flexneri). The K. pneumoniae 
LptB2FG gel-filtration is shown in Figure 14. LptB2FG/LptB2FGC protein complexes 
tended to aggregate and precipitate. The results shown here were under the best 
combination of detergents (see results part for details) that could stabilize the protein 
complex in solution form. With non-suitable detergents, LptB2FG/LptB2FGC would 
precipitate immediately after being eluted from Ni-NTA column. S. flexneri LptB2FGC 
protein complex was analysed on SDS-PAGE (Figure 15). The SDS-PAGE analysis of 
S. flexneri LptB2FG and K. pneumoniae LptB2FG are shown in Figure 16 and Figure 
17, respectively. Interestingly, the same protein complexes from two species that shared 
sequence identity of over 80% showed different SDS-PAGE patterns. The LptF of K. 
pneumoniae seemed to migrate slower than that of S. flexneri however K. pneumoniae 
LptF had only 1 residue less than the S. flexneri LptF. Of course, S. flexneri LptB2FG 
shared exact same pattern with E.coli LptB2FG on SDS-PAGE. However the highly 
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hydrophobic nature of transmembrane residues would attract extra SDS molecules, 
resulting in membrane proteins migrating at a faster rate than the ladder, which was 
supposed to estimate a protein mass under a similar mass-to-charge ratio. Since LptF 
and LpG each contained 6 transmembrane helices as inner membrane transmembrane 
proteins, the migration rate on SDS-PAGE would be much faster than for a normal 
soluble protein. Some residue differences within LptF or LptG between these two 
species might severely affect the group SDS binding of the transmembrane residues, 
influencing the migration rate of these two proteins. Regardless, LptF of K. pneumoniae 
displayed a strong distinguishable SDS-PAGE pattern from other species in the 
screening, which aroused our interests and K. pneumonia LptB2FG was set as the main 
target to be worked on. 
 
10ml of the sample eluted from the Ni-NTA column were loaded into the HiLoad 
16/600 SUPERDEX 200PG pre-equilibrated column. The LptB2FG protein 
complex from K. pneumoniae was purified with 0.05% DDM 20mM Tric-Cl pH 
7.8 150mM NaCl during the gel-filtration, at 1ml/min and room temperature. The 
first peak at 48 ml is an aggregation peak and will precipitate within several 
hours after being collected in to the deep well block. And the LptB2FG main 
Figure 14 Gel-filtration result of K. pneumoniae LptB2FG  
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soluble peak appeared at 62 ml. The gel-filtration result was further analysed 
on SDS-PAGE. When necessary, the main soluble peak may be harvested for 
further studies (crystallization or biochemistry studies). When using the 
detergents that can stabilize the LptB2FG complex, the gel-filtration results 
would be very similar to this one. 
 
S. flexneri LptB2FGC was purified with 0.05% DDM 20mM Tric-Cl pH 7.8 
150mM NaCl and samples were taken from gel-filtration fractions and analysed 
on SDS-PAGE. The strong bands from top to bottom were LptF, LptG, LptB and 
LptC, respectively. LptF and LptG bands are extremely close to each other and 
hard to separate clearly. 5µl protein samples were mixed with 10µl ddH2O and 
5µl 4×SDS-PAGE Loading buffer. The SDS-PAGE samples were loaded into 
The SDS-PAGE gel used is Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well 
(Thermo Fisher Scientific) after heating on 90°C for 10min. The visualization of 
the bands was achieved by dying the gel in Quick Coomassie Stain (Generon) 
for 15min at room temperature. There are several non-specific bands above or 
below target bands and they are regarded as contamination proteins during 
purification. 
 
Figure 15 S. flexneri LptB2FGC SDS-PAGE analysis from gel-filtration  
116kD 
66kD 
 
45kD 
35kD 
25kD 
18.4kD 
14.4kD 
 
--LptF/G (LptF is the upper one) 
--LptB 
--LptC 
57 
 
 
S. flexneri LptB2FG was purified with 0.05% DDM during the gel-filtration and 
samples were taken from the main peaks of the gel-filtration fractions (C8-D8 
cover volume range from 60-75ml) and analysed on SDS-PAGE. The protein 
bands distribution resembles the Figure 15 except for the absence of LptC. The 
LptF and LptG are still hard to separate and the protein ratio of each component 
of the substrate varies a little bit between the different wells (i.e. LptF/G relative 
amount in C8 is bigger than that in D8), suggesting that the purified proteins 
contains extra LptB besides LptB2FG (LptB-8His). 5µl protein samples mixed 
with 10µl ddH2O and 5µl 4×SDS-PAGE Loading buffer. The SDS-PAGE 
samples were loading into The SDS-PAGE gel used is Bolt™ 4-12% Bis-Tris 
Plus Gels, 12/15-well (Thermo Fisher Scientific) after heating on 90°C for 
10min. The visualization of the bands was achieved by dying the gel in Quick 
Coomassie Stain (Generon) for 15min at room temperature. 
Figure 16 S. flexneri LptB2FG SDS-PAGE analysis from gel-filtration 
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K. pneumoniae LptB2FG was purified with 0.05% DDM and samples were taken 
from gel-filtration fractions and analysed on SDS-PAGE. LptF from K. 
pneumoniae migrated a little bit slower compared to the E. coli one or S. flexneri 
one (Figure 16 and Figure 19) making the pattern of the bands different from 
them. 5µl protein samples mixed with 10µl ddH2O and 5µl 4×SDS-PAGE 
Loading buffer. The SDS-PAGE samples were loading into The SDS-PAGE gel 
used is Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher Scientific) 
after heating on 90°C for 10min. The visualization of the bands was achieved 
by dying the gel in Quick Coomassie Stain (Generon) for 15min at room 
temperature. 
 
1.3.2 Detergent stability screening of the inner membrane protein complexes 
LptB2FG and LptB2FGC. 
Crystallization of membrane proteins depended on the level of homogeneous 
distribution of the target protein in the final solution with little aggregation and high 
purity of target protein. And the choice of correct detergents made an essential 
difference. A good qualified detergent choice should stabilize the target protein at a 
reasonable level, preventing it from forming aggregations while not forming a strong 
micelle that affect crystallization. To find a good detergent, detergent screening was 
performed covering all the available detergents in my lab for LptB2FG and LptB2FGC 
Figure 17 K. pneumoniae LptB2FG SDS-PAGE analysis 
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from E.coli representing all other species LptB2FG/LptB2FG protein complexes (Figure 
18 and Figure 19). According to the SDS-PAGE result, around half of the detergents 
here could protect LptB2FG complex until protein complexes were eluted from Ni-NTA 
column during the detergent screening. However, most of the detergents failed to 
protect them after elution from the column as the eluted protein would precipitate within 
a few minutes in the tube. This precipitation would be more severe if large scale 
purifications were tried with those detergents. All the detergents were used at a 
concentration 2-3 times over normal usage amount. Those detergents that could keep 
the protein complexes from forming precipitates over 6 h were labeled as suitable 
detergents. After the detergents were chosen, K. pneumoniae LptB2FG was purified 
trying different combination of suitable detergents at different concentrations (1 CMC 
to 10 CMC) and set into crystallisation trails if applicable. After several rounds 
purification experiments, Cymal 5 and NM behaved better than others on LptB2FG 
complex protection. Desired aggregation levels were observed and the peak positions 
in gel-filtration of LptB2FG moved 3-4 ml later, compared to the DDM gel-filtration 
result. The SEC gel-filtration was the most efficient and practical way to roughly 
analyse a particle size, the gel-filtration peak position shift under the usage of these two 
detergent signifies a smaller average size of the micelles, implying an easier 
crystallisation. (GE Healthcare Data file 18-1100-52 AF) 
 
Figure 18 SDS-PAGE analysis of E.coli LptB2FGC detergent screening 
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In the detergent screening results of LptB2FG, the amount of the inner 
membrane transmembrane domain (TMD) LptF & LptG bands quality decided 
whether a detergent was able to protect the complex. The supernatant were 
loaded into Ni-NTA columns separately and for each sample they were washed 
with different detergents. The eluted samples with the same detergents as the 
wash detergents were analysed here and also by precipitation observation. 
Lane 1: 0.05% DDM; lane2 0.5% C8E4; lane 3: 0.1% LDAO; lane 4: 1% β-OG; 
lane 5: 0.2% DM; lane 6: 0.06% UDM; lane 7: 0.01% LMNG; lane 8: 0.5% NM; 
lane 9: 0.05% Fos-14; lane 10: 0.3% Cymal 5; lane 11: 0.4% β-NG. The DDM 
detergent was used as a control to ensure that the complex was expressed and 
purified. The LptF/G bands were used to evaluate whether a detergent was 
suitable or not since the 8-His tag was attached to LptB. The lanes without or 
with little LptF/G refers to the unsuitable detergent choices.  
 
In the detergent screening results of LptB2FG, the amount of the inner 
membrane transmembrane domain (TMD) LptF & LptG decided whether a 
detergent was able to protect the complex. The screening result resembled that 
of LptB2FG, but the choices of detergent varied a little. Lane 1: 0.05% DDM; 
lane 2 0.5% C8E4; lane 3: 1% β-OG; lane 4: 0.2% DM; lane 5: 0.06% UDM; lane 
6: 0.01% LMNG; 0.5% DDAO; lane 8: 0.1% LDAO: 0.5% NM; lane 9: 0.3% 
Figure 19 SDS-PAGE analysis of E.coli LptB2FG detergent screening 
           1   2  3  4  5   6  7  8  9  10 
 
116kD 
66kD 
45kD 
35kD 
25kD 
18.4kD 
14.4kD 
 
61 
 
Cymal 5; lane 10 0.2% LAPAO. The DDM detergent was used as a control to 
ensure that the complex was expressed and purified. The LptF/G bands were 
used to evaluate whether a detergent was suitable or not since the 8-His tag 
was attached to LptB. The lanes without or with little LptF/G refers to the 
unsuitable detergent choices. 
 
1.3.3 Crystallization and optimization of LptB2FG protein complex 
After trying DDM, NM and Cymal 5 individually or combined in pairs, crystal hits 
were obtained from our detergents candidates (Figure 20). With correct detergent 
choice, new hits from crystallization screening were obtained, however the resolution 
of the crystals stayed below 6 Å, which is not sufficient to determine the protein’s 
structure. To break this deadlock and improve crystal quality, we optimised the whole 
LptB2FG project at three levels: protein purity; detergent; crystallization. For protein 
purity level, we increased the imidazole concentration during Ni-NTA washing step 
from 30 mM (universal protocol) to 60 mM leading to much higher purity, but also loss 
of half the product of each purification. For detergent, we broke the traditional limit of 
two detergent combination and tried mixing all the suitable detergents in a single 
purification experiment, which luckily did not produce any side effect from normal 
observable range (SDS-PAGE gel-filtration). For the crystallization level optimization, 
extensive optimisation solution were designed and prepared by ourselves or  
purchased from Molecular Dimensions to perform optimization on crystal forming 
conditions (0.1 M Sodium chloride 0.1 M MES 6.5 36 % v/v PEG 300) and (0.2 M 
Sodium acetate trihydrate 0.1 M MES 6.5 28 % v/v PEG 400)  Certain substrates were 
tried to be added into final protein samples before setting onto crystallization (ATP, 
ADP or AMP-PNP & MgCl2) as a kind of optimization method. After the advanced 
optimization of the whole procedure, crystals grown from the optimization well were 
much larger, and the best crystals were diffracted to 4.0 Å which finally made the 
structure determination possible. 
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To determine experimental phase of LptB2FG, the crystals were soaked in 2 mg/ml 
potassium tetranitroplatinate (II) K2Pt(NO2)4 for 4 hours at room temperature.  
 
K. pneumoniae LptB2FG crystallized under detergents combination of 0.6% 
Cymal 5 and 0.05% DDM (20mM Tris-Cl pH8.0 150mM NaCl) at room 
temperature and appeared after 2 weeks, the original crystals could diffract up 
to 6 Å resolution. (0.1 M Sodium chloride 0.1 M MES 6.5 36 % v/v PEG 300) 
 
 
Figure 21 Crystals of the K. pneumoniaem LptB2FG after optimization 
Figure 20 Crystals of the K. pneumoniaem LptB2FG grown from original screening 
100µM 
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K. pneumoniae LptB2FG crystallized under detergents combination of 0.6% 
Cymal 5 and 0.05% DDM with buffer 20mM Tris pH8.0 150mM NaCl at room 
temperature. After optimization, the crystal appear after one week and become 
full size within one month. The size of the optimized crystals were about 
100×100×40 µm3 and the resolutions of these crystals were about 3.6-4.0 Å. 
This image was captured at I03 beamline Diamond Light Source before data 
collection. (0.1 M Sodium chloride 0.1 M MES 6.5 36 % v/v PEG 300) 
 
1.3.4 Nucleotide-free form of the K. pneumoniae LptB2FG transporter 
The crystal structure of the Gram-negative inner membrane LPS ABC transporter 
LpB2FG complex was determined. The substructure was determined from the SAD data 
collected on Pt-derived crystals. After correction and modification the final structure 
was determined at 3.7 Å; residues registration was validated Se-Met (S. flexneri) data 
(Table 5). The anomalous difference Fourier map of Pt-derived data (K. pneumoniae) 
and Se-derived data (S. flexneri) are shown in Figure 22. There were about six platinum 
atoms found per transporter for the initial phasing and structure determination and the 
amino acid sequence registry was completed using the Se-derived data with about 21 
selenium atoms found per transporter. Since the LptB2FG from K. pneumoniae reaches 
higher resolution, the following studies are based on K. pneumoniae LptB2FG structure.  
The LptB2FG complex of K. pneumoniae was co-expressed, purified and crystallised 
using methods described in 1.2.3. The crystals belonged to space group I212121 with the 
cell dimensions a = 105.3, b = 210.5, c = 258.9 and α = β = γ = 90°. There was one 
LptB2FG transporter complex molecule per asymmetric unit. The overall structure of 
LptB2FG covers approximately 86 Å in width and 128 Å in length. (Figure 23). As an 
ABC transporter, four typical domains (two TMDs and two NBDs) are clearly seen in 
the structure. LptF and LptG each contained six transmembrane α-helices, TM1~6F and 
TM1~6G respectively, a periplasmic β-jellyroll domain, three periplasmic loops and a 
pair of cytoplasmic turns. The transmembrane helices of LptF and LptG corresponds to 
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TMDs. LptF and LptG formed a hetero-dimer with a hydrophobic cavity between them 
(Figure 23 and Figure 25). The hydrophobic cavity covers a space of 25 Å in width and 
8 Å in length extending from the IM into the periplasm (Figure 25). The centre 
hydrophobic cavity is predicted to be the LPS extraction site when the LPS 
transportation starts. Additionally, two LptB copies form a homo-dimer in a “V” shape 
at the cytoplasmic face of the TMDs region, sealing the bottom part of the complex. 
The two LptB corresponds to the two NBDs of a typical ABC transporter. The LptB2, 
are in nucleotide free form in the K. pneumoniae LptB2FG complex structure. The 
typical Walker A, Walker B, D loop, Q loop, H loop and Signature motif can be clearly 
identified as in Figure 24. The super imposition of LptB protomer of E. coli (nucleotide 
binding form) with LptB protomor of LptB2FG of K. pneumoniae (nucleotide free form) 
with RMSD of 1.953 over 229 Cα atoms reveals some small conformational changes, 
possibly leading to further conformational changes of the whole LptB2FG complex. 
Apart from TMDs and NBDs, the periplasmic domains of LptB2FG makes the 
transporter special. The periplasmic domains adopt β-jellyroll fold, implying the 
function of the periplasmic domains as part of the LPS transporting bridge in the same 
manner of LptA and LptC (28). Despite the high similarity of the folding manner of the 
periplasmic domains, in our K. pneumoniae LptB2FG structure, the periplasmic 
domains of LptF and LptG lean to one side rather than in a mirror equal position (Figure 
23). The periplasmic domains lean to TM1G-5F side, opening the TM5F-1G side 
(Figure 23). At this position, the hydrophobic cavity and the periplasmic domain of 
LptF forms an ideal path for LPS to pass through (Figure 23). In contrast the opposite 
side is closed and currently impossible for substrate to pass. 
No structural homologues to LptF or LptG were found in the DALI server, suggesting 
that LptF/G represents a previously unreported membrane protein fold. The well-
known ABC transporters MalFGK2 (160), BtuCD-F (161), PglK (162) and MsbA (163) 
transported maltose, vitamin B, lipid-linked oligosaccharide and lipid A 
oligosaccharide across the IM, respectively. However, to our knowledge the LptB2FG 
complex is the first crystal structure of an ABC transporter to translocate a substrate 
laterally from the inner membrane’s outer leaflet to periplasmic domain of another 
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protein (LptC), rather than directly across the IM, making it an example of its family. 
Another similar example is LolCDE (164) which recognizes and extracts lipoproteins 
from the periplasmic side of the IM and passes the substrates to LolA. 
 
 K. pneumoniae 
LptB2FG-Pt 
K. pneumoniae 
LptB2FG-Hg 
K. pneumoniae 
LptBFG-sulfur 
S. flexneri 
LptBFG-SeM 
Data collection     
Resolution (Å) 29.96-3.70 (3.90-
3.70) 
22.99-5.14 (5.27-
5.14) 
29.15-4.23 (4.64-
4.23) 
29.96-6.00(6.61-
6.00) 
Wavelength (Å) 1.07226 1.00068 1.77120 0.9795 
Space Group I212121 I212121 I212121 P212121 
Cell dimensions     
a, b, b (Å) 105.3, 210.5, 
258.9 
100.9, 215.9, 
258.6 
106.9, 212.1, 
260.6 
110.15, 124.53, 
398.09 
α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Completeness (%) 99.8 (99.8) 99.0 (99.3) 97.3 (90.1) 99.2(100) 
I/σ(I) 15.5 (1.7) 6.0 (1.1) 26.4 (7.9) 10.7(1.5) 
Redundancy 120.8 (117.5) 26.2 (27.9) 173.6 (81.8) 19.4(20.2) 
Rmerge (%) 26.2(>100) 40.9(>100) 21.1(72.4) 22.0(>100) 
CC1/2 (%) 100 (94.6) 99.5 (76.0) 100 (99.6) 99.8(84.9) 
Phasing     
Resolution (Å) 29.96-3.7    
Site (Pt) 4    
Figure of merit 0.332    
Refinement     
Resolution (Å) 29.96-3.7    
No. reflections 20311    
Rwork/Rfree 0.29/0.32    
No. atoms 8422    
Ligand/ion 2    
B-factors     
Protein 112.40    
R.m.s deviations     
Bond lengths (Å) 0.009    
Bond angles (°) 1.160    
Ramachandran 
statistics 
    
Allowed (%) 96.8    
Outliers (%) 3.2    
PDB code 5L75    
Table 5 Data collection and structure refinement statistics of K. pneumoniae LptB2FG. 
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Rfactor = Σ|| Fobs|−| Fcal||/Σ|Fobs|, where Fobs and Fcal are observed all 
reflection measured and calculated currently model as structure factors, 
respectively. Rfree is calculated using 5% of total reflections, which is randomly 
selected not used in refinement. 
 
 
Figure 22 Anomalous difference map of K. pneumoniae LptB2FG-Pt and anomalous 
difference map of S. flexneri LptBFG-SeM. 
(a) The platinum derived LptB2FG SAD data from was K. pneumoniae collected 
at 1.07226 Å. The 2Fo-Fc and anomalous difference Fourier map were 
calculated with PHENIX (155). The 2Fo-Fc map was contoured at 1.2σ and 
displayed in grey colour and the anomalous difference Fourier map was 
contoured at 7.0σ in pink colour showing the platinum sites. The Cα trace 
structure of LptB2FG was shown here. LptF, LptG and two LptB are shown in 
cyan, yellow, green and blue respectively. (b) The selenomethionine-derived 
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LptB2FG SAD data from S. flexneri was collected at 0.9795 Å. The anomalous 
difference Fourier map was contoured at 3.0σ showing the registry of amino 
acids sequence registry of LptB2FG structure. The LptB2FG from S. flexneri was 
shown in green cartoon and methionine sites were highlighted in sticks with 
sulphur element coloured in deep yellow. 
 
(A) Cartoon representation of LptB2FG. LptF, LptG and two LptB are shown in 
Figure 23 Crystal structure of LPS transporter LptB2FG from K. pneumoniaem 
Periplasmic domain 
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cyan, yellow, green and blue respectively. (B) 180° rotation view along Y-axis 
relative to left panel. (C) The electrostatic potential map of LptB2FG. There is a 
lateral opening between TM1G and TM5F. Positive potential is labelled in blue 
and negative potential is labelled in red. (D) 180° rotation view along the Y-axis 
relative to the left panel. The lateral opening also opens between TM1F and 
TM5G. 
 
 
Figure 24 Superimposition of LptB structures of the E. coli and K. pneumonae 
LptB of E. coli was only crystallized in presence of nucleotide (ATP, ADP or 
AMP). The ATP-free LptB structure of K. pneumonae was determined. 
Superimposition of structures of E. coli LptB (magenta) (PDB code 4QC2) and 
K. pneumonae LptB (green) with RMSD of 1.953 over 229 Cα atoms is 
presented here. The conformational changes were observed when ATP bound. 
The sequence identity of E. coli LptB and K. pneumonae LptB is 95.85%. The 
conserved and important motifs are labelled out. 
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Figure 25 Electrostatic potential map of the cavity of LptB2FG of K. pneumoniae 
The cavity of LptB2FG, shown in the dotted circular lines (black). The cavity in 
the membrane section is very hydrophobic, while the cavity in the periplasm is 
highly positively charged. This feature may be important for LPS binding, as the 
lipid A of LPS is hydrophobic, while the core oligosaccharide is highly negatively 
charged. (a) The electrostatic potential map of LptF, showing the cavity side 
view. (b) The electrostatic potential map of LptG, showing the cavity side view. 
(c) The electrostatic potential map of the cavity of LptB2FG, showing the cross 
section at the widest point of the cavity. The cavity is about 25 Å in length and 
8 Å in width. The cavity is shown in the circular line (white).  
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1.3.5 Functional assays based on K. pneumoniae LptB2FG complex structure 
Based on the crystal structure of K. pneumoniae LptB2FG complex and conserved 
residues analysis (Figure 26), we could identify some potential pathways of LPS 
extraction and transport by LptB2FG. The TM1-F(G) crossed the IM at a 67°(53°) angle 
while TM1-G crossed the IM at a 67°(53°) angle relative to the membrane plane (Figure 
27). These features resulted in a central cavity in between, which was predicted be an 
entry of LPS. Positively charged residues are required for lipids substrate specific 
binding in other membrane proteins, for example PglK (162). The highly conserved 
residues K34 (TM1G) and R136 (TM3G) are located in the upper cavity of the 
transporter. We hypothesised that the residues K34 and R136 may be involved in LPS 
extraction and transport. Functional assays indeed revealed that double glutamic acid 
substitution K34E/R136E caused cell death (Figure 27). In contrast, LptG residues K40 
and K41 shared low sequence conservation among homologues, and the K40E/K41E 
of LptG substitution caused no impact on cell growth. We also expected that the 
hydrophobic cavity is important for LptB2FG. Highly conserved hydrophobic residues 
F26 and L62 of LptF are located in the central cavity and mutagenesis of these two 
residues to alanine caused severe cell growth deficiency (Figure 27). These data suggest 
that the highly conserved residues in the cavity of LptB2FG are essential for the 
functionality of the complex, possibly involved in forming hydrophobic interaction or 
salt bridge with LPS lipid A or inner core phosphate group. 
Besides the importance of the central hydrophobic cavity of LptB2FG, the periplasmic 
domains of LptF and LptG should also play essential role for LPS transporting. The 
periplasmic domains of LptF and LptG adopt the β-jellyroll fold, which together 
comprised of 10 β-sheets, resembling the folding of the periplasmic domain of LptC, 
LptA and N-terminal domain of LptD, implying the similarity in potential functions as 
well. The periplasmic domains of LptF and LptG were in Y-axis-rotationally opposite 
position Figure 23, with the tunnels of both periplasmic domains connecting to the 
central hydrophobic cavity. These structural features suggests the possibility that the 
periplasmic bridge of LPS transport(165) might start with these two periplasmic 
71 
 
domains. To test it, we introduced the double proline mutations (F_D229P/Q231P, 
F_T225P/R223P, G_G228P/W230P and G_T225P/S223P) to disrupt the extracellular 
exposing β-sheets of LptF or LptG. Functional assays of all these mutants in Figure 29 
showed severe growth deficiency. Western blotting detected leaky expression level of 
LptF and LptG Figure 29. To further study on the residual function of the periplasmic 
β-strands of LptF and LptG. We have also generated single mutants at the C-terminal 
β-strands of LptF periplasmic domain (F_D229P, F_Q231P, F_T225P and F_R223P) 
and at the C-terminal β-strands of LptG periplasmic domain (G_G228P, G_W230P, 
G_T225P and G_S223P). Functional studies showed that all the single proline mutants 
severely impaired cell growth, except F_T225P. Collectively, the periplasmic domain 
of last two β-strands of both LptF and LptG are important for LPS transport. The 
mutations are designed based on the amino acids sequence alignment results and the 
figure shows the structure of K. pneumonia and the mutations are based on the E.coli 
protein sequence. 
 
 
Figure 26 Amino acids sequence alignment of LptF and LptG 
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LptF and LptG amino acids alignment of S. flexneri, K. pneumonia, P. 
aeruginosa and E. coli respectively. The α-helices are labelled as α1-6. The β-
strands are labelled as β1-10. Red boxes show conserved residues.  
 
The colour scheme is the same as in Figure 23. (A) The lateral gate of TM15F-
1G. The residues K40 of TM1-G and S318 of TM5-F forming the contact are 
shown as sphere and stick, respectively. The positively charged and highly 
conserved residues K34 and R136 of LptG are also shown as sphere. (B) The 
lateral gate of TM1F-5G interaction. There are five residual interactions within 
TM1F-5G, these residues are shown in stick. The hydrophobic residues F26 
and L62 of LptF are shown in sphere. The TM1-F(G) crosses the IM  at an 
angle of 67°(53°). (C) Functional assays of the double mutants 
LptG_K34E/R136E, LptG_K40E/K41E and LptF_F26D/L62D in NR1113 lptFG 
Figure 27 The transmembrane domains of LptB2FG and the lateral opening 
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depletion strain. All bacterial cultures were adjusted to an OD600 of 0.5 and 
diluted 1:10 serially. (D) Detection of protein expression level of the samples in 
functional assays. 
 
 
Figure 28 Complementation assays of NR1113 with wild type and mutant LptB2FG 
complexes 
(a) Functional assays of the double proline mutants. All bacterial cultures were 
adjusted to an OD600nm of 0.5 with fresh LB medium, serially diluted 1:10 as 
indicated on the top of the figure and then replica plated in agar plates with (+) 
or without (-) 0.2% L-arabinose. (b) Detection of protein expression levels of 
LptF(Flag)G(Myc) of the positive control, negative control, and the double 
proline mutants by Western blotting. The bacterial cells for Western blotting 
were cultured in the presence of 0.2% L-arabinose to ensure that the 
dysfunctional mutant can grow. 
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The colour scheme is the same as in Figure 23. (A) The transmembrane 
domains of LptB2FG, top view. Both LptF and LptG have six TM segments 
respectively, forming a cavity. (B) The superimposition of LptF and LptG from 
K. pneumoniae. The residues selected for proline substitution are shown in 
sphere. The mutations are designed based on the amino acids sequence 
alignment results (Figure 26) and the figure shows the structure of K. pneumonia 
and the mutations are based on the E.coli protein sequence. (C) Functional 
assays of the single proline mutants of periplasmic domains of LptF and LptG. 
The bacterial cells were diluted to an absorbance of 0.5 at OD600nm as the 
starting bacterial cells for the dilution assays. LptF mutants F_D229P, 
F_Q231P, F_T225P and F_R223P, and LptG mutants G_G228P, G_W230P, 
Figure 29 LptB2FG cavity and the periplasmic domains 
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G_T225P and G_S223P were used in the functional assays. Except F_T225P, 
all single proline mutants severely impaired the cell growth or killed the bacteria. 
(D) Detection of protein expression level of the samples in functional assays. 
 
1.3.6 ATPase activity assay 
To study whether E. coli LptB2F(Flag)G(Myc) is functional in vitro, we purified the 
LptB2FG of E. coli and studied the ATPase activity of Wild type and mutants. The 
purification method is same as method 1.2.3. The LptB_E163A and LptB_K42A 
mutants are supposed to be dysfunctional mutants (166). As result 
LptB2F(Flag)G(Myc) has ATPase activity and LptB mutants showed significant 
ATPase disability. LolCDE is another inner membrane ABC transporter used here as 
control.  
 
 
Figure 30 Purified LptB2FG has ATPase activity. 
Purified E. coli LptBF(Flag)G(Myc) transporter has ATPase activity in vitro. The 
E. coli LptB2FG protein complex with LptB_E163A or LptB_K42A mutation 
76 
 
shows significant lower ATPase activity than that of LptBF(Flag)G(Myc). E. coli 
lipoprotein transporter LolCDE is included in the ATPase activity assay as a 
positive control. The 10-folds increasing of the concentration detergent DDM 
has a small amount affection on the ATPase activity of LptB2FG compared to 
LptB2FG in 0,05% DDM. The data was analysed using one-way ANOVA, n=3; 
P<0.01; graphs show mean±S.E.M. 
 
1.4 CONCLUSION AND DISCUSSION  
The unique composition of LPS of Gram-negative bacteria provides the cells extra 
resistance against various toxic compounds compared to Gram-positive bacteria that 
does not have the LPS and OM system. The biogenesis and transports of LPS has been 
studied as a hot spot throughout the years. This chapter revealed some unknown 
mechanism of the inner membrane ABC transporter LptB2FG by determine the crystal 
structure of LptB2FG from K. pneumoniae, which laterally extracts LPS from the 
periplasmic leaflet of the IM and delivers it to LptC. According to our structure, LptF 
and LptG each contain a coupling helix located within a highly conserved groove of 
LptB, and the coupling helices are playing important roles for the functionality of 
LptB2FG (167,168). The interactions between this residues will transfer the energy of 
ATP hydrolysis from LptB to LptF and LptG, leading to conformational changes that 
are required by LPS extraction and transport. According to our functional assays, the 
lethal phenotypes of the dysfunctional substitutions on the conserved positively charged 
and hydrophobic residues inside the cavity showed that they are important in the 
function of the complex. This cavity are suggested to capture the LPS after extraction. 
Further, the single and double proline mutants reveals the importance of both 
periplasmic domains of LptF and LptG, indicating that both periplasmic domains may 
be involved in the LPS transport pathway. 
However, the most interestingly detailed mechanisms are still in the speculative. The 
ABC transporter motion models describe that an ABC transporter (like PglK (162) or 
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ButCD-F (169)) adopts three conformation states in cycle: taking in the substrate, ATP-
hydrolysis and ADP-released/substrate-transported. If based on our current structure, 
the LPS could only enter the LptB2FG from the TM5F-TM1G side into the cavity then 
get delivered to the periplasmic domain of LptF. However, we speculate that LPS would 
be extracted passively into the hydrophobic centre cavity from both sides of the cavity. 
Then, ATP binding and hydrolysis by LptB brings the LptB dimer closer, resulting in a 
whole conformational change of the complex. The conformational changes is around 
the TM1F-5G and TM5F-1G of the cavity, pushing up the LPS molecule into the 
corresponding side of the periplasmic domain of LptF or LptG. Powered by the 
hydrolysis of ATP, the gate of TM1-5G or TM5F-1G opens and closes alternately, 
resulting both sides of the cavity extract and transport LPS alternately. The alternate 
conformational change is also supposed to affect the periplasm domains. In the structure 
both periplasmic domains lean to one side, opening the pathway of its side. We 
speculate that during conformational change, there should be a state when both 
periplasmic domains lean to the other side and open the other side as a pathway for LPS 
to pass through. In summary, we proposed an alternatively working model for LPS 
extraction and transportation pathway through a six-step cycle (Figure 31). The 
LptB2FG complex is first in a resting-state when the NBDs (LptB2) exists in an open 
state as observed in our structure (nucleotide-free). When ATP binds into NBDs, LPS 
is extracted from the outer leaflet of the IM into the cavity via the lateral gate TM5F-
1G, which induces the dimeric of LptB to move closer. Then, ATP hydrolysis of LptB2 
triggers conformational changes through the coupling helix, causes TM5F and TM1G 
to move closer. The lateral gate TM5F-1G then closes and pushes LPS through the 
cavity to the LptF’s periplasmic domain. Another inner membrane protein LptC 
receives the LPS delivered by LptB2FG and the complex will return back to the resting-
state. Next, the ATP binds to the NBDs again, LPS is extracted alternatively into the 
cavity through TM1F-5G and the ATP hydrolysis triggers the transmembrane helices 
TM1F and TM5G to move closer. Then the closed lateral gate TM1F-5G pushes LPS 
through the cavity to the LptG’ periplasmic domain. Finally, the complex will return 
back again to the resting-state again and start a new cycle. The mechanism we propose 
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here represents one possibility of how LptB2FG uses ATP hydrolysis energy to transport 
LPS in an alternative double channel machinery (Figure 31). 
Our proposed working model can partially be validated with the P. aeruginosa LptB2FG 
crystal structure (5X5Y) (168). We first tried to superimpose LptB2FG from S. flexneri 
and K. pneumoniae and found that they are in the same conformation (Figure 32) with 
RMSD of 0.660 over 1011 Cα atoms. Then we superimposed S. flexneri LptB2FG with 
the P. aeruginosa LptB2FG with RMSD of 2.678 over 884 Cα atoms. According to the 
comparison of LptB2FG, the NBDs keep almost unchanged. The TMDs show some 
translational and rotational shifts of the α-helices by 3-10 Å, mainly around the TM1 
and TM5 of LptF and LptG (Figure 32). The TM1G-5F open wider in our structure, 
while TM1F-5G open wider in P. aeruginosa LptB2FG (Figure 32). This is consistence 
with the difference of the position of the periplasmic domains, which is also the major 
difference. The periplasmic domains of our LptB2FG lean to TM1G-5F side and the 
periplasmic domain of LptF is at the position feasible for LPS transportation. In 
contrast, the periplasmic domains of P. aeruginosa LptB2FG lean to the other side, 
opening the LptG periplasmic domain and making it almost feasible for LPS 
transportation (Figure 32). This differences can be described as the rotational shift of 
the periplasmic domains by about 33.5 Å/22.5 Å for LptF/G at their widest points. It 
appears that our LptB2FG is in a state that LptF is responsible LPS transportation while 
P. aeruginosa LptB2FG is in the opposite state that LptG is responsible for LPS 
transportation. These conformational differences between our LpB2FG and P. 
aeruginosa LptB2FG further supported the alternative LPS transportation working 
model, however the conformation of this working model requires further mutagenesis 
and crosslinking experiments.  
The recognition of LPS is predicted to happen within the cavity. Our mutagenesis 
studies and the recently publish paper (168) suggest that the positively charged residues 
and the hydrophobic residues in the cavity may play important roles (Figure 27, Figure 
28 and Figure 29). The hydrophobic interactions with the lipid A and the salt bridge 
between phosphate group of LPS and the positively charged residues both may be 
important for the recognition of LPS. Other lipids, which may be smaller than LPS, 
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should also enter the cavity. The complex should be able to distinguish between them. 
MsbA could flip both lipid A and lipid A core (46), however the components that make 
up the OM does not have lipid A but only LPS. So, the most possible explanation of the 
selectivity is from the core oligosaccharide of LPS, because the O-antigens share low 
similarity even within a single cell.  
Another interesting issue is the interaction between LptB2FG and LptC, which I have 
tried to avoid mention throughout this chapter. It has been reported that LptB2FG could 
form complex with LptC at 1:1 ratio (1). Everyone who has heard about this project 
supports the thought that LptF and LptG would form a tunnel together and connecting 
to LptC in the similar manner of LptA oligomerization bridge, until we solved the 
structure. According to our structure, it seems that only LptF is responsible for LPS 
transportation, and LptG seems to be a scaffolding domain. Considering the high 
similarity of the folding manner of the periplasmic domain of LptF and LptG, we 
proposed the alternative LPS transportation working model (Figure 31). The only flaws 
of this mechanism is where we should put LptC at the 1:1 ratio with our LptB2FG 
complex. Since LptC and LptA form the LPS trans-periplasm bridge without forming 
a stable complex (28), one explanation of the LptB2FGC complex is that the affinity of 
LptC with LptB2FG is accidently about 50% and the native complex in vivo should be 
LptB2FGC2. The purification steps caused the complex to decompose partially. The 
other explanation is that LpB2FGC is correct and the LptC interact with the periplasmic 
domain of LptF or LptG alternatively in the same pace as the alternation of the 
transportation path switch. The details of the relationship of LptC with LptB2FG worth 
further studies. By using Cryo-EM (Cryo-electron microscopy) techniques, we may 
identify the way LptC in complex with LptB2FG.  
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Figure 31 A proposed working model of LptB2FG. 
This model described the alternative mechanism of LptB2FG transport LPS 
from the lateral gates TM5F-1G and TM1F-5G to the internal cavity and then to 
the periplasmic domains of LptF and LptG. The LptB binds and hydrolyses ATP 
to provide the energy for LPS extraction and transport. The details of this 
working model are discussed in the discussions above. Ra-LPS is used as the 
substrate, smooth LPS is proposed to be transported in the similar manner with 
O-antigen passively dragged in the periplasm. 
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Figure 32 LptB2FG structure comparison between K. pneumoniae, S. flexneri and P. 
aeruginosa (5X5Y) (168). 
LptB2FG structure of S. flexneri is similar to that of P. aeruginosa with a root 
mean squared deviation (RMSD) of 2.678 over 884 Cα atoms. A LPS inner core 
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motif is modelled into the internal cavity, which is sufficiently large to host it. (a) 
Front view of superimposition of LptB2FG structure of S. flexneri and P. 
aeruginosa. Cartoon representation of LptB2FG. Two copy of LptB is shown in 
green and wheat. LptF is shown in dark red colour and LptG is shown in blue 
colour. The LptB2FG structure of P. aeruginosa is shown in yellow. (b) Rotation 
180° along the y-axis relative to the left panel (c) Rotation 90° along the y-axis 
relative to the up panel. The periplasmic domain of LptF of P. aeruginosa is 
rotationally shifted of about 33.5 Å compared to the structure of S. flexneri, 
moving closer to TM5F-1G lateral gate. (d) Rotation 90° along the y-axis relative 
to the up panel. The periplasmic domain of LptG of P. aeruginosa is rotationally 
shifted of about 22.5 Å compared to that of the S. flexneri, moving far away 
from TM1F-5G lateral gate. (e) Front view Front view of superimposition of 
LptB2FG structure of S. flexneri and K. pneumonia with RMSD of 0.660 over 
1011 Cα atoms. The LptB2FG of K. pneumonia is shown in lime colour. (f) 
Rotation 180° along the y-axis relative to the left panel. There is little 
conformational changes between the two LptB2FG structures from S. flexneri 
and K. pneumonia.  
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2 CHAPTER 2 Core oligosaccharide of lipopolysaccharide synthesis enzyme 
WaaB 
2.1 INTRODUCTION   
Lipopolysaccharide (LPS) is an essential component of the outer membrane outer 
leaflet for most of the Gram-negative bacteria viability. LPS contains three component, 
lipid A (the hydrophobic membrane anchor), core oligosaccharide (a nonrepeating 
oligosaccharide) and O-antigen (a polymer of repeating oligosaccharide unit). The core 
oligosaccharide can be further divided into two structural distinct regions: the inner 
core and outer core. Both cores play important roles for the survival and virulence of 
Gram-negative bacteria. 
Among Gram-negative bacteria, S. typhimurium causes serious diseases in humans and 
a wide variety of farm animals (170-172). The effective impermeable outer membrane 
provide resistance against a large number of noxious agents (for example vancomycin), 
making S. typhimurium such a destructive pathogen. While the O-antigen portion of 
LPS has been recognized as an important virulence determinant in the pathogenesis of 
systemic salmonellosis (173-175), recent research suggests that the core 
oligosaccharide of LPS also contributes a lot to the maximum bacterial virulence (176-
179). 
The synthesis of the S. typhimurium LPS outer core region needs the sequential addition 
of glycosyls to a growing polysaccharide chain. The most studies example of LPS core 
oligosaccharide synthesis are E. coli and S. typhimurium. The inner core of the bacteria 
is highly conserved as shown in Figure 8, WaaA add the first two Kdo to lipid A, 
forming Re-LPS (Figure 8). Then WaaC adds one Hep to the product of WaaA (Figure 
8). These three glycosyl residues are essential and conserved in most bacteria. In E. coli 
and S. typhimurium (5), WaaF are responsible for adding another Hep onto the product 
of WaaC (Figure 8), forming the Rd-LPS. At this time, the inner core of LPS has been 
synthesised. The outer core synthesis starts with the participation of WaaG, which add 
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a glucosyl residue onto the inner core of the LPS precursor. Then the product of WaaG 
is added by a glucosyl in E. coli by WaaO or a galactosyl in S. typhimurium by WaaI 
(180) (Figure 33). Then WaaR in E. coli or WaaJ in S. typhimurium transfer another 
glucosyl residues onto the previous products. Side chain glycosyl residues are 
transferred by WaaB onto the product of WaaG. In E. coli K-12, WaaU transfer another 
Hep and N-Acetylglucosamine to the WaaR product while in S. typhimurium WaaK 
transfer only N-Acetylglucosamine to the product of WaaJ at the similar outer core 
position as E. coli K-12. At this step the oligosaccharide of the outer core is fully 
synthesised. There are additional modifications on the core regions which, in some 
species, plays more important roles than the sugar groups. In E. coli and S. typhimurium 
the modifications, as described in 1.1.5, requires the strictly ordered enzymatic event 
by WaaP, WaaQ and WaaY. WaaP is a kinase that adds a phosphate group linked PEtN 
on to the product of WaaC (Figure 8). WaaQ transfers a Hep onto the product of WaaF 
(Figure 8). WaaY adds a phosphate group to the product of WaaQ (Figure 8). At this 
end, the synthesis of the outer core is completed and the combination of outer core, 
inner core and lipid A is calls a Ra-LPS (Figure 4). After being flipped from the IM 
cytoplasmic leaflet into the periplasmic leaflet, Ra-LPS would be ligated with the O-
antigen by WaaL, forming a mature LPS (Figure 9, Figure 10 and Figure 11).  
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Figure 33 E. coli K-12 and S. typhimurium LPS outer core oligosaccharides (180). 
The enzymes proposed to catalyse each glycosylation are shown. The linkages 
among the sugars are indicated (5); all are α linkages except sugars added by 
WaaU from E. coli K12, which are β linkages. The dashed line attached to Hep 
II indicates where the rest of the inner core and lipid A is attached. The location 
at which the O-antigen is attached to the outer core oligosaccharide in dashed 
line.  
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A LPS can be divided into three moieties: lipid A (the membrane anchor), core 
oligosaccharide and O-antigen. The core oligosaccharide can be further divided 
into outer core and inner core. The inner core is highly conserved throughout 
Gram-negative bacteria, while the diversity of outer core is higher. The O-
antigen is highly variable among difference species and even within one single 
cell. 
 
Except WaaY and WaaP, all other Waa proteins mentioned above belonged to glycosyl 
transferses. The genes responsible for the glycosyl transferases are located in the 
rfaGB1J gene cluster (36,181,182). In S. typhimurium the gene product of rfaB, also 
named waaB, is the α1, 6-linked D-galactosyl transferase WaaB. WaaB transfers D-
galactosyl residue from UDP-galactose to the polysaccharide core. The waaB deletion 
mutants lacks the α1, 6-linked D-galactosyl residue of the core LPS. The deficiency of 
the LPS core region leads to attenuation in the virulence of S. typhimurium 
Figure 34 A LPS can be divided into three parts: lipidA, Core and O-antigen. 
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(177,179,182). Further, waaB deletion strain is less tolerant to bile salts, which suggests 
that the glycosyl residue added by WaaB to the core lipopolysaccharide contributes to 
the detergent resistance of S. typhimurium (180,183,184). 
WaaB is one of the glycosyl transferases (GTs) belonging to the GT4 family, that 
contains several enzymes of therapeutic significance. This family contains examples of 
enzymes that not only utilize the nucleotide-sugar donors, but also simple phospho-
sugars and lipid-phospho-sugar donors, hinting at the ancient origin of this family 
(185). The mechanisms of the glycosyl transferase can be categorised into two kinds: 
inverting and retaining (186) (Figure 35). The inverting and retaining mechanism 
depends on whether the stereochemistry of the donor's anomeric bond is retained (α→
α) or inverted (α→β), during the transfer. This allows the categorisation of glycosyl 
transferases as either retaining or inverting enzymes. The inverting mechanism is 
widely understood and acknowledged, while the retaining mechanism is still in debate 
with several kinds of proposed ways of achieving the retaining glycosyl transferase 
(Figure 35) (187). In the inverting mechanism, the conserved residues with carboxylic 
acid group usually serve as the catalyse site and facilitate the glycosyl transfer step. The 
hydrogen oxygen bond in the hydroxyl group of the acceptor is attacked by the 
negatively charged residue with carboxylic acid and the donor carbon and oxygen bond, 
activating the related reaction groups. After electrons moving within these bonds, the 
glycosyl residue is transferred from the donor to the acceptor in an inverting position 
(Figure 35). In the retaining mechanism, there are several kinds of possible mechanisms 
and we would describe the two most popular mechanisms. The reaction group 
activations are similar to the inverting mechanism. One is the double replacement, in 
this mechanism the carboxylic acid residue first accept the glycosyl residue from the 
donor, and then transfer it to the acceptor (Figure 35). The other is the SNI like 
mechanism, in this mechanism the donor release the glycosyl for a short time and the 
acceptor receive the glycosyl residue (Figure 35).  
Sharing the functional similarity with other LPS synthesis-related glycosyl transferases, 
WaaB possess a nucleotide-glycosyl (UDP-galactose for WaaB) binding site, an 
enzyme hydrolysis activity site and a potential sugar-acceptor substrate binding site 
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(intermediate LPS). Those glycosyl transferase matches lots of glycosyl transferase 
within LPS oligosaccharide biosynthesis such as D-glucose-transferase WaaG, the 
structure of which has been reported in 2006 (185). Interestingly, despite the similarity 
between LPS related glycosyl transferases, the highest sequence identity of WaaB, 
compared to all other functional similar glycosyl transferase, is only 17% suggesting 
that WaaB might have some special features. By evaluating the donor of WaaB and the 
product of WaaB, we could find that WaaB catalyse the galactosyl transferase in a 
retaining mechanism, which is in consistent with the GT4 family (Figure 36).  
In this chapter, we present the first X-ray crystal structure of WaaB, providing insight 
into the addition of galactosyl on LPS biosynthesis. Our glycosyl-transferase activity 
assays has determined the UDP-galactose hydrolysis activity centre. 
 
 
Figure 35 Two kinds of glycosyl transferase catalyze mechanism  
Depending on whether the stereochemistry of the donor's anomeric bond is 
inverted or retained during the reacting, enzymes are classified into two kinds 
using different mechanisms. In the inverting mechanism, the negatively 
charged base group usually serve as the catalyse site and facilitate the glycosyl 
transferase step. The hydrogen oxygen bond in the hydroxyl group of the 
acceptor is attacked by the negatively charged residue and the donor carbon 
and oxygen bond, activating the reaction groups. Then, the glycosyl residue is 
transferred from the donor to the acceptor in an inverting position. In the 
retaining mechanism, there are several kinds of possible mechanisms. One is 
the double replacement, in this mechanism the base residue first accept the 
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glycosyl residue from then donor, and then transfer it to the acceptor. The other 
is the SNI like mechanism, in this mechanism the donor release the glycosyl for 
a short time and the acceptor receive the glycosyl residue. The B in the image 
refers to the base, which is negatively charged and usually contain carboxylic 
acid group. The R refers to the rest part of the donor or acceptor except the 
shown reaction groups.  
 
 
Figure 36 WaaB catalyze the galactosyl transferase via the retaining mechanism 
Left panel is the UDP-galactose molecule. The right panel is part of the outer 
core oligosaccharide of S. typhimurium, galactose residue attached to the core 
as branch sugar chain as in Figure 33. Compare the stereochemistry of the 
galactose residue between the donor and acceptor, they are in the same 
orientation without bond inverting, suggesting that the WaaB enzyme catalyse 
this step in a retaining mechanism. Molecules are shown in ball-and-stick model 
[O atom (red), N atom (blue), P atom (orange)] 
  
90 
 
2.2 METHODS AND MATERIALS  
2.2.1 S. typhimurium WaaB gene cloning   
The waaB gene from Salmonella typhimurium LT2, was cloned into an expression 
plasmid pLOU3 (AmpR) with double restriction enzyme digestion site NcoI and 
HindIII. The final construct was able to express the WaaB in a fusion protein form: 
6×Histag-MBP-TEVcleavage site-WaaB. pLOU3 vector is a gift from Prof. Jim 
Naismith the map of this vector is shown in Table 12 
 
2.2.2 S. typhimurium WaaB Expression strain  
The pLOU3 plasmid harboring waaB was transformed into expression strain E. coli 
BL21 (DE3) (Novagene). A single colony was inoculated into 10 ml of LB for overnight 
culture. 20% glycerol (final concentration) was added into the overnight cultured cells 
to prepare a glycerol stock, which was kept in -80°C freezer for further experiments.  
 
2.2.3 Expression and purification of S. typhimurium WaaB  
The glycerol stock (BL21 DE3) containing pLOU3-waaB plasmid) cells was inoculated 
into 500 ml LB overnight culture with 100 µg/ml ampicillin antibiotics. 12L LB 
medium were inoculated from 1:200 of overnight cell culture supplemented with 100 
µg/ml ampicillin. The cells were cultured in a 37°C shaker at 200rpm until the OD600 
reached 0.8-1.0 and the protein expression was induced by adding 0.1mM IPTG final 
concentration of 0.1 mM into the culture for 3-4 h at 37°C 200 rpm. Cell pellet was 
then harvested by centrifugation of 12 L culture at 5,000 rpm (4,300g) for 15 min. 
Followed by re-suspending in Balance buffer (20 mM Tris-Cl, pH 7.8, 300 mM NaCl 
and 10 mM imidazole 10% glycerol cOmplete EDTA-free Protease Inhibitor Cocktail 
Tablet (Roche) 50 µg/ml DNAse I (Sigma) and 100 µg/ml Lysozyme). After that the 
cells were lysed by passing through cell disruptor at 30,000 psi. The unbroken cells and 
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cell debris were removed by centrifugation at 20,000 rpm (40,000g) for 30 min. The 
supernatant was applied to pre-balanced (with Balance buffer) 5 ml HP HisTrap (GE 
Healthcare). The column was washed using Wash buffer which is prepared by adding 
30mM imidazole to the Balance buffer to 30 mM final concentration, and then the 
fusion-protein was eluted by Elution buffer (20 mM Tris-Cl, pH 7.8, 300 mM NaCl, 
300 mM imidazole and 10% glycerol). The fusion protein sample was desalted using a 
pre-equilibrated desalting column (GE Healthcare) with Balance buffer to remove the 
high imidazole concentration. TEV protease was added to the desalted protein at a TEV 
enzyme to protein mass ratio 1:100 and incubated overnight to cleave the MBP together 
with 6×His tag off from the fusion protein at the TEV cleavage site. After cleavage, the 
sample was loaded onto the pre-balanced 5 ml HP HisTrap again to remove the TEV 
protease and the cleaved MBP. During this step, the S. typhimurium WaaB would 
directly go through the column and be collected and concentrated to 5-10 ml. The 
protein was further purified by gel-filtration using pre-equilibrated SEC (HILOAD 
16/600 SUPERDEX 200 PG, GE Healthcare) (with 150mM NaCl and 20mM Tris pH 
7.8). The protein purity was checked on SDS-PAGE and the most pure fractions were 
pooled and concentrated to 5-10 mg/ml for crystallization. 
 
2.2.4 In situ proteolysis of S. typhimurium WaaB 
To increase the possibility of crystal hits during crystallization screening, we tried to 
use proteases to remove the disordered regions and obtain a stable soluble domain after 
purification. We screened seven proteases, Papain (1 mg/ml), Elastase (1 mg/ml), V8 
(2 mg/ml), α-Chymotrypsin (2 mg/ml), Subtilisin (2 mg/ml), Thermolysin (1 mg/ml), 
and Trypsin (2 mg/ml). Firstly, 50 µg of the purified protein was prepared into separate 
tubes and in each tube individual protease at mass ratio 1:100 or 1:50 (protease: protein) 
was added and incubate at room temperature. Samples were taken every 30 min for 
SDS-PAGE analysis to select one or two of the best performing proteases, which would 
be chosen for in situ proteolysis during crystallization. The performance of the 
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proteases was analysed on SDS-PAGE and an ideal choice should exhibit almost single 
strong band on the SDS-PAGE, which should also display a small molecular weight 
shift compared to the non-digested control. 
 
2.2.5 Crystal forming, optimization and chemical soaking of S. typhimurium 
WaaB  
S. typhimurium WaaB crystallization was performed using the sitting drop diffusion 
method with drop size 0.3 µl (sample): 0.3 µl (mother liquid) using the crystallization 
robot Gryphon (Air). The screening solutions were purchased from Hampton research 
and Molecular dimensions (Table 10).  
After crystal appeared, the optimizations were performed by designing and preparing 
2D extension of pH and PEG concentration of crystallization condition (1% tryptone; 
0.001M sodium azide; 0.05 M HEPES pH7.0; 20% w/v PEG 3350), developing several 
5×5 home-made optimization solution in deep well blocks. 
In order to determine the experimental phase of WaaB, which is crucial for structure 
determination and model building, we soaked crystals grown from optimization 
conditions with solutions containing different kinds of anomalous signal scattering 
elements (including Hg, I, Au and etc.).  Crystals were soaked with substrates (UDP-
galactose or UDP) for substrate binding structure determination. Before being flash 
frozen by liquid nitrogen, crystals soaking condition were screened at different 
concentrations, from 1 mM to 500 mM metal ion solution or sodium iodide solution, 
and at different time durations, from 10 s to 24 hour. 
 
2.2.6 Data collection and structure determination of S. typhimurium WaaB 
All crystals from different treatments were flash frozen in liquid nitrogen with certain 
cryoprotectant (0.05 M HEPES pH7.0; 20% w/v PEG 3350 20% glycerol) and kept in 
pucks stored in a dewar, which were both pre-cooled by liquid nitrogen. The crystals 
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were sent to Diamond Light Source for data collection at beamline I02.  
The native crystal data and iodide-derivative data were collected at wavelength 1.82325 
Å, Oscillation 0.1° and 360°. The iodide-derived SAD data were collected at the peak 
wavelength of iodide elements according to the X-ray Anomalous Scattering 
Information (Ethan A Merritt ©1996-2011/ merritt@u.washington.edu / Biomolecular 
Structure Center at UW) and according to the fluorescent signal scan result at I02. The 
original data was processed by Diamond Light Source automatic pipeline (including 
XIA2 (144) with Dials (145)), to generate a MTZ file. The crystals soaked with 100 
mM NaI for 10 min behaved best and the iodide-derived LapB structure were further 
solved by Crank (CCP4i) (188), which was a pipeline that gather lots of programs 
together. Crank is an automatic program that can solve the macromolecular structure of 
SAD, MAD and SIRAS data. Crank interfaces with several crystallographic programs. 
For substructure detections, Crank can interface with CRUNCH2(189) and SHELXD 
(190). For substructure phasing, BP3(191) can be used. For density modification, 
SOLOMON (192), DM(193), SHELXE(194), PARROT, PIRATE (195)and 
RESOLVE(196) can be used. For model building, RESOLVE (197), BUCANEER 
(154) and ARP/wARP (198) are available in CRANK. For refinement ARP/wARP 
(198) and REFMAC5 (199) can be used. To calculate FA values needed for substructure 
detection, SHELXC (200) or AFRO including SFTOOLS and TRUNCTATE can be 
interfaced by CRANK. Also, COOT (157) is available to visualize the map or the model 
if necessary.  
In this case, the substructure of iodide-derived WaaB crystal was determined and 
refined by AFRO/CRUCH2 (148) and BP3 (191,201) respectively, hand determination 
and density modification was complete by SOLOMON (192), finished by model 
building by BUCCHANEER (154). After the Crank pipeline, REFMAC5 and were 
used to perform final refinement. Program COOT (157) was used to fix the rest errors. 
Iodide atom coordinates were removed from coordinates file of the structure to produce 
the primary model for molecular replacement of following structure determination. 
The native data or substrate soaked crystal structure were determined using Molecular 
Replacement PHASER MR (202) (CCP4i) using the primary model and refined by 
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REFMAC5 (158). Bond angle adjusting for Ramachandran plots and final error 
corrections were achieved by COOT (157).  
PHASER is a program for phasing macromolecular crystal structures with maximum 
likelihood methods. Molecular replacement programs always use a 3D atomic model 
obtained from a known structure to solve the crystal structure of an unknown structure. 
By computing the agreement of the measured diffraction data with the computed model, 
the program tells whether a structure is solved. Likelihood measures the agreement of 
the model with the data by using probabilities. For molecular replacement, the ‘model’ 
tested includes not only the structure itself, but also the orientation of the template in 
the unit cell, as well as the sizes of difference sources of errors. In refinement, the error 
can be calculated by comparing the Fob and Fcalc. In molecular replacement, the errors 
are set aside until the replacement problem is resolved. In molecular replacement, the 
components of the structure are treated as rigid bodies that are rotated and translated to 
place them correctly in the unit cell of target unknown structure. These components can 
be proteins, complexes and flexible domains. In PHASER, each type of component that 
is treated as a rigid body referred to an ensemble. For each ensemble, PHASER 
computes a set of statistically-weighted average structure factors, which is used in the 
molecular replacement calculations. In most cases, we use automatically PHASER to 
do molecular replacement. PHASER runs several steps in sequence: anisotropic 
correction, cell content analysis, rotation search, translation search, packing check and 
rigid-body refinement. The anisotropic corrections will remove overall anisotropy from 
the diffraction data. Rotation search is the likelihood-based fast rotation function 
followed by rescoring of the op peaks using rotation likelihood function. Translation 
search is a likelihood-based fast translation function followed by rescoring of the top 
peaks using the translation likelihood function. Packing search is testing for overlaps 
and selecting symmetry-related copies of molecules to create a tightly packed assembly. 
The automated search can search for multiple copies of molecules or multiple kinds of 
molecules and can test multiple space groups as well. After PHASER, the top solution 
would be written into the output coordinates file by default. The MTZ reflection file 
after automate PHASER search contains the data from the input reflection file and new 
95 
 
columns (FC/PHIC, FWT/PHWT, DELFWT/PHDELWT, FOM and 
HLA/HLB/HLC/LD). 
 
2.3 RESULTS  
2.3.1 S. typhimurium WaaB purification  
S. typhimurium WaaB was first purified at a 6×Histag-MBP-TEVcleavagesite-WaaB 
fusion form, which was confirmed by gel-filtration (Figure 37) and SDS-PAGE (Figure 
38). In the Figure 37 the peak B was the fusion protein while the peak C mainly 
consisted of MBP. In Figure 38 the band that was located around 85 kD was the fusion 
protein while the band that appeared at molecular weight of 44 kDa was the MBP which 
is refered to as the peak B in Figure 37. After overnight TEV cleavage, the mixture was 
passed through a Ni-NTA column. The non-tagged WaaB protein went through the Ni-
NTA column, and was then concentrated. The WaaB was further purified by gel-
filtration. The gel-filtration of WaaB showed almost a single peak (Figure 39), which 
was verified on SDS-PAGE as well (Figure 40). 
 
7.5ml fusion WaaB-MBP protein eluted from Ni-NTA column was loaded into 
gel-filtration during first purification to verify the fusion protein expression using 
Figure 37 Gel-filtration of S. typhimurium WaaB-MBP fusion protein. 
A     B    C  
96 
 
buffer (20mM Tris-Cl pH 8.0 300mM NaCl and 10% glycerol) at 1ml/min flow 
rate and room temperature. The SEC column used throughout the thesis was 
(HILOAD 16/600 SUPERDEX 200 PG, GE Healthcare). The peak A was an 
aggregation peak, the peak B was WaaB-MBP fusion protein peak and the peak 
C was MBP peak, which were verified in SDS-PAGE in Figure 38.  This result 
was the first time we purify WaaB. In the following similar repeating 
purifications, the checking of the expression step and removing of imidazole for 
the following TEV protease digestion were achieved via desalting, which is a 
simpler method. 
 
Lanes 1-4 are sample fractions of the peak B of Figure 37 and lane 5-9 were 
from fractions of the peak C. The peak B contained the WaaB-MBP fusion 
protein, while the peak C was mainly made up of MBP. The peak A aggregation 
peak was not analysed here. 5µl samples were mixed with 10µl ddH2O and 5µl 
4×SDS-PAGE Loading buffer. The SDS-PAGE samples were loaded into Bolt™ 
4-12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher Scientific) after heating 
on 90°C for 10min. The visualization of the bands was achieved by dying the 
gel in Quick Coomassie Stain (Generon) for 15min at room temperature 
 
 
 
 
Figure 38 SDS-PAGE analysis of S. typhimurium WaaB-MBP fusion protein.  
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After TEV protease digestion on the fusion protein, the mixture were purified 
through a reverse Ni-NTA column to remove the TEV protease. The flow 
through that contained non-tagged native WaaB was concentrated to 7.5-10ml 
and loaded on to SEC column (HiLoad 16/600 Superdex 200 pg) using buffer 
20mM Tris-Cl pH8.0 and 150mM NaCl. The main peak at 85ml was the WaaB. 
There is a small peak at 75ml, which may correspond to the WaaB-MBP that 
survived during the TEV cleavage and reverse Ni-NTA chromatography 
purification. 
 
Figure 39 Gel-filtration of S. typhimurium WaaB after TEV protease digestion  
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Figure 40 SDS-PAGE analysis of S. typhimurium WaaB.  
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SDS-PAGE samples were taken from the final gel-filtration fractions from Figure 
39 and boiled with 4×reducing SDS-Loading buffer. After finishing all steps of 
purifications, the purity of WaaB was absolutely enough for cystallization. The 
lanes 1-8 were sample from D3, D2, D1, E1, E2, E3, E4 and E5 (volume range 
82ml-95ml). 5µl samples were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE 
Loading buffer. The SDS-PAGE samples were loaded into the SDS-PAGE gel 
after heating on 90°C for 10min. The visualization of the bands was achieved 
by dying the gel in Quick Coomassie Stain (Generon) for 15min at room 
temperature. Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher 
Scientific) 
 
2.3.2 Limited proteolysis of S. typhimurium WaaB  
Besides the normal native purification and crystallization, I also tried limited 
proteolysis to remove possible disordered regions of the protein that might interfere 
with crystal formation of WaaB. According to the results of the 45 min limited 
proteolysis (Figure 41), none of the proteases were treatment showed a desired results. 
They neither destroyed WaaB protein into peptide pieces nor failed to remove any 
residues off WaaB. However, we still believed in trying the non-cleavage protease, 
because these protease mightremovetwo or three flexible residues, which facilitated 
crystal forming. And no visible molecular weight changes could be observed on SDS-
PAGE. (203). 
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Proteolysis screen of S. typhimurium WaaB. Lane 1: α-Chymotrypsin; lane 2: 
Subtilisin; lane 3: Trypsin; lane 4: Thermolysin; lane 5: Elastase; lane 6: Papain; 
lane 7: V8; lane 8: control. All the proteases were used at 1:100 mass ratio of 
protease to S. typhimurium WaaB. The reactions were performed at room 
temperature. SDS-loading buffer was added into every sample after 45 min to 
terminate all the reactions. 5µl samples were mixed with 10µl ddH2O and 5µl 
4×SDS-PAGE Loading buffer. The SDS-PAGE samples were loaded into the 
SDS-PAGE gel after heating on 90°C for 10min. The visualization of the bands 
was achieved by dying the gel in Quick Coomassie Stain (Generon) for 15min 
at room temperature. Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well (Thermo 
Fisher Scientific) 
 
2.3.3 Crystallization of S. typhimurium WaaB 
Native S. typhimurium WaaB crystallization trials were performed using the sitting drop 
diffusion method and Gryphon crystallization robot. The none of the proteases from the 
proteolysis performs satisfactorily enough. The native WaaB crystals were successfully 
grown in a few conditions at room temperature (Figure 42). Some crystals diffracted 
well, with high resolution up to 1.89 Å. Extensively to optimize the crystals by varying 
crystallization conditions had been tried. The crystals were reproducible and had been 
optimized with hand-made 5×5 optimization solutions to produce enough good quality 
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Figure 41 Limited proteolysis screening of S. typhimurium WaaB. 
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crystals for further soaking experiments (Table 6). 
 
Crystal was grown in 1% tryptone; 0.001M sodium azide; 0.05 M HEPES pH7.0; 
20% w/v PEG 3350 at room temperature. The crystals appeared after 1 month. 
Native WaaB protein concentration was 9.7 mg/ml; drop size 0.3ul: 0.3ul vapour 
diffusion sitting drop. 
 
PEG 3350 
w/v 
pH (HEPES) 
0.05 M     pH 
 
16% 
 
18% 
 
20% 
 
22% 
 
24% 
7.4      
7.2      
7.0      
6.8      
6.6      
Table 6 optimization condition array of S. typhimurium WaaB 
The concentration of all other components stayed the same as the original one. 
1% tryptone; 0.001 M sodium azide. ddH2O was used to fill the rest volume to 
1ml of each conditions of the optimization. And the 5×5 solutions were prepared 
into the deep well block. All other home-made optimization conditions are 
similar to this one, we vary the pH and the PEG concentration of the crystal 
growing in most cases. And the optimization sizes vary from 5×5 to 8×12 
depending on the optimization depth. 
Figure 42 The crystal image of S. typhimurium WaaB 
100µM 
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2.3.4 Crystal structure of S. typhimurium WaaB and UDP-WaaB 
The substructure and an initial model of WaaB was determined from iodide anomalous 
scattering SAD data as described in method 2.2.4 and Table 7. The iodide anomalous 
difference Fourier map contoured at 10σ is shown in Figure 43, ten iodide atoms are 
located in the structure. Buccaneer (154) was used to build the initial model. The final 
models were generated by molecular replacement using this initial model as template 
for both apo and UDP bound WaaB high resolution datasets. Refinement and final 
model improvement were performed by REFMAC5 (158) and PHENIX (155).  
The overall crystal structure of WaaB, a galactosyl transferase, adopted a two domain 
“Rossmann-like” (β/α/β) domains, the N-terminal domain (the acceptor substrate 
binding domain) and the C-terminal domain (the donor substrate binding domain), 
which is a typical GT-B fold. (Figure 44). The N-terminal domain comprises residues 
Met1-Val161 and displays seven parallel β-strands sandwiched by six α-helices with 
two helices at one side and four helices at the other side. The C-terminal domain 
contains residues Ala181-Gln358, which consists of six parallel β-strands forming a β-
sheet, six α-helices with three of them at one side and the remaining three at the other 
side of the β-sheet, and an additional two C-terminal α-helices. The first C-terminal α-
helix associates with the C-terminal domain, while the last C-terminal helix (residues 
Asp342- Gln358) joins to the N-terminal domain (Figure 44). Therefore, the N-terminal 
domain and the C-terminal domain are connected by the C-terminal helices and a long 
loop consisting of residues Tyr 162 to Pro180 (Figure 44).  
The structure is consistent with its glycosyl transferase function, which captured the 
potential substrates between these two domains while hydrolyzing UDP-galactose into 
galactosyl residue and then transferred it onto the sugar core part of LPS. Looking into 
the hydrophobic cavity between the C-terminal domain and N-terminal domain, several 
conserved residues form a potential active site. The UDP-bound structure of WaaB also 
confirmed that the cavity should also be responsible for UDP-galactose bound (Figure 
47). Unfortunately, neither of the UDP-galactose soaked crystals nor co-crystallization 
provided us any data that contained galactose or galactosyl molecules inside WaaB. In 
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fact, we did collected crystal diffraction data from UDP-galactose soaking treatment, 
however all those data turned out to be UDP binding conformation rather than the UDP-
galactose bound conformation. This finding suggests that the UDP-galactose hydrolysis 
by WaaB, occurs even inside the crystal.  
 
 S. typhimurium apo 
WaaB 
S. typhimurium UDP-
WaaB 
S. typhimurium 
WaaB NaI (SAD) 
Data collection      
Space group P43212 P43212 P43212 
Cell dimensions    
    a, b, c (Å) 104.27, 104.27, 88.44 104.44, 104.44, 89.64 104.09, 104.09, 89.00 
, ,  ()  90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Wavelength (Å) 1.823 0.979 1.823 
Resolution (Å) 67.64-1.81 (1.85-1.81) 73.85-1.92 (1.97-1.92) 67.64-1.90 (1.95-1.90) 
Rmerge (%) 12.5 (86.3) 16.0(133) 14.5 (192.2) 
CC1/2 (%) 100 (60) 100 (50) 100 (70) 
I /(I) 29.0 (3.1) 16.1 (1.9) 18.5 (1.4) 
Completeness (%) 98.5 (86.2) 99.9 (99.5) 99.8 (97.5) 
Redundancy 60.1(18.2) 23.4 (11.8) 34.7 (18.6) 
Anomalous 
Completeness 
  99.8 (97.6) 
Anomalous 
Redundancy   
  18.1 (9.4) 
Phasing    
Resolution   67.64-1.90 
Site (I)   10 
Figure of merit   0.6828 
Refinement    
Resolution (Å) 67.45-1.81 (1.85-1.81) 73.85-1.92 (1.97-1.92)  
No. reflections 44277 (3879) 38400 (3752) 39073 (2766) 
Rfactor / Rfree 0.2294/0.2591  0.2392/0.2713  
No. atoms    
    Protein 2837 2849  
    Ligand/ion 0 25  
    Water 92 81  
B-factors 29.30 31.00  
    Protein 29.30 30.90  
    Ligand 
    Solvent                            
 
30.00 
49.20 
30.00 
 
R.m.s.deviations    
    Bond lengths 0.008 0.009  
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(Å) 
    Bond angles 
() 
1.34 1.28  
Ramachandran 
statistics 
   
    Allowed (%) 94 96  
    Outliers (%) 1.7 0.56  
PDB code 5N7Z 5N80  
Table 7 Data collection and structure refinement statistics of S. typhimurium WaaB. 
Rfactor = Σ|| Fobs|−| Fcal||/Σ|Fobs|, where Fobs and Fcal are observed all reflection 
measured and calculated currently model as structure factors, respectively. Rfree is 
calculated using 5% of total reflections, which is randomly selected not used in 
refinement. 
 
Figure 43 Anomalous difference Fourier map of iodide derived WaaB 
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The anomalous difference Fourier map of iodide-derived WaaB data was 
calculated using PHENIX (155) and contoured at 10.0σ. The peaks in the 
images represented the iodide atom that were soaked into the crystal of WaaB. 
WaaB structure was shown in cartoon and in green colour.  
 
 
Figure 44 Structure of WaaB 
(a) Cartoon representation of WaaB. WaaB can be divided into N-terminal 
domain and C-terminal domain. UDP is bound at the C-terminal domain (donor 
substrate binding domain). The highly hydrophobic and positively charged 
patch in grey may be the membrane anchor of WaaB. The Fo-Fc map 
contoured at 3.0σ matches the UDP molecule perfectly. LPS related 
biosynthesis glycosyl transferases are predicted to anchor into the IM. The 
highly hydrophobic and positively charged patch is the region we predict to help 
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WaaB get anchored into the IM (b) Topology of WaaB. (c) WaaB residues 
involved in UDP binding. UDP and the shown side chains are in ball-and-stick 
model [O atom (red), N atom (blue), P atom (orange)]. (d) Superimposition of 
structures of the apo WaaB and WaaB in complex with UDP. The overall 
structure of WaaB in complex with UDP is almost identical to the apo structure 
of WaaB with a RMSD of 0.5624 Å over 357 C atoms  
 
2.3.5 Donor substrate and potential receptor substrate binding site 
The UDP molecule has been successfully located in the UDP-WaaB. The UDP 
molecule binds to the C-terminal domain and is located in the cleft formed by the C-
terminal and the N-terminal domains. The uracil of UDP is located in a hydrophobic 
pocket consisting of residues W243, I216, P247 and V186, where the uracil is anchored 
by two hydrogen bonds formed between the uracil and the amide and carbonyl groups 
of Q244. The ribose of UDP is stabilized by two hydrogen bonds with E276 and by 
hydrophobic interactions with T273, while the two phosphate groups form salt bonds 
with the side chains of K195 and R188 (Figure 45 and Figure 47).  
The overall structure of WaaB in complex with UDP is almost identical to the apo 
structure of WaaB with a RMSD of 0.5624 Å over 357 Cα atoms, suggesting that 
binding the donor product UDP does not induce significant conformational changes of 
the apo WaaB structure (Figure 45). The N-terminal domain structure showed a minor 
shift while the C-terminal domain structure remained mostly unchanged to that of the 
apo state. The helix α5 was slightly stretched into a loop and α2 turned from a loop into 
a helix after UDP entered the WaaB structure (Figure 45). Amino acid sequence 
analysis showed that residues W243, P247, V186, Q244, E276, I216, T273, K195 and 
R188 are highly conserved in WaaB (Figure 48), suggesting that these residues play 
important roles in UDP-galactose binding and hydrolysis. 
We tried to compare structures of WaaB in complex with UDP with WaaG in complex 
with UDP-2-deoxy-2-fluoro glucose. WaaG is a UDP-D-glucosyltransferase 
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participating in LPS core oligosaccharide biosynthesis directly upstream of WaaB. 
Although WaaB shares low identity in amino acids sequence with WaaG, the WaaB 
structure shares a high degree similarity to WaaG (Figure 45), with a RMSD of 3.2589 
Å over 358 aligned Ca atoms. By comparing the structures of WaaG in complex with 
UDP-2-fluoro-Glc and WaaB in complex with UDP, we may identify the possible UDP-
glycosyl hydrolysis centre, as well as the different residues needed for the different 
substrate bindings. Superimposition of WaaG and WaaB by overlapping their own 
ligands (Lignalign Pymol) (204), allowed us to identify conserved spatial arrangements 
local to the UDP-sugars. Accordingly, WaaB and WaaG structures share a high degree 
similarity in the C-terminal domain, which is mainly responsible for UDP-glycosyl 
binding (Figure 45). The diphosphate forms salt bridges with K209 and R208. 
However, F13 of WaaG is located in its N-terminal domain and UDP-glucose binding 
requires both the N-terminal and the C-terminal residues of WaaG. This is different 
from that of the WaaB where superimposition of the two structures showed that the 
WaaG’s N-terminal domain is rotated toward to a closing conformation of WaaG (Fig. 
4A). WaaB also forms a pocket as WaaG, but formed by E268, G269, F120, F270, G15, 
and Q194, which may be responsible for galactose binding (Figure 45). These 
differences between WaaB and WaaG for the donor substrate binding sites may be 
important for the selectivity of the donor substrates. To test whether this pocket is 
important, the potential galactose binding site residues E268 and Q194 were selected 
for mutagenesis, where E268 of WaaB is conserved and Q194 of WaaB is highly 
conserved. Galactosyltransferase assays showed that the mutant E268A activity is 
significant reduced (Figure 49), while the mutant Q194A has the same activity as the 
wild type WaaB, indicating that the E268 is critical for the WaaB’s activity.  
The di-phosphates of the UDP binding at the donor substrate binding domain point to a 
groove of the N-terminal domain, the acceptor substrate binding domain. This groove 
is in close proximity to the UDP. We speculate that this groove is the putative acceptor 
substrate binding site for the premature lipopolysaccharide (LPS), Glc-Hep2-1-
dephospho-Kdo2-lipid A (Figure 46). In particular, E17 and G15 of WaaB are absolutely 
conserved in WaaB homologues and occupy the same positions as E31 and G30 of 
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WaaA (Figure 46). The E31 residue is proposed to act as a general base for WaaA, 
suggesting that E17 of WaaB may be important for the WaaB functionality. This groove 
is highly charged, which is ideal for binding the acceptor substrate Glc-Hep2-1-
dephospho-Kdo2-lipid A (Figure 46). The potential acceptor substrate binding groove 
of WaaA is formed by residues E31, S54, L74, P75, D77, E98, E100, W102, R56, R99 
and K121 (Figure 46). Although the two grooves share similarity, they are different in 
term of electrostatic potential (Figure 46).  
 
Figure 45 The Donor substrate binding groove of WaaB 
(a) WaaB and WaaG (2IV7) structures are superimposed over their ligands with 
a RMSD of 3.2589 Å over 358 aligned Ca atoms. (b) The potential galactose 
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binding site of WaaB is identified by the structure superimposition. (c) The 
WaaB electrostatic potential map of the potential donor substrate UDP-
galactose binding site. Substrates and the shown side chains are in ball-and-
stick model [O atom (red), N atom (blue), P atom (orange)] (d) The WaaG 
electrostatic potential map of the donor substrate binding site. Red represents 
negatively charged which blue represents positively charged. 
 
 
Figure 46 The potential acceptor substrate binding groove of WaaB. 
(a) The N-terminal domain of WaaB is the acceptor binding domain. WaaB 
potential acceptor substrate binding groove is highly positively charged. The 
shown side chains are in ball-and-stick model [O atom (red), N atom (blue)] (b) 
WaaA (2XCU) acceptor substrate binding groove. (c) The electrostatic potential 
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map of the potential WaaB acceptor substrate binding grove. (d) The 
electrostatic potential map of WaaA acceptor substrate binding groove. Red 
represents negatively charged which blue represents positively charged. 
 
S. typhimurium WaaB crystal was soaked with 100mM UDP for 60 min at room 
temperature before flash frozen into liquid nitrogen. The extra electron density 
in this map perfectly matched the UDP molecule, and no additional electron 
density was present part the diphosphate. The electron density is the 2Fo-Fc 
map contoured at 1.0σ after refinement with UDP molecule. The residues 
interacting with UDP were shown in sticks and the distances were measured. 
Substrates and the shown side chains are in ball-and-stick model [O atom (red), 
N atom (blue), P atom (orange)]. 
 
2.3.6 S. typhimurium WaaB enzyme activity sites determination 
According to the conserved residue analysis by Consurf (205) and superimposition of 
WaaG and WaaB structure, we focused on several conserved residues that interact with 
UDP or might interact with the UDP-galactose and generated mutants trying to disable 
the enzyme activity of the protein (Figure 48). Those mutants were Q194A, K195A, 
Figure 47 UDP molecule in S. typhimurium WaaB structure at 1.92Å resolution 
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I216A, W243A, E268A, T273A and E276A. After performing an enzyme activity 
determination assay, the result was almost as expected (Figure 49). Wild type WaaB 
represented a positive control activity. The residues Q194, K195, I216, E268, and E276 
are located at the hydrophobic pocket next to the UDP. Mutants Q194A, K195A, I216A, 
E268A, and E276A showed relatively inhibited activity in Figure 49, suggesting that 
the hydrophobic pocked next to the UDP binding site was important and possibly was 
the activity site of WaaB. By locating the dysfunctional mutant residues in WaaB 
structures, E268 and K195 were at the position for performing a galactose recognizing 
and hydrolysis. In contrast, the galactosyl transferase activity of mutant Q194A was 
little impaired, indicating that Q194 might not participated much in the transferase 
activity of WaaB. Interestingly, mutant T273 displayed an extremely higher activity 
even than wild type WaaB (Figure 49).  
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By uploading S. typhimurium WaaB protein sequence into the online conserved 
residue analysis program, Consurf (206), each residues were listed and 
labelled according to its conserved level from ten homologous protein 
sequences. The residues above level 7 were considered as conserved residues 
and could selected for mutagenesis.  
Figure 48 Conserved residue analysis of sequence alignment of S. typhimurium WaaB 
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Figure 49 WaaB mutants UDP-galactosyl transferase relative activity 
Left panel: The UDP-galactose transferase ability of wild type WaaB and its 
mutants were assayed. The concentration of the enzymes formed a gradient 
and the recorded luminescence reading of all the samples represented their 
activity. n = 4. (Work by G.J.A) Right panel: Relative activity of all the mutants 
were calculated using the wild type WaaB as positive control, n = 4. T273A 
mutant showed high activity and was not included in the relative activity graph. 
(Work by G.J.A) 
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2.4 CONCLUSION AND DISCUSSION  
The Gram-negative bacterial double membrane system provides them with extra 
protection from toxic compounds. The asymmetric outer membrane is especially 
important, which is regarded as the source of the unique barrier of Gram-negative 
bacteria (4,5). The difference between the component of the inner leaflet and the outer 
leaflet causes the asymmetry of the OM. While the inner leaflet is composed of GPL 
similar to other membranes, the outer leaflet is made up of a large amphipathic 
lipopolysaccharide (LPS) (207). LPS, distinct from other membrane component, 
consists of three moieties: lipid A, core oligosaccharide and O-antigen (207). The 
biogenesis of LPS is a complicated process. In brief, lipid A is synthesized at the inner 
leaflet of the IM, then glycosyls are added to lipid A to form rough LPS (180). The 
rough LPS is flipped to the periplasmic leaflet of the IM by MsbA (208). In the 
meantime, the O-antigen unit is synthesized at the inner leaflet of the IM as well and is 
flipped to the periplasmic side of the IM by Wzx (209). Finally O-antigen units are 
polymerized by Wzz-Wzy (210) into O-antigen, which is then ligated to rough LPS by 
WaaL (211-215) to form mature LPS. Some of glycosyls on the rough LPS are essential 
for the survival of Gram-negative bacterial cells, such as the Hep and two early Kdo in 
the inner core region. The other glycosyls in the core oligosaccharide region also have 
various special functions contributing to the maintenance of cellular morphology or 
extra resistance against different kinds of toxic molecules. The biosynthesis of the core 
oligosaccharide is a process requiring the co-operation of a number of UDP-glycosyl 
transferases, each of them transfer a glycosyl onto the product of the previous 
transferase producing a precursor for the next glycosyl transferase. Amongst these, 
WaaB transfers a galactose from UDP-galactose onto the intermediate rough LPS 
(180,184,216).  
This project focused on digging into the mechanism of this important step. Through 
crystallizing, X-ray diffraction and data processing of WaaB, we successfully 
determined the first structure of WaaB and WaaB-UDP. WaaB, sharing the features of 
all other glycosyl transferase, is structurally a clamp-shaped molecule, which may be 
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responsible for the WaaB molecule to capture the substrates and facilitate the galactosyl 
transferase. WaaB belongs to the GT-B family and folds into two “Rossmann-like” 
(β/α/β) domains, namely C-terminal domain and N-terminal domain.  Similar to other 
members in the GT-B family, two domains binds donor and acceptor separately. In 
WaaB, C-terminal domain can bind UDP, which is confirmed by the UDP-bound WaaB 
structure (Figure 47), suggesting that the N-terminal domain corresponds to the 
acceptor binding domain.  
Comparing the UDP-galactose (donor) structure and the outer core oligosaccharide 
(acceptor) structure of S. typhimurium, WaaB should catalyse the galactosyl transfer by 
retaining mechanism according to structure superimposition (Figure 45) and conserved 
sequence alignment analysis (Figure 48), we focused on the residues that may form the 
galactosyl transferase activity site. Single residue site direct mutants Q194A, K195A, 
I216A, W243A, E268A, T273A and E276A were generated aiming at dysfunction the 
potential activity site. K195, I216, W243, T273 and E276 formed interactions with UDP 
(Figure 47). According to the superimposition, Q194, K195 and E268 are located next 
to the potential galactosyl-UDP linkage position (Figure 45). However, Q and K are 
positively charged and could not catalyse the UDP-galactose hydrolysis, which usually 
require negatively charged residues. We still generated mutations on it as a negative 
control. Through the galactosyl transferase assay results, WaaB mutants K195A, 
I216A, W243A, E268A, and E276A showed deficiency in the UDP-galactose 
hydrolysis assay (Figure 49). K195 is the key residue of forming interactions with the 
phosphate group of UDP and the mutation K195A would disable the UDP binding thus 
prevent the hydrolysis by WaaB. And residue Q194 is not essential for this activity. 
Further K195 and E268 are at the position to be a galactosyl recognizing or hydrolysis 
residues while the others mainly interact with UDP (Figure 45). In Figure 47, residue 
K195 forms interactions with the β phosphate group of UDP and appears not feasible 
to participate in the hydrolysis when keeping the interactions at same time. The E268 
residue is located perfectly for hydrolysis, its high conservation property enhanced the 
possibility of its catalysing ability (Figure 48). The catalysing site of glycosyl 
transferases are made up of the conserved negatively charged residue, usually glutamic 
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acid, which has a negatively charged carboxylic acid group in the side chain. Thus, we 
propose that the E263 residue is the key residue for the hydrolysis of UDP-galactose 
by WaaB. The negatively charged carboxylic acid group may attack and activate the 
donor and acceptor to initiate the galactose transferase.  
Notably, T273A mutant displays extra activity compared to the wild type WaaB, which 
may be explained in a speculation that the alanine substitution of threonine on 273 
residue position will facilitate the release of UDP, thus speeding up the UDP-galactose 
hydrolysis cycle. Possibly WaaB has a substrate retention mechanism to keep either 
substrates inside the WaaB for a while to ensure the galactosyl transfer rather than 
release the substrates immediately after hydrolysis as the in vitro assay shows. T273 
and E276 both locates around the oxygen atoms of pentose sugar ribose, E276 formed 
interaction with ribose by hydrogen bond using the carboxylic acid end with the 
hydroxyl group of the ribose. The hydroxyl group on the side chain of T273 may form 
hydrogen bond with E276 using hydroxyl group of T273 with carboxylic acid group 
with E273. This interaction may keep E276 in position for capturing the ribose of UDP. 
The recognition and initial capture of UDP is multi-residual selection on the entering 
molecules, particularly V186, R188, Q244, E276 and K195. The T273A mutant loses 
the ability of keeping E276 in position, thus the WaaB is less able to lock UDP within 
it and the releasing of UDP is faster than wild type. However the key residues of 
hydrolysis and UDP recognizing/binding keep unchanged, thus the hydrolysis reaction 
of WaaB stays as usually with the entering and releasing speed of UDP-Gal/UDP 
increased, making WaaB able to hydrolyse more substrate in same time.  
By determining the WaaB crystal structure and studying the WaaB mutation catalytic 
efficiency, we have found the residue E268 that is the catalytic site of WaaB. And we 
have also understood further on how proteins recognize UDP and perform biological 
functions. We also tried to propose the acceptor binding site of WaaB by comparing 
WaaB with other LPS synthesis related glycosyl transferases, and a speculative acceptor 
binding site is found in WaaB. 
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3 CHAPTER 3 Lipopolysaccharide synthesis regulation heat shock protein 
LapB 
3.1 INTRODUCTION  
Gram-negative bacteria cell envelop is made up of three distinct layers: the outer 
membrane (OM), the periplasm peptidoglycan wall, and the inner membrane (IM). The 
OM is an effective relative impermeability barrier to keep out most of the hydrophobic 
molecules and is responsible for the resistance to antibiotics, detergents and dyes (4). 
As has been described in the introduction in 1.1.1, the OM is an asymmetric lipid 
bilayer, of which the outer leaflet is made up by LPS, an essential component for cell 
survival (217). Any perturbations in synthesis, assembly or function of LPS affects 
normal barrier properties of the OM, leading to cell death or cell growth deficiency. 
The two precursors of the LPS are synthesized on the cytoplasmic leaflet of the IM 
which include the O-antigen units and rough LPS.  
The detailed synthesis of lipid A is characterized in E .coli, and here we take it as an 
example to illustrate the biosynthesis pathway of lipid A. The final product of the fatty 
acid membrane anchor chains of LPS is lipid A. The first step of the biosynthesis of 
lipid A is the acylation of the sugar nucleotide UDP-GlcNAc (Figure 50). The enzyme 
for this step is LpxA, which uses the acyl carried protein (ACP) thioester as the donor 
and transfer the acyl chain (β-hydroxymyristate) on to UDP-GlcNAc (218). The active 
centre of LpxA functions as an accurate hydrocarbon ruler. The LpxA incorporation 
affinity of 14-carbon acyl chains is two times higher than 12- or 16- carbon acyl chains 
(219,220). The balance for the acylation of UDP-GlcNAc is important (221). LpxC, a 
zinc metalloenzyme, committed the step of deacetylation of the product of LpxA (222-
226). Following deacetylation, LpxD incorporated another β-hydroxymyristate moiety 
onto the product of LpxC using the same donor as LpxA (40). The sequences of LpxA 
and LpxD are related due to the similar function and similar secondary structures (40). 
UDP-2,3-diacylglucosamine is cleaved at its pyrophosphate bond by LpxH to form 
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lipid X (Figure 50) and a UMP is released (41). LpxB then condensate another UDP-
2,3-diacylglucosamine with lipid X to generate a β,1’-6 linked disaccharide (227,228). 
The kinase, LpxK, then phosphorylates the disaccharide to form lipid IVA (Figure 50) 
(42). WaaA then add two Kdo glycosyl residues on to lipid IVA (43). The last steps of 
lipid A synthesis are adding of lauroyl and myristoyl residues to the distal glucosamine 
unit, resulting in acyloxyacyl moieties (44) (Figure 50), using similar donor as LpxA 
and LpxD. In addition, there is another gene product termed LpxP which function at the 
same site as LpxL in E. coli under cold shock (12°C). Instead of insertion of laurate (C-
12) by LpxL, LpxP inserts palmitoleate (C-16) at the same position (229). Perhaps this 
mechanism can adjust the outer membrane fluidity at low temperature (229).  
There are additional modifications on lipid A with various kinds of moieties, including 
phosphoethanolamine, 4-amino-4-deoxy-L-arabinose (L-Ara4N) and/or palmitate 
groups. The corresponding enzymes are usually latent in E .coli K-12 but can be 
expressed in presence of metavanadate (230). Addition of phosphoethanolamine and L-
Ara4N moieties are induced by exposure to mildly acidic conditions or by mutation on 
activation PmrA transcription factor (231-235). The palmitate modification of lipid A 
is controlled by PhoP/PhoQ system (236,237). S. typhimurium mutants without 
palmitate to their lipid A are more sensitive than wild type to some cationic 
antimicrobial peptides (236). The palmitate is a C-16 chain fatty acid. 
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Figure 50 Biosynthesis of Lipid A in E.coli (5,238). 
All the enzymes participated in synthesis of lipid A and Kdo2-lipid A. KdtA is now 
named as WaaA. Every enzyme completes its step by themselves. ACP: acyl 
carried protein. GlcNAC: N-Acetylglucosamine. GlcN: Glucosamine. 
 
The synthesis of the lipid A is regulated at the deacetylation step catalyzed by LpxC as 
this is the first committed step of the lipid A biosynthetic pathway (223,239). LpxC is 
modulated at the level of proteolysis by an essential metalloprotease FtsH in E. coli 
(240). Absence of FtsH stabilizes LpxC, leading to enhanced levels of LPS that causes 
cell death. Furthermore, LpxC will accumulate in the cell if the early step of lipid A 
biosynthesis are blocked. All these previous reports together point to the existence of a 
possible feedback regulation of LpxC in the LPS synthesis, which sets a balance in 
between phospholipid and LPS biosynthesis (217,241,242). However, there are 
additional proteins participate that in the biosynthesis. In 2013 and 2014 LapB (YciM) 
and LapA (YciS) were identified, which were both found to be able to participate in 
lipid A biosynthesis with unknown function (217,242). Deletion of LapB, the conserved 
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tetratricopeptide repeat (TPR) transmembrane inner membrane protein, is found to 
increase the LpxC enzyme levels resulting in an abnormal increase of LPS, ultimately 
leading to cell death. More interestingly, the lapB gene is found to be essential under 
laboratory growth conditions which means that the deletion strain of lapB gene could 
only be constructed under minimal medium at 30°C (242). Conversely, a modest 
increase of LapB significantly reduces the amount of LpxC leading to a lower LPS 
levels and an increased OM permeability. Consisted with a role in the LPS assembly, 
during pull-down experiments, LapA and LapB were co-purified with LPS, FtsH, and 
Lpt proteins. Those result together indicate that LapB participates in LPS synthesis in 
negative feedback (243-245). It has also been reported that lapA and lapB gene belong 
to the RpoH regulon and their transcription will increase at 42°C high temperature, 
confirming that LapA and LapB are heat shock proteins (242). LapB is anchored into 
the inner membrane via an N-terminal 20 residues long transmembrane helix and is 
facing into the cytoplasm (244). Topological and sequence analysis shows the soluble 
domain of LapB contains the conserved tetratricopeptie repeat (TPR) and a C-terminus 
domain (Figure 51). Interestingly, the C-terminus domain contains two cysteine-X-X-
cysteine motifs that are supposed to be coordinate a redox-sensitive iron centre of the 
rubredoxin type. However the incorporated metal ion type has not been yet identified 
accurately, Zn2+ or Fe3+. It has been reported that the over expressed and purified LapB 
cytoplasmic domain is pink under aerobic condition (colour of Fe3+) and, if purified 
under anaerobic conditions it is colourless (non-metal ion, Zn2+ or Fe2+) (244). In 
addition mass spectral data shows that, when over expressed, the concentrations of the 
medium ions determine the final incorporation ion ratio (LapB might contain multiple 
metal ion) (242). The non-specific metal ion incorporate ion makes LapB “passive” on 
metal ion binding relying on surrounding ion concentrations. In fact, Zn2+ concentration 
in native bacteria is much higher than Fe3+, which indicates that LapB is possibly a Zn2+ 
binding protein (246). 
This project is focused on generating S. typhimurium soluble domain LapB expression 
plasmids, solving the crystal structure of LapB soluble domain and performing 
functional studies within reach. In this Chapter, we report a successfully LapB soluble 
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domain structure determination at 2.2Å resolution. 
Unfortunately, just one week after we solved the crystal structure, another group 
published that of the E. coli Zn2+ binding LapB soluble domain (156). Differently, our 
structure is in a totally different conformation, an ambiguous lipid substrate binding 
state. The conformational changes and the lipid substrate may illustrate the mechanism 
of LapB on LPS synthesis. 
 
3.2 METHODS AND MATERIALS  
3.2.1 S. typhimurium and E. coli lapB gene cloning  
LapB cytoplasm domain of S. typhimurium and E. coli were amplified from E. coli K12 
MG1655 genome with primers listed in Table 11, respectively, with 5`-end NcoI and 
3`-end HindIII restriction enzyme sites. The gene fragments were digested with 
restriction enzymes NcoI and HindIII and the same treatment was applied to vectors 
pLOU3 and pHISTEV as well. The gene fragments were then inserted into these vectors 
by T4 DNA ligase (Table 4). All plasmids were sequenced and confirmed the correct. 
 
3.2.2 Expression and purification of LapB from S. typhimurium and E. coli.  
The plasmids were transform into BL21 (DE3) cells with 100µg/ml ampicillin. A single 
colony was picked and cultured overnight in 5ml LB to prepare a glycerol stock. The 
glycerol stock BL21 (DE3) with pLOU3 or pHISTEV harboring gene fragments 
encoding LapB cytoplasmic domain) cells were cultured in 500 ml LB overnight. Each 
1L LB medium was inoculated 40 ml of overnight culture with 50 µg/ml ampicillin 
(pLOU3) or 50 µg/ml kanamycin (pHISTEV). The cultures were grown at 37°C until 
the OD600 reached 0.8-1.0 and the proteins were induced by adding 0.1 mM IPTG for 
3-4 hours at 37°C with shaking at 200 rpm. 12L of cell culture were then harvested by 
centrifugation at 5,000 rpm (4,500 g) for 15 min. Followed by re-suspending the cell 
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pellet in Balance buffer (20 mM Tris-Cl, pH 7.8, and 300 mM NaCl 10mM imidazole 
10% glycerol, cOmplete EDTA-free Protease Inhibitor Cocktail Tablet (Roche) 50 
µg/ml DNAse I (Sigma) 100 µg/ml lysozyme). The cell pellets were lysed by passing 
them through a cell disruptor at 30,000 psi. The unbroken cells and cell debris were 
removed by centrifugation at 20,000 rpm (40,000g) for 30 min. The supernatant was 
applied to pre-balanced (with Balance buffer) 5 ml HP HisTrap column (Ge 
Healthcare). The column was washed using Wash buffer which was made by increasing 
imidazole concentration to 30 mM in Balance buffer; the fusion protein was eluted by 
Elution buffer (20 mM Tris-Cl, pH 7.8, and 300 mM NaCl 500mM imidazole and 
10%glycerol). The fusion protein sample was desalted using a pre-equilibrated 
desalting column (GE Healthcare) with Balance buffer to remove imidazole. TEV 
protease was added into the desalted protein at a TEV to protein mass ratio 1:100 and 
incubated overnight to cleave the MBP together with 6×Histag off from the fusion 
protein at the TEV cleavage site. The post-cleavage mixture was loaded onto the pre-
balanced 5 ml HP HisTrap column again to remove the TEV protease and the cleaved 
MBP during this step the WaaB protein would directly go through the column and been 
collected and concentrated to 5-10ml. The protein was further purified by gel-filtration 
using a pre-equilibrated SEC (HILOAD 16/600 SUPERDEX 200 PG, GE Healthcare) 
(with 150 mM NaCl and 20mM Tris pH 7.8). The protein purity was checked using 
SDS-PAGE and the most pure fractions were pulled and concentrated to 5-10 mg/ml 
for crystallization. 
 
3.2.3 In situ limited proteolysis crystallization of LapB 
To increase the possibility of crystal hits during crystallization screening, we tried to 
use proteases to remove the disordered regions and obtain a stable soluble domain after 
purification. We screened 7 proteases, Papain (1 mg/ml), Elastase (1 mg/ml), V8 (2 
mg/ml), α-Chymotrypsin (2 mg/ml), Subtilisin (2 mg/ml), Thermolysin (1 mg/ml), and 
Trypsin (2 mg/ml). Firstly, 50 µg of the purified protein was prepared into separate 
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tubes and in each tube individual protease at mass ratio 1:100 or 1:50 (protease: protein) 
was added and incubate at room temperature. Samples were taken every 30 min for 
SDS-PAGE analysis to select one or two of the best performing proteases, which would 
be chosen for in situ proteolysis during crystallization. The performance of the 
proteases was analysed on SDS-PAGE and an ideal choice should exhibit almost single 
strong band on the SDS-PAGE, which should also display a small molecular weight 
shift compared to the non-digested control. 
The target protein was digested using the best protease at low concentration 1:500-
1:1000 rather than 1:50 which was used during the screening. Then a longer time course 
trail that spanned from 30 min to 4 hour at room temperature was conducted. Through 
this analysis, we could find the best desired condition that would digest the target 
protein into a stable protein without flexible fragments. It gives us a general idea on 
when the over digestion started because the protease could still have minor activity in 
crystallization condition. The promising proteases were incubated with S. typhimurium 
LapB at 1:500 for 2 hour at room temperature before we set the mixture onto 
crystallization experiments directly. 
 
3.2.4 LapB crystallization and crystal sodium iodide soaking  
Native or limited proteolysis treated LapB crystallization experiments were performed 
using the sitting drop diffusion method with drop size 0.5 µl (sample): 0.5 µl (mother 
liquid) using the crystallization robot Gryphon (Air). The screening kits were purchased 
from Hampton research and Molecular dimensions and Hampton research Table 10. 
After crystals appear the optimization was performed by designing and preparing 2D 
expansion of pH and PEG concentration from crystallization condition resulting in 
several 5×5 home-made optimization solution arrays in 96 deep well plates. 
In order to determine the experimental phases, which was crucial for final structure 
determination and model building, the crystals grown from optimization conditions 
were soaked with sodium iodide which was quite successful in the WaaB project. To 
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find the best match between sodium iodide solutions with target crystals, we tried 
sodium iodide at 100 mM from 10 second to 15 min. The sodium iodide solution was 
prepared in cryoprotectant in advance the day before crystal harvesting and rapid 
freezing in liquid nitrogen.  
 
3.2.5 Data collection and structure determination of LapB 
All crystals, including native and sodium iodide soaked, were flash frozen in liquid 
nitrogen with cryoprotectant (21.25% Ethylene glycol 15% glycerol) and kept in pucks 
stored in a dewar, which were both pre-cooled by liquid nitrogen. The crystals were 
sent to Diamond Light Source I02 for data collection.  
The native crystal data were collected at 1.82 Å, Oscillation 0.1°, and 3600 images. 
Iodide-derived SAD data were collected at its anomalous signal scattering wavelength 
(1.8000Å) according to X-ray Anomalous Scattering Information (Ethan A Merritt 
©1996-2011/ merritt@u.washington.edu / Biomolecular Structure Centre at UW). The 
original data was processed by Diamond Light Source automatic pipeline (including 
XIA2 (144) with Dials (145)), to generate a merged reflection file. The crystal soaked 
with 100 mM sodium iodide for 10 min behaved best and the experimental phase and 
initial structure was determined by Crank (CCP4i) ((188)), which was a pipeline that 
gather lots of programs together. Both native crystals and iodide-derived crystal 
belonged to space group P212121 with cell dimensions: a=124.06Å, b=70.07Å, 
c=78.96Å, α=90°, β=90°, γ=90° for native crystals and a=124.34Å, b=71.86Å, 
c=79.09Å α=90°, β=90°, γ=90° for iodide-derived crystals. The highest resolution 
native crystals reach 2.2 Å and the highest resolution iodide-derived crystals reach 3.2 
Å. For my case the substructure of iodide-derived LapB crystals was determined and 
refined by AFRO/CRUCH2 (188) and BP3 (247) respectively, hand determination and 
density modification was completed by SOLOMON, and model building by 
BUCCHANEER (154) model building. After the Crank pipeline, REFMAC5 (159) and 
COOT (157) were used to make final refinement removal of iodide coordinates from 
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the output coordinates file to produce the primary model for following Molecular 
Replacement. The high resolution native data were determined using PHASER MR 
(CCP4i) (202) using the primary model, refined by REFMAC5 (159) and further 
improved by COOT (157).  
3.2.6 Functional assay and the related plasmids generation 
In order to study the functions of LapB. We have bought the Δlapb strain (#9144) from 
E. coli Genetic Resources at Yale University CGSC, The Coli Genetic Stock Centre. 
The strain was tested to be sensitive to 100µg/ml vancomycin, while the wild type 
BW25113 strain could survive. To rescue the phenotype of lapB deletion strain, two 
plasmids were generated, pBAD24-LapB/pBAD24-LapB-LpxC. By inserting full 
length E.coli lapB gene into pBAD24 vector, we have generated pBAD24-LapB. And 
we have inserted another lpxC gene fragment into pBAD24-LapB to generate pBAD24-
LapB-LpxC. We transformed these two plasmid respectively into Δlapb strain under 
100µg/ml ampicillin and 50µg/ml kanamycin. The culture was diluted to 
OD600nm=0.1 before streaking onto the agar plates with 0.0002%-0.02% L-arabinose 
and 100µg/ml vancomycin, trying to rescue the phenotype of the deletion strain.  
 
3.3 RESULTS  
3.3.1 Cloning of the cytoplasmic domain of lapB from S. typhimurium and E. coli 
Gene fragments encoding for the lapB cytoplasmic domain from S. typhimurium and E. 
coli were successfully amplified from the respect genomic DNA by PCR using Q5 
polymerase and primers listed in Table 11. PCR fragments were then digested by 
appropriate restriction enzymes (Figure 52). Followed by ligation with same restriction 
enzyme treated vectors. Finally the colonies from the ligation mixture transformation 
agar plate (with appropriate antibiotics) were inoculated into 10 ml of LB for plasmids 
mini-prep and validation (Figure 53). One plasmid from each cloning, confirmed the 
correct inserts in double restriction enzyme digestion, was sent for sequencing. 
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Figure 51 S. typhimurium LapB secondary structure analysis by YASPIN server (248) 
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S. typhimurium LapB amino acids sequence was uploaded into YASPIN server 
(248) and the data shows that the LapB contains several α-helices forming a 
typical tetratricopeptide repeat (TPR) domain. The N-terminal is an anchor of 
20 residues into the cell membrane and The C-terminal contains four conserved 
cysteine residues which correspond to a metal binding centre. (244). 1-9 refers 
to the possibility from low to high. 
 
Gene fragments encoding E. coli and S. typhimurium LapB were amplified 
using PCR, digested with restriction enzyme NcoI and HindIII. Vectors pLOU3 
and pHISTEV were treated with same restrictions as well. Digested PCR 
products and vectors were checked and purified on 0.8% agarose gel. Lane 1: 
E. coli lapB gene fragment 1101bp; lane 2: S. typhimurium lapB gene fragment 
1101bp; lane 3: pHISTEV vector 5432bp; lane 4: pLOU3 vector 6702bp. All 
PCR products or vectors had been digested with restriction enzymes NcoI and 
HindIII.  
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Figure 52 Agarose gel analysis of double restriction enzyme treated LapB PCR 
products and vectors 
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lapB gene amplified from E.coli and S. typhimurium were inserted into pHISTEV 
or pLOU3 respectively by T4 ligation. The single colonies from the 
transformation of the ligation products were cultured. The plasmids extracted 
from theses colonies were double digested to check whether the insertions 
were correct. The restriction sites used here were NcoI and HindIII. Lane 1, 2 
were E. coli lapB in pHISTEV; lane 4, 5 were E. coli lapB in pLOU3; lane 7, 8 
were S. typhimurium lapB in pHISTEV; lane 10, 11 were S. typhimurium lapB 
in pLOU3.  
 
3.3.2 E. coli LapB in pLOU3 and pHISTEV expression and purification 
E. coli LapB was purified from expression vector pLOU3, in which the LapB 
cytoplasmic domain was expressed at a fusion protein form, 6×Histag-MBP-
TEVcleavagesite-LapB, and then the LapB protein was separated from the fusion state 
using TEV protease and Ni-NTA purification in vitro. Interestingly once the protein was 
eluted from the column, it showed crimson color. The special crimson color indicated 
that the protein contains Fe3+ ion inside. We could not exclude the presence of other 
metal ions, like Zn2+ or Fe2+. The metal binding ability of LapB was also consistent 
with previous reports (156). From the gel-filtration (Figure 54 and Figure 55) and SDS 
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Figure 53 Double restriction enzyme digestion validation of lapB gene cloning. 
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PAGE (Figure 56), the LapB was purified successfully. According to the gel-filtration, 
the peak started earlier than expected which is estimated to be about 39kD. However, 
in Figure 56, LapB still presented a normal molecular weight band of 39kD, LapB 
probably formed dimer in solution which were confirmed later from the structure 
determination of LapB. Although the protein was successfully expressed and purified, 
some degradation bands were apparently observed after TEV protease digestion and 
final gel-filtration (Figure 56).  
After detecting the degradation, I optimized some details in purification method, and 
also tried to express LapB in pHISTEV plasmid on the other hand. Unlike pLOU3, 
pHISTEV vector did not carry a 42kD MBP fused with your protein (Figure 57). To 
minimize the degradation of LapB during, the TEV protease digestion was performed 
on ice in the following experiments. As a result, the degradation was well controlled.  
 
E. coli LapB-pLOU3 fusion proteins were eluted from the Ni-NTA columns. 10ml 
of the eluted fusion proteins were loaded into the gel-filtration with buffer 20mM 
Tris pH8.0 300mM NaCl and 10% glycerol. The columns used was 16/600 
SUEPERDEX 200PG (GE health care). The first peak is E. coli LapB-MBP 
fusion protein peaked at 70ml (molecular weight 100 kD-200 kD). The second 
peak appeared at 90ml (30-60 kD) is MBP.  
Figure 54 Gel-filtration of E. coli LapB-pLOU3 fusion protein  
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After TEV cleavage and the reverse Ni-NTA purification to remove TEV 
protease from the LapB, MBP and TEV mixture. The flow through containing 
LapB was concentrated to 7.5ml before being loaded into the gel-filtration with 
buffer 20mM Tris-Cl pH8.0 150mM NaCl. The first peak was the purified E. coli 
LapB protein confirmed by SDS-PAGE analysis in Figure 56. The second peak 
was MBP that was not fully captured by reverse Ni-NTA purification after TEV 
protease digestion. 
 
Figure 55 Gel-filtration of E. coli LapB-pLOU3 fusion protein after TEV digestion  
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Figure 56 SDS-PAGE analysis of E. coli LapB-pLOU3 fusion protein purification  
-MBP 
-LapB 
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Several different samples during E. coli LapB purification was prepared and 
analysed with SDS-PAGE. Lane1 1: E. coli MBP-LapB fusion protein; lane 2: 
After TEV protease digestion; lane 3: After TEV protease digestion Ni-NTA flow 
through; lane 4-10: Gel-filtration first peak from fractions in Figure 55; lane 11: 
MBP peak sample. MBP bands is a little above LapB bands, and gel-filtration 
can almost separate them because LapB formed a dimer. LapB showed 
obvious degradation bands and form a ladder-like pattern from about 40kD to 
35kD. 5µl samples were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE Loading 
buffer. The SDS-PAGE samples were loaded into SDS-PAGE gel after heating 
on 90°C for 10min. The visualization of the bands was achieved by dying the 
gel in Quick Coomassie Stain (Generon) for 15min at room temperature. Bolt™ 
4-12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher Scientific) 
 
 
E. coli LapB purified from pHISTEV and the purification step was similar with 
that from pLOU3. The LapB after TEV cleavage was purified again through a 
reverse Ni-NTA column and loaded into gel-filtration subsequently using buffer 
20mM Tris-Cl 150mM NaCl. The gel-filtration was performed on 16/600 
SUPERDEX 200PG GE Health care at 1ml/min room temperature. 
 
Figure 57 Gel-filtration of E. coli LapB-pHISTEV after TEV protease digestion 
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Lane 1-10: Gel-filtration fraction samples from Figure 57; lane 10: flow through 
after TEV protease digestion; lane 11: E. coli LapB before crystallization. This 
purification differs from the batch shown in Figure 56, the TEV digestion was 
performed on ice overnight rather than at room temperature. Some nonspecific 
degradations of LapB were prevented. LapB appeared to be stable at this a this 
stage. 5µl samples were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE Loading 
buffer. The SDS-PAGE samples were loaded into SDS-PAGE after heating on 
90°C for 10min. The visualization of the bands was achieved by dying the gel 
in Quick Coomassie Stain (Generon) for 15min at room temperature. Bolt™ 4-
12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher Scientific) 
 
3.3.3 S. typhimurium LapB expression and purification in pHISTEV vector.  
While continuing trying to grow crystals of E. coli LapB, I have also tried to crystallize 
LapB from S. typhimurium which showed some slight differences. During the protein 
purification, the pink color of S. typhimurium LapB showed lighter compared to the E. 
coli LapB and minor precipitation appeared after cell lysis which did not affect 
purification. As a result, we could still produce high yield protein (Figure 59). During 
gel-filtration, the target peak appeared at around 67 ml with an aggregation peak before 
           1   2  3  4   5  6   7  8  9  10  11 
116kD 
66kD 
 
45kD 
35kD                                                           
25kD           
18.4kD 
14.4kD 
 
 
Figure 58 SDS-PAGE of E. coli LapB-pHISTEV after TEV digestion at 4°C 
132 
 
it and the target fractions were collected for TEV protease digestion. After TEV 
digestion and reverse chromatography to remove TEV protease and cleaved 6×Histag, 
the protein was further purified by another gel-filtration. The protein purity was finally 
checked by SDS-PAGE (Figure 60 and Figure 61). As we can see from the SDS-PAGE, 
the S. typhimurium LapB displayed a small shift before and after TEV cleavage which 
confirmed the efficiency of TEV protease digestion. Although the TEV protease 
digestion was performed on ice, small degradation bands were still visible just below 
LapB, which meant that S. typhimurium LapB, similar to the E. coli one, was not very 
stable. Considering that S. typhimurium LapB showed lighter pink colour, we could 
conclude that this protein contains less Fe3+ compared to E. coli LapB. Since bacterial 
cells contained much higher concentration of Zn2+ than Fe3+, the native LapB is likely 
to be a Zn2+ binding protein rather than a Fe3+ binding protein. The Fe3+ binding could 
be a non-specific binding. In that case, S. typhimurium LapB was chosen as the main 
target to focus on. 
 
S. typhimurium LapB was expressed in pHISTEV plasmid and purified using 
the same method as the E.coli one. After eluted from the Ni-NTA, 10ml LapB-
Histag sample was loaded into the gel-filtration using buffer 20mM Tris pH8.0 
300mM NaCl 10% glycerol at 1ml/min and room temperature. The first peak is 
Figure 59 Gel-filtration of pHISTEV S. typhimurium LapB after Ni-NTA purification 
and before TEV protease digestion 
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the aggregation peak caused by slight precipitation in the supernatant of LapB 
before purification. The second peak is 6×Histag-TEVcleavagesite-Sal-LapB. 
The fractions from volume 65ml to 80ml were collected for TEV digestion, and 
the first aggregation peak was discarded. The reason for slight precipitant in 
the supernatant remained unknown, but it had never happened in the repeating 
purifications. In the following purifications, desalting was used in place of gel-
filtration to remove the imidazole from the fusion protein for TEV cleavage.  
 
After TEV protease cleavage and a reverse Ni-NTA purification to remove TEV 
protease, S. typhimurium LapB in the flow through was concentrated into 10ml 
before further purified by gel-filtration in 20mM Tris-Cl pH8.0 150mM NaCl. The 
protein samples were confirmed by SDS-PAGE (Figure 61). The slightly 
asymmetry of the peak could be caused by the slight degradation of S. 
typhimurium LapB. The protein harvested after this gel-filtration were 
concentrated to 5-10mg/ml for crystallization. 
Figure 60 Gel-filtration of S. typhimurium LapB  
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Lane 1: S. typhimurium LapB purified in pHISTEV plasmid before TEV protease 
digestion; lane 2-10: gel-filtration fraction samples from Figure 60. The band of 
S. typhimurium LapB was similar to E. coli one. Although the protein is purified 
with high purity, the degradation problem still existed. 5µl samples were mixed 
with 10µl ddH2O and 5µl 4×SDS-PAGE Loading buffer. The SDS-PAGE 
samples were loaded into SDS-PAGE after heating on 90°C for 10min. The 
visualization of the bands was achieved by dying the gel in Quick Coomassie 
Stain (Generon) for 15min at room temperature Bolt™ 4-12% Bis-Tris Plus 
Gels, 12/15-well (Thermo Fisher Scientific) 
 
3.3.4 Limited proteolysis of LapB from E.coli and S. typhimurium.  
Observing the degradation of LapB from both species, I tried to remove the flexible 
regions by limited proteolysis treatment to increase the possibility of crystallization. 
Seven different proteases was used on both LapB at 1:100 mass ration for 30 min room 
at temperature (Figure 62 and Figure 63). From the limited proteolysis result, proteins 
contain an unstable domain, which could be easily removed by several proteases. 
However, some proteases behaved better on LapB of two species, such as Elastase and 
Thermolysin. These two proteases can remove a certain part of peptide from the LapB 
protein and were used in situ proteolysis digestion crystallization for both S. 
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Figure 61 SDS-PAGE analysis of S. typhimurium LapB  
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typhimurium and E. coli LapB. As a result, there were actually more crystal hits 
appearing in wells compared to untreated crystallization and the quality of some 
crystals was increased to about 2.4 Å. However, the high resolution crystals were not 
very reproducible. By using the same method during crystal optimization, only small 
crystals could be grown. The resolution of the optimized crystals were worse compared 
to the original one and they were also quite fragile under X-ray diffraction. The small 
crystals disappeared after two week with lots of cracks, finally became debris. The 
proteases were possibly still active at and could still digest the protein during the crystal 
formation, resulting in such low crystal quality. I decided to screen different proteolysis 
condition. A time course experiment with 1:500 mass ratio of Thermolysin to LapB was 
performed and samples at 1 h, 4 h and 24 h were taken from the proteolysis reaction 
and visualized by SDS-PAGE (Figure 64). According to the SDS-PAGE result of time 
course, it was apparent that the Thermolysin could digest about half of the S. 
typhimurium LapB at 1 hour using 1:500 ratio, and would fully digest the sample by 4 
hour and over digestion was observed after 1 day. Based on the time course result and 
considering the possible protease activity during crystal growth, 2 hour digestion at 
1:500 ratio was chosen for further in situ proteolysis crystallization. 
 
Proteolysis screen of E. coli LapB. Lane 2: Control; lane 3: α-Chymotrypsin; 
Figure 62 SDS-PAGE analysis of E. coli LAPB limited protease digest screen 
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lane 4: Subtilisin; lane 5: Trypsin; lane 6: Thermolysin; lane 7: Elastase; lane 8: 
Papain; lane 9: V8. All the proteases were used at 1:100 mass ratio of protease 
to E. coli LapB at room temperature for 30 min. 4×SDS-PAGE Loading buffer 
was added into each samples to terminate the reactions. The SDS-PAGE 
samples were loaded into SDS-PAGE after heating on 90°C for 10min. The 
visualization of the bands was achieved by dying the gel in Quick Coomassie 
Stain (Generon) for 15min at room temperature Bolt™ 4-12% Bis-Tris Plus 
Gels, 12/15-well (Thermo Fisher Scientific). The control LapB showed some 
instability and there are two strong bands next to each other. The proteases 
that could produce a band shift with least protein loss were selected for 
proteolysis treatment, namely Thermolysin and Elastase. 
 
Proteolysis screen of S. typhimurium LapB. Lane 2: Control; lane 3: α-
Chymotrypsin; lane 4: Subtilisin; lane 5: Trypsin; lane 6: Thermolysin; lane 7: 
Elastase; lane 8: Papain; lane 9: V8. All the proteases were used at 1:100 mass 
ratio of protease to S. typhimurium LapB at room temperature for 30 min. 5µl 
samples were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE Loading buffer. 
The SDS-PAGE samples were loaded into SDS-PAGE. The visualization of the 
bands was achieved by dying the gel in Quick Coomassie Stain (Generon) for 
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Figure 63 SDS-PAGE analysis of S. typhimurium LapB limited protease digest screen 
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15min at room temperature. Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well 
(Thermo Fisher Scientific) after heating on 90°C for 10min. The LapB control 
seemed to be stable with little degradation, but after protease treatments the 
flexible part of it would be easily removed, which could be found in several kinds 
of proteases. The proteases that could produce a band shift with least protein 
loss were selected for proteolysis treatment, namely Thermolysin and Elastase 
in this case. After tested both for crystallization, Thermolysin can help produce 
crystals while Elastase cannot. 
 
 
S. typhimurium LapB was digested with Thermolysin at 1:500 mass ratio and 
room temperature. Samples was taken at 1 hour, 4 hour, 24 hour, and loaded 
into lane 1, 2, 3, respectively. 5µl samples were mixed with 10µl ddH2O and 5µl 
4×SDS-PAGE Loading buffer. The SDS-PAGE samples were loaded into SDS-
PAGE after heating on 90°C for 10min. The visualization of the bands was 
achieved by dying the gel in Quick Coomassie Stain (Generon) for 15min at 
room temperature. Bolt™ 4-12% Bis-Tris Plus Gels, 12/15-well (Thermo Fisher 
Scientific). This is a time course limited proteolysis digestion trying to find the 
best combination of concentration and duration to achieve best effect. As 
shown in the figure, 4h and 1:500 appeared to be a promising choice. 1h 
seemed to be not enough, we could still identify two bands which may refer to 
before/after digestion. 24h is too long, about half of LapB disappeared. 
Figure 64 S. typhimurium LapB Thermolysin time course proteolysis digestion  
  kD 
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3.3.5 Crystallization of LapB of S. typhimurium/E. coli and seeding optimization 
Both S. typhimurium and E. coli LapB could crystallize (Figure 65 and Figure 66), but 
only S. typhimurium LapB could produce large and high quality crystals. In contrast, 
the resolution of the crystals from E. coli LapB were very poor. However, optimization 
and limited proteolysis of S. typhimurium LapB did not work sufficiently well, with 
problems mainly about the crystal size and reproducibility (Figure 66). Microcrystal 
seeding could be an alternative choice, the S. typhimurium LapB crystals, together with 
the crystal growing solution, were pipetted out from one well and the mixture was dilute 
in 20 µl reservoir solution. Then after pipetting the diluted mixture for hundreds of 
times to fully destroy the crystals into microcrystals, the solution was diluted again to 
a volume of 200µl using buffer (20mM Tris-Cl pH8.0 and 150mM NaCl). This 200 µl 
stock was stored at -80°C and named as Seeding Stock for S. typhimurium LapB. 1 µl 
of the Seeding Stock was added into 100 µl purified S. typhimurium LapB solution that 
was treated with limited proteolysis before setting onto crystallization. Combining 
limited proteolysis and crystal seeding methods, we have improved the quality and the 
reproducibility of the LapB crystals (Figure 67). The original crystals were obtained 
from 21.25% Ethylene glycol 15% glycerol at room temperature; the crystals appeared 
after 1-2 weeks. 
 
E. coli LapB formed small crystals after Elastase proteolysis repetition. These 
Figure 65 E. coli LapB crystals after Elastase proteolysis repetition 
100µM 
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crystals were bad and could only diffract up to 15 Å. There were about 3-4 hits 
like this through all the screens. Compared to the S. typhimurium LapB crystals 
(Figure 67), E. coli ones seemed to be difficult to optimize to reach high 
resolution. So we focused on the S. typhimurium LapB in the following 
experiments. 
 
Based on the time course of Thermolysin proteolysis digestion, S. typhimurium 
LapB crystals became reproducible using the 1:500 mass ratio and 4h room 
temperature digestion condition, however the occurrence was 1 out of 10 and 
the crystals were not large enough for high resolution data collection. (21.25% 
Ethylene glycol 15% glycerol) 
 
Figure 66 Small crystals of S. typhimurium LapB after advanced limited proteolysis 
Figure 67 High resolution crystals of S. typhimurium LapB  
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By using optimized proteolysis method based on time course proteolysis result 
and microcrystal seeding, large crystals were grown with occurrence hit of 7 out 
of 10. The best of these crystal have good resolutions of 2.2 Å. 1:500 mass 
ratio protease, 4h at room temperature, 1:100 Seeding. It took 1 week for these 
crystal to form and 3 weeks to grow into full size. (21.25% Ethylene glycol 15% 
glycerol) 
 
3.3.6 S. typhimurium LapB structure contains a lipid molecule  
To determine the experimental phases of S. typhimurium LapB, crystals were soaked 
with cryoprotectant solution containing 100 mM sodium iodide (21.25% Ethylene 
glycol 15% glycerol 100 mM sodium iodide). The crystals were harvested and flash 
frozen in liquid nitrogen after 10 s, 1 min, 3 min, 5 min, 10 min and 15 min soaking. 
The soaking solution was added at 1:1 (drop size to soaking solution). All crystals were 
sent to Diamond Light Source beamline I04 for data collection. Native data were 
collected at wavelength 1.00 Å while sodium iodide soaked SAD data were collected 
at 1.80 Å with high multiplicity (Table 8). Initial model was determined from iodide-
derived SAD data using CRANK (188). The iodide anomalous Fourier map was shown 
in Figure 68. Then Molecular Replacement was used to solve the high resolution native 
dataset using the initial model. COOT (157) was used to build and fix the final model. 
According to the overall structure in Figure 69, the S. typhimurium LapB structure was 
determined from dataset of in situ proteolysis crystals with the N-terminal 140 residues 
missing from the structure. Our construct truncates 20 transmembrane residues, so the 
rest about 120 residues were removed by proteolysis. The LapB protein was divided 
into two domains: the N-terminal domain made up with TPRs and the C-terminal metal 
binding centre (Figure 69). The N-terminal TPRs consists of several α-helix pairs (six 
pairs in our LapB structure) and may contain more in full length LapB. TPR domain is 
usually supposed to form scaffolds to mediate protein-protein interactions and may 
assembly multi-protein complex. As a rather new identified LPS biosynthesis related 
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protein, LapB may utilize the TPR domain to interact with enzymes from lipid A 
synthesis (Figure 50). The C-terminal domain of LapB consists of a four-cysteine motif 
located at the corners of a tetrahedron with metal binding site in the centre of this 
tetrahedron (Figure 71). S. typhimurium LapB is supposed to be a metal binding protein. 
However, our crystals from the microscope images (Figure 66 and Figure 67) did not 
contain any colour, which meant that our crystals did not have Fe3+ ions bound. These 
details indicated that the purified LapB protein was probably in a Zn2+ binding form. 
We tried to build a Zn2+ into our structure and refine with it against the high resolution 
data. 2Fo-Fc map contoured at 8.0σ still contains signal in the Zn2+ site, suggesting that 
our structure is in Zn2+ form (Figure 71). Comparing to the 4ZLH (249), the E. coli 
LapB crystal structure whose C-terminus metal binding centre captured a Zn2+, our S. 
typhimurium LapB displayed a similar architecture (Figure 72). According to the 
superimposition result, S. typhimurium LapB showed a 31.9 Å rotational shift between 
the two monomer in the asymmetric unit, which opened the hydrophobic cavity 
between the two LapB monomers and might allow the entry of the lipid substrate 
(Figure 72). In our LapB structure we could observe an extra chain-shaped electron 
density between the two LapB protomer on the Fo-Fc map contoured at 3.0σ (Figure 
69). Considering the relationship of LapB and LPS, we anticipate it to be a lipid or fatty 
acid molecule that may be involved in LPS biosynthesis. The tunnel space of the LapB 
dimer structure and the electron density both suggested that only single carbon chain 
could be put there (Figure 69). We modelled a palmitoleic acid molecule into it, and it 
fit well. It is no exclusive that this additional density can be assigned to other similar 
C-16 chain, including palmitic acid, or even C-14 chains. The synthesis of lipid A of 
LPS require the lipid donors in C12-ACP or C14-ACP form. And C16-ACP (palmitic 
acid) may also be required when modification on lipid A happens. This unassigned 
lipids may be this lipid or some precursor.  
 
 LapB and lipid complex LapB-iodide  
Data collection   
Space group P212121 P212121 
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Cell dimensions   
    a, b, c (Å) 124.06, 70.07, 78.96 124.34, 71.86, 79.09 
α, β, γ ()  90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Wavelength (Å) 0.91731 1.8000 
Resolution (Å) 48.92–2.2(2.279–2.201) 73.85-3.12 (3.20-3.12) 
Rmerge (%) 14.3 (26.4) 22(81.9) 
CC1/2 (%) 100 (82) 100 (100) 
I / σ(I) 8.24(?) 19.6 (5.6) 
Completeness (%) 100 (100) 100 (100) 
Redundancy 13.3 (11.1) 47.2 (24.6) 
Anomalous 
Completeness 
 100(100) 
Anomalous 
Redundancy 
 25.2(12.7) 
 
Phasing   
Resolution (Å)  73.85-3.12 
Sites (I)  11 
Figure of merit  0.612 
Refinement   
Resolution (Å)& 48.72 – 2.50(2.589-2.5)  
No. reflections 23448(1675)  
Rfactor / Rfree  0.2346/0.2785  
No. atoms   
    Protein 4067  
    Ligand/ion 20  
    Water 94  
B-factors   
    Protein 58.10  
    Ligand 
    Solvent                            
54.4 
49.5 
 
R.m.s.deviations   
    Bond lengths (Å) 0.005  
    Bond angles () 1.260  
Ramachandran statistics   
    Allowed (%) 97.8  
    Outliers (%) 2.2  
Table 8 Data collection and structure refinement statistics of S. typhimurium LapB lipid 
binding form. 
Rfactor = Σ|| Fobs|−| Fcal||/Σ|Fobs|, where Fobs and Fcal are observed all 
reflection measured and calculated currently model as structure factors, 
respectively. Rfree is calculated using 5% of total reflections, which is randomly 
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selected not used in refinement. 
 
 
Figure 68 Anomalous difference Fourier map of iodide derived S. typhimurium LapB 
The iodide derived S. typhimurium LapB SAD data was collected at 1.8000 Å. 
The anomalous difference Fourier map of iodide derived S. typhimurium LapB 
was calculated with PHENIX (155) and contoured at 7.0σ, by using the 
anomalous dataset and final model (without lipid substrate and Zn2+). The 
peaks in the images shows the iodide sites that entered the crystals during the 
sodium iodide soaking.  
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(a) There are two LapB molecules per asymmetric unit with dimensions of about 
81.6 Å in length and 79.7 Å in height. There is one zinc ion per protomer located 
in the C-terminus domain. The lipid is located in the hydrophobic tunnel 
between the two protomers. (b) The LapB soluble domain can be divided into 
two domains; the N-terminal domain and the C-terminal domain (244) which 
form a bird wing shape with a dimensions of approximately 36.4 Å in length and 
79.7 Å in height. There are six tetratricopetide repeats motifs (TPR1-6) while 
the C-terminal domain is the rubredoxin-like domain, with four cysteine 
Figure 69 S. typhimurium LapB with lipid bound between two monomer 
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residues. (c) Superimposition of the two protomers of S. typhimurium LapB from 
one asymmetric unit. Two protomers in dimer LapB are in almost same 
conformation. (d) The unassigned electron density map and palmitoleic acid 
docking in the hydrophobic tunnel. The Fo-Fc map of the unassigned density is 
contoured at 2.5σ. 
 
 
Figure 70 Electron density map of S. typhimurium LapB refined with lipid substrate 
After refinement of the S. typhimurium LapB native data using the S. 
typhimurium LapB structure with palmitoleic acid substrate, the palmitoleic acid 
chain match the electron density well. And the extra electron density in Fo-Fc 
map (panel d in Figure 69) before refinement disappeared, suggesting that C-
16 lipid may be the substrate. Due to the 2-fold symmetry of the LapB dimer 
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structure, it is hard for LapB to discriminate between the carboxylic acid end 
and the carbon chain end. This is also in consistence with our structure, there 
is no significant electron density difference between two ends of the lipid 
substrate region. And the direction of the lipid substrate in our structure is 
representing one possibility and there may be an opposite position of the lipid 
within the crystals. The image shows both the 2Fo-Fc and the Fo-Fc map. 2Fo-
Fc map is coloured in blue and contoured at 1.0σ. Fo-Fc map is coloured in 
green/red and contoured at 3.0σ. The Fo-Fc map before refinement with the 
substrate is shown in (d) in Figure 69. 
 
 
Figure 71 S. typhimurium LapB contains Zn2+ in the C-terminus 
S. typhimurium LapB contains a zinc ion at the C-terminal domain and the zinc 
ion is captured by four cysteine residues. (a) The zinc binding site is shown. 
The S. typhimurium LapB is shown is cartoon labelled in green colour. The four 
cysteine residues are highlighted in sticks. 2Fo-Fc map contoured at 1.5σ 
shows the electron density at this zinc binding site. (b) 2Fo-Fc map contoured 
at 8.0σ still contains signal at the zinc site, suggesting that there is a zinc ion at 
this position. Zinc atom and the coordinating cysteine residues are shown in 
ball-and-stick model [O atom (red), N atom (blue), S atom (yellow), Zn atom 
(slate)]. 
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(a) Conserved residues surface map of one protomer of S. typhimurium LapB 
cytoplasmic domain. The online program Consurf (206) was used to calculate 
the amino acid conservation and PyMol (204) is used to display the 
conservation map following the Consuf online instructions. (b) Superimposition 
of one protomer of LapB from E. coli (4ZLH) and S. typhimurium (this study) 
with the RMSD of 1.51Å over 243 aligned residues. E. coli LapB contains eight 
TPRs, while S. typhimurium LapB has six, with two TPRs cleaved during 
proteolysis. There are few conformational changes when comparing one 
protomer between E. coli and S. typhimurium (c) Front view of the 
superimposition result of dimer LapB from E. coli and S. typhimurium. S. 
Figure 72 Superimpostion result of S. typhimurium LapB and E.coli LapB (4ZLH) 
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typhimurium LapB is superimposed with one protomer of E. coli LapB with 
RMSD of 1.51Å over 243 aligned residues. The comparision is based on the 
dimer LapB (d) Side view of superimposition of dimer LapB from E. coli and S. 
typhimurium. It shows that the second protomer of the dimeric LapB from E.coli 
is rotationally shifted for about 40° and 31.9Å at the widest point compared to 
that from S. typhimurium. 
3.4 CONCLUSION AND DISCUSSION 
Gram-negative bacterial cell envelope is made up of a double membrane system. Within 
the two membranes, the OM, an asymmetric membrane, is essential for cell viability 
and provide drug resistance. The asymmetry of the OM is caused by the distinct 
difference of inner leaflet and outer leaflet. While the GPL composes the inner leaflet, 
the outer leaflet comprises of lipopolysaccharide (LPS) which is regarded as the source 
of the relative impermeability (4,5). The biogenesis of LPS is always a hot topic 
throughout these years and a promising target for novel drug development. LPS 
contains three components, lipid A, core oligosaccharide and O-antigen. Precursors of 
LPS are synthesized at the inner leaflet of the IM and matured at the outer leaflet of the 
IM into LPS. The synthesis of lipid A is a complicated multi-enzyme process (Figure 
50). In this biosynthesis process, LpxC acts as a balancer between the biogenesis of 
GPL and LPS, both of which consume lipids, partially shared ingredients. Through the 
degradation of LpxC by FtsH, a degradation product from LpxC (250) is added onto 
the intermediate lipid A completing an essential step towards mature lipid A (Figure 50) 
(5).  
This chapter reveals the crystal structure of the cytoplasmic domain of IM protein LapB 
that may participates in the LpxC feedback balancing. S. typhimurium LapB is a dimer 
in both the solution and crystal forms. LapB contains an N-terminal domain and a C-
terminal domain. N-terminal is a TPR domain that may help LapB interact with multi 
proteins. C-terminal is a zinc binding domain with four cysteine residues locking a zinc 
ion in site. Our S. typhimurium LapB crystal structure revealed a new lipid bound form 
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compared to the E. coli LapB (4ZLH) (249). We have superimpose S. typhimurium 
LapB to one protomer of E. coli LapB. Structurally, the TPR region of the other 
protomer of the dimer S. typhimurium LapB is rotationally shifted by around 31.9 Å 
and 40° compared to 4ZLH, opening the hydrophobic cavity between the dimer to hold 
a lipid-like substrate (Figure 72). The structural conformational changes indicate the 
motion cycle of LapB when anchored in the IM facing cytoplasmic side (244). Based 
on the two conformation of LapB structure, we anticipate that LapB could intake and 
release a lipid substrate when the LapB dimer is anchored in the IM inner leaflet. 
Through the TPR domain, LapB may interact with LPS synthesis or transport related 
proteins (i.e. LpxC or LptB2FG) and control the donation of lipid substrate of LapB. 
We speculate that the conformation changes would be caused by the passive substrate 
intake of LapB. Notably, the lipid within the LapB has not been identified yet. Since 
that LapB soluble domain is expressed in the cytoplasm but not expressed as IM 
anchored protein, where the LapB may interact with related proteins to ensure its 
functionality. LapB soluble domain in cytoplasm may not be associated with the 
interaction proteins, so that the lipid it captures inside might be something similar rather 
than its biofunctional substrate. Considering the participation of LapB on LPS 
biosynthesis, the unidentified lipid could possibly be some precursor or products of 
LpxC related steps. C-12-ACP and C-14-ACP are donor of lipids of the six fatty acid 
chains of the lipid A. It is quite possible for the unassigned lipid to be a C-12, C-14 
lipids or their precursors. C-16-ACP is also a lipid donor in the modification step of 
lipid A, so it is also possible for the unassigned density to be a C-16 lipid or the 
precursor. Another potential evidence is that C-14-ACP is also the donor of the lipids 
in GPL synthesis, the nature that LPS and GPL synthesis share C-14-ACP as a precursor 
indicates that LapB could act as a balancer between LPS and GPL synthesis (243). 
Due to the 2-fold rotational symmetry in LapB dimer structure, the LapB protein itself 
could not discriminate between the carboxylic acid terminal and the carbon chain 
terminal. It is difficult to determine the exact length and the component of the lipid 
substrate from the crystal structure (the uncertainty of the direction of the lipids may 
blur the additional electron density of the lipid substrate). Based on the electron density 
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map, we modelled a palmitoleic acid molecule into the density, but it does not reflect 
the corresponding or functional substrate. Mass spectrum analysis on the purified full 
length inner membrane anchored LapB may answer this question better.  
Our attempts on setting up the functional assay in LapB deletion system, unfortunately, 
failed. The LapB knockout strain JW1272-3 (#9144) (251), gained from CGSG E. coli 
strain collection, was confirmed to be conditionally lethal under 100 µg/ml 
vancomycin, while wild type BW25113 stain could still survive under the lethal 
conditions. This phenotype is consistent with that it participates in the outer membrane 
biosynthesis, and that outer membrane is an important barrier for hydrophobic 
antibiotics. To rescue the phenotype of lapB deletion strain, I generated two plasmids, 
pBAD24-LapB/pBAD24-LapB-LpxC. However the LapB deletion strain transformed 
with neither of these two plasmids failed to survive under any of the 0.0002%-0.02% 
arabinose concentration. This result could be explained by the LapB & LpxC feedback 
‘regulation’. The level of the native LapB is strictly controlled in vivo and the 
expression level of pBAD24-LapB could not be replaced in vivo but relied on the 
arabinose concentration. As a result, the LpxC-relied lipid A synthesis balance is 
broken, thus lead to the cell death. The plasmid pBAD24-LapB-LpxC, as described 
above, failed to rescue the phenotype again, even attempting to stabilize the LpxC level 
by co-expression. Additional experiments need to be performed to study into the 
mechanism of LPS synthesis controlling by LapB. An improved plasmid targeting at 
rescuing the conditional death phenotype has been designed as well: inserting LapB 
gene fragment together with its own upstream promoter regulation sequence into a low 
copy vector or even together with all the genes inside its operon. The LapB expression 
level in this modified plasmids should probably reach native level and can rescue the 
phenotype. In that case, site direct mutations and Western blotting can be then 
introduced to explore the detailed mechanism of LapB regulation in LPS synthesis. 
Additionally, the lapB deletion strain showed cell growth deficiency which can be 
observed under microscope. The intermediate LPS would also accumulate inside the 
cells when lapB is deleted. Experimental targeting in those directions would also 
illuminate some of the LapB participation pathway on LPS synthesis. 
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4 CHAPTER 4 Cardiolipin inner membrane transporter PbgA 
4.1 INTRODUCTION 
As discussed in the previous Chapters, Gram-negative bacteria contains two 
membranes, the inner membrane (IM) and the outer membrane (OM). Between these 
two membranes, there is a solvent filled periplasmic space and peptidoglycan. 
Comparing Gram-negative and Gram-positive bacteria, the peptidoglycan in the Gram-
positive case is much thicker, however in Gram-negative bacteria the peptidoglycan 
binds to the OM by lipoproteins and contributes to the protection of the bacteria 
(207,252). The OM is an asymmetric membrane, in which the inner leaflet is composed 
of glycerophospholipids (GPL) while the outer leaflet is composed of 
lipopolysaccharide (LPS). The biosynthesis regulation, and transport of LPS has be 
described in the previous Chapters. In this Chapter, the mechanism of the transportation 
of GPL from IM to OM is studied. 
The glycerophospholipids (GPL) molecules consist of phosphatidylethanolamine (PE), 
phosphatidylglycerols (PG) and cardiolipin (CL) in an approximately 75: 20: 5 ratio in 
most bacterial membranes. Phospholipids are synthesised at the inner leaflet of the IM 
(25,26). It is not clear whether a flippase is required, while LPS and lipid A have been 
confirmed to be flipped by MsbA. In species like N. meningitides, MsbA deletion strain 
appears to be viable and still produce a double membrane system, showing 
phosphoplipid transport does not require MsbA at least in this strain (253). Moreover, 
various α-helical IM proteins may induce phospholipids translocation, which means 
that phospholipids flipping may not require a specific transporter but a range of α-
helical IM proteins (254).  
CL is also known as diphosphatidyglycerol because structurally it appears to contain 
two overlapping PG units. CL is also located in the OM of most Gram-negative bacteria 
under the regulation of the PhoPQ two-component system (255,256). PhoPQ is a 
protein complex that regulates the OM remodelling in S. typhimurium. E. coli and S. 
typhimurium rely on the PhoPQ regulators to active genes and downstream pathways 
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that function to increase OM hydrophobicity and decrease OM negative charge, to 
protect the bacteria (255) .It is also essential for bacterial pathogenesis and survival in 
various environments. However, CL is synthesized at the IM, which means that there 
should be a pathway for transporting CL from the IM to the OM (257,258). CL contains 
a tetra-acylated dimeric structure which allow cardiolipin to self-associate and form 
non-bilayer hexagonal phases (259). Some bacterial proteins bind CL for membrane 
fission during sporulation and cytoskeletal arrangement during cell division (260).  
Interestingly, CL is also present in the IM of mitochondria, where it occupies 20% of 
the total lipids and is required for the normal function of mitochondria (261,262). In 
yeast, the UPS1-Mdm35 complex has been identified to be responsible for transporting 
phosphatidicacid (PA) from the mitochondria outer membrane to inner membrane 
(263,264). In Gram-negative bacteria the Mla pathway (MlaA-F) has been speculated 
to be able to transport phospholipids form the OM to the IM (265). According to a 
report in 2015, in S. typhimurium, an inner membrane protein named PbgA (yejM gene 
product) was identified, which binds CL to promote PhoPQ-regulated trafficking of CL 
from the IM to the OM (256). It has also been reported that purified PbgA oligomers 
contain five transmembrane helices and a globular domain which binds to the OM in a 
PhoPQ-dependent manner (256).  
However, it remains unknown how PbgA interacts with cardiolipin and whether PbgA 
can bridge the envelope for regulated cardiolipin delivery. In this chapter, we will 
describe the successful cloning of PbgA and the PbgA globular domain. Furthermore, 
the first crystal structure determination of PbgA and related functional assays of PbgA 
are also included. 
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Figure 73 Cardiolipin sodium salt from bovine heart. 
Cardiolipin sodium salt from bovine heart is purchased from Sigma Aldrich 
(#C0563) and is used as the experimental substrate of PbgA in this chapter.  
 
 
Figure 74 PbgA binds to the OM in a PhoPQ-dependent manner. (256) 
A working model for how S. typhimurium regulate cardiolipin trafficking to the 
OM. Host environments that activate PhoPQ (left panel) induce PbgA to bind 
the OM and deliver cardiolipin that promote the barrier necessary for bacteria 
survival and replication within host tissues. When PhoPQ are not activated 
(right panel), PbgA is mostly unbound to the OM and OM-cardiolipin levels 
remain at baseline. (255) 
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4.2 METHODS AND MATERIALS 
4.2.1 Generation of PbgA expression plasmids from S. typhimurium and E. coli 
S. typhimurium and E. coli ycjM gene fragments from these two species encoding 
truncated PbgA protein from 191-586 and 245-586, respectively were amplified by 
PCR with restriction sites 5`-end NcoI and 3`-end EcoRI . The fragments were inserted 
into the same restriction enzymes treated plasmid pHISTEV which contains a 6×Histag 
and a TEV protease cleavage site between 6×Histag and the N-terminus of the cloned 
genes. Four plasmids encoding for the PbgA globular domain were generated named 
Sal-PbgA245-586 Sal-PbgA191-586 E.coli-Pbga245-586 E.coli-PbgA191-586 respectively. The 
full length PbgA gene from S. typhimurium and E.coli were inserted into pBAD24 in 
the same way, generating Sal-PbgA and E.coli-PbgA for full-length PbgA expression. 
All plasmids were sequenced and found to be correct. 
4.2.2 Expression and purification of PbgA globular domain 
All the different plasmids of the PbgA globular domain were transformed into 
SoluBL21 (DE3) (Invitrogen) and a single colony was picked, and inoculated, stored as 
glycerol stocks. The glycerol stock (SoluBL21 harbouring Sal-PbgA245-586, Sal-Pbga191-
586, E.coli-Pbga245-586 or E.coli-PbgA191-586) was inoculated into 500 ml LB overnight 
culture with 50 µg/ml kanamycin antibiotics. 12L LB medium were inoculated by 1:200 
of overnight cell culture with 50 µg/ml kanamycin. The cells were cultured in a 37°C 
shaker at 200 rpm until the OD600 reached 0.8-1.0 and the protein expression was 
induced by adding IPTG at 0.1 mM final concentration for 20 hours at 20°C and 200 
rpm shaking overnight. 12L of cell culture were then harvested into pellet by 
centrifugation at 5,000rpm (4,300g) for 15 min. Followed by re-suspending the cell 
pellet in Balance buffer (20 mM Tris-Cl, pH 7.8, and 300 mM NaCl 10mM imidazole 
10% glycerol, cOmplete EDTA-free Protease Inhibitor Cocktail Tablet (Roche) 50 
µg/ml DNAse I (Sigma) and 100µg/ml lysozyme). The cell re-suspension were lysed 
by passing a cell disruptor at 30,000 psi. The unbroken cells and cell debris were 
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removed by centrifugation at 20,000 rpm (40,000g) for 30 min. The supernatant was 
applied to pre-balanced (with Balance buffer) 5ml HP HisTrap (Ge Healthcare). The 
column was washed using Wash buffer which is prepared by increasing imidazole 
concentration of the Balance buffer to 30mM, and then the PbgA protein was eluted by 
Elution buffer (20 mM Tris-Cl, pH 7.8, and 300 mM NaCl, 300 mM imidazole and 10% 
glycerol). The protein sample was desalted using a Balance buffer pre-balanced 
desalting column (GE healthcare) to remove imidazole. Subsequently, TEV protease 
was added into the desalted protein at a TEV protease to protein mass ratio 1:100 and 
incubated overnight to cleave the 6×Histag off the fusion protein at the TEV cleavage 
site. After cleavage, PbgA protein sample was loaded into the pre-balanced 5ml HP 
HisTrap to remove the TEV protease (TEV protease contains a 6×Histag) and the 
cleaved 6×Histag. During this step PbgA globular domain would directly go through 
the column into a collection tube and be concentrated below 10 ml. The PbgA protein 
was further purified by gel-filtration using a pre-equilibrated SEC (HILOAD 16/600 
SUPERDEX 200 PG, GE Healthcare) with (150 mM NaCl 20 mM Tris pH 7.8). The 
gel-filtration fractions were analysed using SDS-PAGE and the most pure fractions 
were pulled and concentrated to 5-10 mg/ml for crystallization trails. 
 
4.2.3 Selenomethionine labelling of Sal-PbgA245-586 
The selenomethionine mediums and related solutions are listed in Appendix 1 (247). 
The glycerol stock (SoluBL21 harbouring Sal-PbgA245-586) was inoculated into 500ml 
LB overnight culture with 50 µg/ml kanamycin. 500 ml cell culture was harvested under 
sterile conditions. The pellet was washed with sterile PBS 2 times and re-suspended 
into 200 ml PBS for subsequent cultures. In each 1L M9 medium 50 µg/ml kanamycin, 
50 ml Selenomethionine Medium Nutrient Mix solution and Additional solution were 
added before inoculation of 20 ml PBS re-suspended overnight culture. The cells were 
cultured in 37°C shaker at 200 rpm until the OD600 reached 0.5 just in the same way as 
for the native protein and then 10ml SeMet inhibitor amino acid solution was added to 
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each 1 L culture. After 15 min incubation, 1 ml Selenomethionine solution was added 
to each litre of culture and waited for another 15 min before Sal-PbgA245-586 expression 
was induced by adding IPTG at final concentration at 0.1 mM for 20 hour at 20°C and 
200 rpm shaking overnight. The rest steps followed the native PbgA245-586 purification 
method. 
 
4.2.4 Full-length PbgA expression and purification 
The plasmid pBAD24-PbgA encoding full length PbgA was transformed into C43 
(DE3) strain (Novagen) for protein expression. The glycerol stock was first inoculated 
into 500 ml LB overnight culture supplemented with antibiotic (ampicillin 100 µg/ml). 
Then the bacterial cell culture were amplified into 12 L LB supplemented with 
ampicillin 100 µg/ml at 37 °C until the OD600 reached 0.6. Then PbgA expression was 
induced with 0.02% L-arabinose for 16 h at 20 °C. Cells were harvested into a pellet 
by centrifugation at 5,000rpm (4,300g) the next day and the pellet was re-suspended in 
20 mM Tris-Cl, pH 7.8, and 150 mM NaCl supplemented with cOmplete EDTA-free 
protease inhibitor tablet (Roche), 1 mM DNaseI (Sigma-Aldrich) 100 µg/ml lysosome. 
The cells were broken by passing twice through a cell disrupter at 30,000 psi (Constant 
Systems Ltd). The cell debris was removed by centrifugation at 18,000 g for 15 min at 
4°C. The cell membrane was collected by ultracentrifugation at 100,000 g for 1 h at 
4°C. The membrane fraction was solubilized with Extraction Buffer (20 mM Tris-Cl, 
pH 7.8, and 300 mM NaCl 10 mM imidazole) supplemented with 1% (w/v) n-Dodecyl-
β-D-Maltopyranoside (DDM) (Anatrace) supplemented with cOmplete (Roche) at 
room temperature for 20 min. The suspension was then ultracentrifuged at 100,000 g 
for 30 min before loaded onto a 5ml HisTrap HP column (GE HealthCare) and washed 
with Wash Buffer (20 mM Tris-Cl pH 7.8 300 mM NaCl 60 mM imidazole) 
supplemented with 0.05% (w/v) DDM. The PbgA full length protein was eluted with 
Elution Buffer (20 mM Tris-Cl, pH 7.8, 300 mM NaCl and 300 mM imidazole) 
supplemented with 0.05% (w/v) DDM. The protein was further purified using size 
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exclusion chromatography with a HiLoad 16/600 Superdex 200 prep grade column (GE 
Healthcare) in 20 mM Tris-Cl, pH 7.8, 150 mM NaCl and 0.05% (w/v) DDM. Protein 
fraction of the highest purity were collected and concentrated to 10-30 mg/ml. 
 
4.2.5 Crystallization and data collection of PbgA globular domain 
Protein crystallization trails were performed using 1µl protein plus 1µl reservoir 
solution by the sitting-drop vapour diffusion at room temperature using a Gryphon 
robot. The screening solutions were purchased as commercial membrane protein 
screens (Table 10). Optimization were prepared for several top quality crystals. The 
crystals were harvested after 21 days and cryoprotected before flash freezing by liquid 
nitrogen. The cryoprotectants were prepared by replacing 20% of water with glycerol 
in final crystallization condition. Sal-PbgA245-586 native and Se-Met incorporated 
crystals were obtained from 0.1M Bis-tris pH 5.5 and 16% PEG3350. E.coli-PbgA245-
586 crystals were obtained from 0.2M lithium sulphate, 0.1M sodium acetate pH 4.3 and 
48% PEG400. Sal-PbgA191-586 crystals were obtained in 0.1M Bis-tris pH 6.5 and 25% 
PEG3350. 
Native data were collected at Diamond Light Source, UK at beam station I04. All data 
were processed by the XDS pipeline at beam centre automatically. Selenomethionine 
derivation SAD data was collected at I02 using the peak wavelength resulting from a 
fluorescence scan of the selenomethionine-labelled sample.  
 
4.2.6 Crystallization of full length PbgA and unexpected AcrB crystal  
Unexpected crystal structure of acrB gene product was determined during our trails of 
crystallization the full length PbgA (266). During our purification and crystallization of 
PbgA full length experiments, we have obtained a small triangle shaped crystal and 
diffracted up to 4.2 Å in the initial screening. After optimizing, the crystals become 
bigger and diffracted up to 3.5 Å with an impressive unit cell dimensions, of which one 
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axis is over 550 Å. The Matthew cell content analysis of CCP4i shows that there should 
be at least three PbgA full length protomers in the asymmetric unit. However, we could 
not just ignore the unit cell dimensions, so we have put the crystal parameter into the 
nearest-cell (267) online program. The result contained several structure files with 
nearly exact unit cell parameters. Unfortunately, this crystal was AcrB, the 114kD 
multidrug resistance bacterial IM protein. We did not continued on PbgA full length 
inner membrane protein because there were no more crystal hits besides this one. It is 
a common difficulty to perfectly purify a bacterial inner membrane protein (LptB2FG 
complex is also not perfect pure as well). But we still didn`t expect such a faint bands 
on SDS-PAGE at top of lane 9 in Figure 75 would result in such a high resolution 
crystal.  
 
4.2.7 Structure determination of PbgA globular domain 
Selenomethionine anomalous SAD data of S. typhimurium was processed and scaled 
with XIA2 (144) automate pipeline. According to the Cell content analysis in CCP4i, 
the asymmetric unit may contain 3-4 PbgA molecules. The substructure and 
experimental phases of Sal-PbgA245-586 were solved using the SHELXC/D/E suite 
(148). SHELX C generates column labels of the SAD data making preparation for 
SHELX D, which SHELX D determine the substructure of the SAD data. Finally 
density modification was performed by SHELX E to generate an initial electron density 
map. 35 selenomethionine sites were found by SHELX suit.  According to the SHELX 
graphic figures, the inverted hand is correct. So, we selected the inverted reflection 
output file (.mtz file) for model building. The initial model of the Sal-PbgA245-586 was 
automatically built using the program BUCCANEER (154) from CCP4i on the initial 
map. After several rounds of refinement by REFMAC5 (159), the initial PbgA structure 
was solved automatically, with Rfree=0.35. In the asymmetric unit there are four PbgA 
molecules. Then we changed the MSE residue to MET residue in the coordinates file 
and save single PbgA as a separate coordinate file to generate a model for molecular 
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replacement to solve the native S typhimurium data and the E. coli PbgA. All the 
structures were finally refined by REFMAC5, improved by COOT and validated by 
Molprobilty (268),  
The crystal structure of PbgA191-586 belonged to the space group P21 with cell 
dimensions a = 51.48, b =195.65, c = 70.92, α = γ = 90°, β = 96.39°. The structure of 
Sal-PbgA191-586 was determined by molecular replacement with a final Rfree = 0.27 
(Table 9). However according to the structure, there was no visible electron density for 
loop regions from residue 191 to residues 586. Similarly, there were 4 protomers within 
the asymmetric unit. The protomer A is superimposed well with protomers B, C and D 
with RMSD of 0.2642Å, 0.4338Å and 0.5627Å over 340 Cα atoms, respectively. 
The crystals of E. coli PbgA245-586 belonged to the space group P3121 with cell 
dimensions a = b = 57.42 Å, c = 191.31 Å, α = β = 90°, γ = 120° Table 9. This structure 
was also determined by molecular replacement. However there was only one monomer 
within the asymmetric unit rather than four. These three structures above were strikingly 
similar to each other with only limited conformational changes was observed after 
superimposition of each other. The Sal-PbgA191-586 structure is very similar to Sal-
PbgA245-586 structure with RMSD of 0.5945 Å over 340 Cα atoms. The E.coli-PbgA245-
586 structure resembles Sal-PbgA254-586 structure with a RMSD of 0.9264Å over 340 Cα 
atoms. In particular, the β4 of E.coli-PbgA245-586 moves away approximately 8Å 
 
4.2.8 Site direct mutagenesis functional assay in PbgA deletion strain 
The NRD183 strain, used as PbgA deletion strain in this Chapter, contained kanamycin 
resistance gene during ycjM knockout generation and harboured a pBAD origin rescue 
plasmid pNR217 (AmpR) at the same time. The NRD183 strain yet contained the part 
of the ycjM gene that encode the transmembrane domain of PbgA while only the part 
of gene, that encoded the periplasmic domain of PbgA, was deleted resulting in an 
essential transmembrane domain remained genotype. In fact, the NRD183 strain was 
an ycjM partial deletion strain and conditional lethal under 50 µg/ml vancomycin.  
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As for the functional assays, a leaky expression vector encoding full length E. coli PbgA 
was cloned into the pACYC-Duet plasmid (Novagen) using the same method as other 
gene cloning 4.2.1. This plasmid was used as the template to generate all the rest single 
or double mutations and used as positive control in the following functional assay 
experiment. All site direct mutations were generated following Liu`s protocol (143) and 
confirmed by sequencing.  
All mutations, positive control and negative control (empty pACYC-Duet plasmid) 
were transformed into NRD183 strain respectively. The transformed cells were grown 
on LB agar plate supplemented with 0.2% L-arabinose and antibiotics (kanamycin 50 
µg/ml, chloramphenicol 34 µg/ml, ampicillin 50 µg/ml). Single colony was picked into 
5 ml overnight culture supplemented with same component as above for functional 
assay streaking. In functional assay analysis, cells were harvested, washed and diluted 
in sterile LB medium to OD600 = 0.5 and streak onto LB agar plates supplemented with 
50 µg/ml vancomycin, 50 µg/ml, chloramphenicol 34 µg/ml and 5 mM IPTG. Cell 
growth was recorded after overnight incubation at 37°C. All the assays were repeated 
in triplicate. 
 
4.2.9 PbgA-cardiolipin co-sedimentation assays 
CL from sigma (Cat#: C0563) was first dissolved in chloroform using a glass tube at 
500 mM concentration and dried up again under nitrogen gas flow, which protected it 
from being oxidized by O2 from air. Then the fine powder was re-suspended in 20 mM 
Tris (pH 7.8) and 150 mM NaCl by sonication until solution became almost clear. After 
the cardiolipin aqueous solution been prepared, Sal-PbgA245-586 was mixed with 
cardiolipin solution at 1:10 molar ratio (2 mM: 20 mM final concentration respectively) 
at 37°C for 1 hour. After that the mixture was centrifuged at 13,200rpm (12,000g) for 
15min until the supernatant looks clear without turbidity, the supernatants were pipetted 
out into an tube and the precipitants were re-suspended in 20 µl 20 mM Tris (pH 7.8) 
150 mM NaCl. To each sample 4×SDS-Loading buffer was added until fully dissolved 
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and proteins were separated on SDS-PAGE after 10 min boiling at 95°C. 
 
4.3 Results 
4.3.1 Expression and purification of PbgA globular domain and full length PbgA  
Both the E. coli and S. typhimurium PbgA globular domains (PbgA245-586 & PbgA191-
586) have been successfully purified (Figure 75). The PbgA191-586 protein degraded 
easier compared to PbgA245-586 protein, which suggests that the loop region between 
residues 191 and 245 could be quite flexible and might affect crystallization.  
PbgA is located in Gram-negative bacteria with the globular domain extending into the 
periplasm. The full length PbgA was purified from inner membrane manner, using 
detergent DDM to solubilize and stabilize PbgA (Figure 75). Both the full length E. coli 
and S. typhimurium PbgA were successfully expressed and purified (only S. 
typhimurium PbgA SDS-PAGE was presented here). 
 
  
Various PbgA samples were analyzed on SDS-PAGE to verify the protein 
expressions. Lane 1: Purified Sal-PbgA191-586 protein; lane 2: Crystals of Sal-
PbgA191-586; lane 3: Elastase digested purified Sal-PbgA191-586 protein; 
lane 4: Crystals of Elastase digested Sal-PbgA191-586; lane 5: Purified Sal-
               1  2   3   4  5  6   7   8  9 
111kD 
66kD 
 
45kD 
35kD                                                                 
25kD           
18.4kD 
14.4kD 
 
Figure 75 SDS-PAGE analysis of various PbgA samples 
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PbgA245-586 protein; crystals of Sal-PbgA245-586; lane 9: Purified full length 
Sal-PbgA. All crystals from this SDS-PAGE analysis had been washed with 
reservoir buffer three times by immersing crystals inside for 1 min. 5µl samples 
were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE Loading buffer. The SDS-
PAGE samples were loaded into SDS-PAGE gel after heating on 90°C for 
10min. The visualization of the bands was achieved by dying the gel in Quick 
Coomassie Stain (Generon) for 15min at room temperature. Bolt™ 4-12% Bis-
Tris Plus Gels, 12/15-well (Thermo Fisher Scientific) 
 
4.3.2 Crystallization and optimization of the PbgA globular domain 
Both the E. coli and S. typhimurium PbgA globular domains were crystalized using the 
sitting drop diffusion method by crystallization robot Gryphon. Lots of crystals were 
grown from various conditions of different PbgA proteins. Most of the crystals 
diffracted well, with resolution up to 1.64 Å. We had tried extensively to optimize the 
crystals by varying crystallization conditions. Those crystals were reproducible and had 
been optimized with hand-made 5×5 optimization solutions to produce enough crystals. 
Selenomethionine labeled Sal-PbgA245-586 protein crystallized in both native crystal 
conditions and other screen conditions. Sal-PbgA245-586 native and Se-Met incorporated 
crystals were obtained from 0.1M Bis-tris pH 5.5 and 16% PEG3350. E.coli-PbgA245-
586 crystals were obtained from 0.2M lithium sulphate, 0.1M sodium acetate pH 4.3 and 
48% PEG400. Sal-PbgA191-586 crystals were obtained in 0.1M Bis-tris pH 6.5 and 25% 
PEG3350. 
 
4.3.3 Crystal structure determination of the PbgA globular domain 
The structure of the Sal-PbgA245-586 was determined using SAD data from 
selenomethionine-incorporated crystals. The crystal belonged to space group P21 and 
diffracted to high resolution, 1.64 Å, (Table 9). There were four protomers of PbgA245-
163 
 
586 in the asymmetric unit. The structure of each protomer in the asymmetric unit shared 
high similarity with the other three with only minor differences. The final model of the 
PbgA245-586 contained residues Q245-I563 and P568-585, while no electron densities 
for the loop between I563-P568 was visible, indicating that this loop might be 
disordered. Overall, the structure of PbgA245-586 shaped like a burger with an α/β fold. 
The crystal structure of PbgA191-586 belonged to the space group P21 with cell 
dimensions a = 51.48, b =195.65, c = 70.92, α = γ = 90°, β = 96.39°. The structure of 
Sal-PbgA191-586 was determined by molecular replacement with a final Rfree = 0.27 
(Table 9. However according to the structure, there was no visible electron density for 
loop regions from residue 191 to residues 586. Similarly, there were 4 protomers within 
the asymmetric unit. The protomer A is superimposed well with protomers B, C and D 
with RMSD of 0.2642Å, 0.4338Å and 0.5627Å over 340 Cα atoms, respectively. 
The crystals of E. coli PbgA245-586 belonged to the space group P3121 with cell 
dimensions a = b = 57.42, c = 191.31, α = β = 90°, γ = 120° Table 9. This structure was 
also determined by molecular replacement. However there was only one monomer 
within the asymmetric unit rather than four. These three structures above were strikingly 
similar to each other with only limited conformational changes was observed after 
superimposition of each other. The Sal-PbgA191-586 structure is very similar to Sal-
PbgA245-586 structure with RMSD of 0.5945 Å over 340 Cα atoms. The E. coli-PbgA245-
586 structure resembles Sal-PbgA254-586 structure with a RMSD of 0.9264Å over 340 Cα 
atoms. In particular, the β4 of E.coli-PbgA245-586 moves away approximately 8Å. 
Due to the insufficiency on PbgA functional studies (potential CL transporter), we tried 
to identify whether there are similar structures of PbgA for functional information. The 
Dali server (269) was used with Sal-PbgA245-586 as initial model. According to the 
result, the PbgA globular domain have similarities to sulfatase family enzymes, where 
arlsulfatase (PDB code 1HDH (270)) has Dali-sore of 29.9. The sulfatases hydrolyze 
different sulfate esters, utilizing an active site consisting a metal binding site combined 
with several conserved and oxidized cysteine or serine residues. Although the overall 
structure of PbgA was quite similar to the sulfatase, superimposition showed that Sal-
PbgA245-586 does not contain a cysteine or serine at the enzymes’ active site (Figure 78). 
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The Dali-server also suggested another structure with Dali score of 28.4 a lipoteichoic 
acid synthase from Straphylococcus aureus (LatS, PDB code 2W5T). Despite only 17% 
sequence identity to Sal-PbgA, LatS is also located in the inner membrane with five 
transmembrane domains and a globular soluble domain which was strikingly similar to 
Sal-PbgA245-586 (Figure 79). The LatS structure contained an active site pocket for 
binding a Mn2+ ion and β-glycerol phosphate. However, according to the 
superimposition, the residues that make up the pocket of Sal-PbgA245-586 was totally 
different from the LtaS, suggesting that it is impossible for Sal-PbgA245-586 to bind metal 
ion or bind PG. 
 
 E. coli-PbgA245-586 
Native 
Sal-PbgA191-586 
Native 
Se-Met Sal-PbgA245-586 
 (SAD) 
Data collection      
Space group P3121 P21 P21 
Cell dimensions    
    a, b, c (Å) 57.21, 57.42, 191.31 51.48, 195.65, 70.92 51.60, 196.09, 70.27 
, ,  ()  90.0, 90.0, 120 90.0, 90.0, 96.39 90.0, 90.0, 95.79 
Wavelength (Å) 0.9795 0.9795 0.9795 
Resolution (Å) 47.83-1.67 (1.71-1.67) 65.22-2.19 (2.25-2.19) 65.85-1.64 (1.68-1.64) 
Rmerge (%) 14.3 (26.40) 16.5 (27.80) 15.2 (25.03) 
CC1/2 (%) 100 (59.5) 98.7 (54.5) 99.9 (49.5) 
I /(I) 17.8 (1.1) 5.8 (1.8) 15.1 (1.1) 
Completeness (%) 99.6 (99.2) 99.4 (99.4) 95.1 (89.2) 
Redundancy 9.6 (7.6-9.9) 6.1 (6.4-4.8) 11.8 (13.1-6.1) 
Anomalous  
Completeness 
   
Anomalous  
Redundancy   
   
Phasing    
Resolution (Å) 47.83-1.67  65.22-2.19 65.85-1.64 
Site (Se)   35 
Figure of merit   0.672 
Refinement    
Resolution (Å) 47.83-1.67  65.22-2.19 65.85-1.64 
No. reflections 44003 (4034) 51747 (5044) 66831 (6540) 
Rfactor / Rfree 0.18/0.21 0.20/0.24 0.19/0.22 
No. atoms    
    Protein 2604 10724 10745 
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    Water 498 961 1243 
B-factors    
    Protein    
    Ligand 
    Solvent                            
 
 
  
R.m.s.deviations    
Bond lengths (Å) 0.014 0.02 0.017 
Bond angles () 1.90 1.93 1.80 
Ramachandran statistics    
    Favoured (%) 97 93 95 
   Allowed (%) 3 7 5 
PDB code 5I5H 5I5F 5I5D 
Table 9 Data collection and structure refinement statistics of PbgA globular domian. 
Rfactor = Σ|| Fobs|−| Fcal||/Σ|Fobs|, where Fobs and Fcal are observed all 
reflection measured and calculated currently model as structure factors, 
respectively. Rfree is calculated using 5% of total reflections, which is randomly 
selected not used in refinement. 
 
 
Figure 76 Amonalous difference Fourier map of selenomethionine deirved Sal-PbgA245-
586 and the 2Fo-Fc map of the 1.64 Å dataset. 
(a) The SAD data of selenomethionine incorporated crystals were collected at 
0.9795 Å. The anomalous difference Fourier map contoured at 8.0σ was 
calculated using PHENIX (155) with the anomalous dataset and the final Se-
Met model. The peak position matches the Se atoms confirming the phasing is 
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accurate (b) 2Fo-Fc map of the 1.64 Å PbgA dataset is contoured at 1.0σ. PbgA 
structure is shown in ball-and-stick model [O atom (red), N atom (blue), S atom 
(yellow)]. 
 
 
Figure 77 Superimposition of of structures of Sal-PbgA and E. coli-PbgA 
(a) Sal-PbgA and E. coli-PbgA are superimposed well with each other. Sal-PbgA 
is coloured in red, and E. coli-PbgA is coloured in green. (b) Rotates 90° along 
y-axis relative to the left panel. Cα atoms of Loop S371-S360 moves away by 
a maximum of approximate 8Å from of Sal-PbgA to E. coli-PbgA. The E. coli-
PbgA245-586 structure resembles Sal-PbgA254-586 structure with a RMSD of 
0.9264Å over 340 Cα atoms. 
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The Dali server showes that PbgA resembles the sulfatases that hydrolyse 
different sulphate esters, utilizing an active site consisting a metal binding site 
combined with several conserved and oxidized cysteine or serine residues. Sal-
PbgA245-586 (red) is superimposed to arylsulfatase (matanga) with RMSD of 
2.9 Å over 296 Cα atoms. Although the overall structure of PbgA is quite similar 
to the sulfatase, superimposition shows that Sal-PbgA245-586 does not contain 
a cysteine or serine at the enzymes’ active site. The arylsulfatase has additional 
α-helices and loops (blue) which might function in substrate binding. Sal-
PbgA245-586 is similar to it but did not contain the same catalytic residues. Side 
chains are shown in ball-and-stick model [O atom (red), N atom (blue), S atom 
(yellow)]. 
Figure 78 Superimposition of Sal-PbgA245-586 with arylsulfatase 
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The Dali server showed PbgA resembles the lipoteichoic acid synthase. Sal-
PbgA245-586 (red) is superimposed to lipoteichoic acid synthase (yellow) at the 
active site with RMSD of 3.0 Å over 284 Cα atoms. GP refers to the β-Glycerol 
phosphate (sn-glycerol-2-phosphate) which is the substrate for lipoteichoic acid 
synthase (271). However, the corresponding GP binding residues are not found 
in PbgA indication that PbgA does not have GP binding ability. Side chains and 
GP are shown in ball-and-stick model [O atom (red), N atom (blue), S atom 
(yellow) Mn atom (purple)].  
  
Figure 79 Superimposition of Sal-PbgA245-586 with lipoteichoic acid synthase 
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4.3.4 Functional assay of PbgA in E. coli PbgA deletion strain 
After determining the structure of PbgA globular domain, we designed a series 
experiments to explore the possible function and mechanism related to PbgA. 
Mutations: F349A, F292A, F519A, R215A/R216A, L343A, F394A, V471A, W477A, 
F285A, F362A, S351C/D303C, W396A, F310A, Y354A, F344A, F275A, L359A, 
W393D, W379C/S395C, D372C/F399C were generated by site direct mutagenesis, on 
pACYC-E.coli-pbgA. And pACYC-E.coli-pbgA was used as the positive control in the 
functional assays as well. These mutations cover the region of the three layers of PbgA 
globular domain. In particular, the second layer is made up of β1-7 and the third layer 
is made up of α-helices 2, 4, 5 and 10. This region fold into a hydrophobic core by 
residues L343, W396, F394, V262, W477, L473, V471, F292 from the β-sheet of the 
second layer, and residues F349, Y354, L334, F310, L309, F519 from the third layer 
(Figure 80 and Figure 81). We speculate that this hydrophobic core between the second 
and third layer may be responsible for CL transportation, so mutations L359A, F292A, 
F349A, F519A, L334A, L343A, F394A, W396A, V471A and W477A, as well as a 
double alanine substitution R215A/R216A were generated. It is also possible that the 
hydrophobic core between the first layer and the second layer is the CL transportation 
pathway. To explore this possibility, mutations F344A, W393D, and double mutants 
F399C/D372C and W397C/S395C were generated. The NRD183 strain was 
conditional lethal under 50 µg/ml vancomycin, which stimulates a stressful bacterial 
living conditions. Under this condition, the lethal phenotype of NRD183 could be 
rescued by positive control, which demonstrate that the leaky expression of E. coli 
PbgA could reach native level and was functional. From the similarity between Sal-
PbgA245-586, sulfatase and LtaS (Figure 78 and Figure 79), we speculated that the 
hydrophobic core between second and third layers might be responsible for cardiolipin 
binding. To explore this possibility, single alanine substitution of hydrophobic residues 
were generated as described. The F292A mutant was lethal, the F349A, R215/216A, 
W396A, F362A and F275A severely impaired bacterial growth under 50 µg/ml 
vancomycin, while mutants L343L, F394A, V471A and W477A had minor effect on 
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cell growth (Figure 81). Those results suggest that the residues F292, R215/216, W396, 
F362 and F275 in the hydrophobic core between second and third layer were important 
for cardiolipin transport. While, mutants F344A, W393D F399C/372D and 
W397C/S395C between the first and second layer are not involved in cardiolipin 
binding or transfer. This results suggested that it is the hydrophobic core between the 
second and third layer that may participate in the CL transport. 
As a potential cardiolipin transporter, PbgA should possess a pathway, in which 
cardiolipin could pass. To explore that, we designed double cysteine disulfide bond 
mutants S351C/D303C to lock the flexible loop (D347-Q370). This loop had high B-
factors between helices α4 and α6, indicating that this loop was flexible and might act 
as a lid for the cardiolipin binding and transport. S351C/D303C cause severe cell 
growth deficiency, indicating that this might be a pathway for Cl transport (Figure 81 
and Figure 82). 
 
 
Figure 80 The Sal-PbgA245-586 contains three layers. 
Cartoon representation of crystal structure of Sal-PbgA245-586 in rainbow. The 
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PbgA structure is coloured in rainbow. The structure of Sal-PbgA245-586 has the 
α/β fold, which looks like a burger, where helices α1, α6 and α7 are at the top 
layer, β-strands 1, 2, 3, 4, 5, 6, 7, 8, α8 and α9 form the second layer, α-helices 
2, 4, 5 and 10 form the third layer, and β-strands 8, 9, 10, 11, α11 and α12 form 
the bottom layer 
 
Figure 81 Mutations and in vivo functional assay of E.coli PbgA in NR183 strain 
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(a) The potential cardiolipin binding site between layer 2 and 3 (layer division 
shown in Figure 80). The hydrophobic residues were coloured in deep salmon. 
(b) Rotation of 180° along y axis relative to the left panel. (c) Hydrophobic 
residues between layer 1 and 2 are coloured in purple. (d) Rotation of 180° 
along y axis relative to left panel. (e–i) The functional assay plates of PbgA 
mutants against 50 µg/ml vancomycin environmental pressure. The functional 
assays are performed using NRD183 conditional lethal strain. WT or mutants 
were transformed into NRD183 respectively. P: positive control. (NRD183 with 
pACYC-PbgA) N: negative control (NRD183 with pACYC empty vector).  
 
(a) Cartoon demonstration of the potential cardiolipin binding lid coloured in 
yellow. The double cysteine mutants S351C/D303C are labelled and might form 
a disulphide bond closing the lid for cardiolipin binding. (b) The cartoon 
demonstration of the B-factor of Sal-PbgA structure. The radius of the cartoon 
structure represent the relative B-factor. The larger the radius of the region, the 
higher B-factor, suggesting the higher flexibility of the respect region. The PbgA 
loop, consisting of residues D347-Q370, had higher B-factor than other local 
secondary structure representing the flexibility of this loop. This structure 
feature is same in the E. coli PbgA globular domain, suggesting that the flexible 
Figure 82 Sal-PbgA potential cardiolipin binding lid 
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loops may have conformational changes when CL binds in. 
 
4.3.5 PbgA-CL co-sedimentation assays 
Cardiolipin binding was confirmed in vitro by PbgA-cardiolipin co-sedimentation 
assays. The wild type of E.coli-PbgA191-586 can form co-sedimentation product at the 
presence of CL while R215A/216A mutant nearly cannot (256). Mutant proteins 
(F349A, R215A/216A, F292A and F362A) of E. coli-PbgA191-586 were overexpressed 
and purified as described in method 4.2.2. Mutants F349A, R215A/216A, F292A and 
F362A showed low cardiolipin co-sedimentation levels compared to the wild type 
Figure 83. This result was consistent with our functional assays, supporting that the 
cardiolipin binding of these mutants was impaired. F519A mutant formed inclusion 
bodies during purification and failed to be purified like other mutants. 
 
Wild type E. coli-PbgA191-586 and its mutants were mixed with cardiolipin 
solutions and incubated at room temperature before centrifugation was applied. 
Supernatant and resuspended pellets were subjected to SDS-PAGE. Wild type 
Figure 83 PbgA191-586-cardiolipin co-sedimentation result  
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E. coli-PbgA191-586 showed the highest level of co-sedimentation after 
incubation with CL at 1:10 (protein: CL) molar ratio. S: supernatant, P: pellet. 
Different mutant proteins showed different co-sedimentation level, 
R215A/R216A was the weakest one, while the other mutant proteins fell in 
between. The mutations that affected the CL-PbgA co-sedimentation levels 
were suggested to play important roles in CL binding. F519A PbgA mutant is 
not detected. The other mutants were found to decrease PbgA-CL co-
sedimentation level, suggesting that they may participate in CL transportation. 
5µl samples were mixed with 10µl ddH2O and 5µl 4×SDS-PAGE Loading buffer. 
The SDS-PAGE samples were loaded into SDS-PAGE after heating on 90°C 
for 10min. The visualization of the bands was achieved by dying the gel in Quick 
Coomassie Stain (Generon) for 15min at room temperature. 
 
4.4 CONCLUSION AND DISCUSSION 
The OM of Gram-negative bacteria is an asymmetric membrane composed of 
phospholipids and lipopolysaccharide. Both lipids play important roles in the 
pathogenesis and drug resistance. Despite extensive studies on LPS biosynthesis and 
transport pathways, the mechanism for phospholipids transport and assembly in Gram-
negative bacteria remains to be further studied at a structural level. According to the 
previous studies, it seems that GPL flipping from the inner leaflet of IM to the outer 
leaflet of the IM does not require a specific flippase but can be achieved via a broad 
range of α-helix fold IM transmembrane proteins (110).  
However, the delivery of the GPL from the IM to the inner leaflet of the OM remains 
unknown. One possible explanation is that the inner leaflet of the OM and the 
periplasmic leaflet of the IM may form communication in bilayer lipids manner and 
lipids flow from IM to the inner leaflet of the OM and balancing the lipid amount. The 
other explanation is that there are some proteins or protein complexes responsible for 
transporting GPL from IM to the OM across the hyphophilic periplasm. By whichever 
175 
 
methods, the remodelling of the OM does exists and there are proteins that can adjust 
the GPL component ratio in the OM inner leaflet (272). Cardiolipin plays an essential 
role in the OM remodelling and is critical for mitochondrial function (272). PbgA 
transports CL from the IM to the OM in Gram-negative bacteria via the PhoPQ 
dependent mechanism (256). Mitochondria evolved from bacteria and the UPS1-
Mdm35 (273) complex has been identified for phospholipid transport from the OM to 
the IM in yeast. The structure of UPS1 does not resemble PbgA. The UPS1 contains a 
concave 7-antiparellel stranded β-sheets, which hold PA molecules inside. In contrast, 
PbgA does not contain such cavity, implying that in PbgA it might be the third layer 
rather than the first or second layer that is responsible for CL transportation. This 
analysis is also consistent with our functional assays (Figure 81). Superimposition of 
PbgA245-586 with arylsulfatases and lipoteichoic acid synthase showed striking overall 
similarity, but low structural identity in the active sites or metal binding sites. The result 
of superimposition suggest that PbgA is different from arylsulfatases or lipoteichoic 
acid synthase. Our functional assays and co-sedimentation results both point to the 
importance of residues F292, F349 and F362 in the functionality of PbgA and the 
mutants of them would impair cell growth or affect CL binding affinity. These three 
residues are located in the hydrophobic core between layer 2 and 3 suggesting that this 
it is a potential cardiolipin binding or transporting site. Additionally, the mutations that 
aimed at disrupting the first or second layer, cause relatively weak impairment of cell 
growth, which further confirm the importance of hydrophobic space between of layer 
2 and 3. The structures of the E.coli-PbgA245-586 and Sal-PbgA245-586 are very similar 
without little conformational difference (Figure 77). The loop made up of residues 
D347-Q370 between these two structures is in different conformation between E.coli-
PbgA245-586 and Sal-PbgA245-586, and the B-factor along this loop are higher than 
neighbouring residues (Figure 82), suggesting the flexibility of this loop. We speculate 
that this loop region may be the lid for CL binding, which can open or close the space 
between layer 2 and 3 for the entry of CL. 
Our structural and functional studies have revealed that the hydrophobic core between 
the layer 2 and 3 may be responsible for CL binding, and that the residues D347-Q370 
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may form a lid for CL transport. This is the first structure study of PbgA, a bacterial 
protein involved in phospholipid transport from the inner membrane to the OM. 
However, the missing N-terminal transmembrane domain may also play an important 
role in the CL transportation function. There are five transmembrane α-helices in the 
transmembrane domain of PbgA (256). And the transmembrane domain of PbgA is 
essential rather than the globular domain (256). Our functional studies were based on 
the conditional lethal PbgA globular domain deletion strain NRD183, and the mutations 
were generated on the globular domain. If we could try to solve the full length structure 
of PbgA, we may study further into the mechanism of CL transportation. It is still 
interesting that how the CL is recognized from the IM and delivered from the IM to the 
OM. According to the previous studies, PbgA may for a tetramer to facilitate CL 
transport (255), which is consistent with our S. typhimurium PbgA crystal structure. 
There are 4 protormers in asymmetric unit. One hypothesis is that PbgA forms a 
tetramer by the interactions of four transmembrane domains, and forming a pathway 
for CL to pass through, the globular domain forms a CL pass channel that may facilitate 
the CL to be protected in the water filled periplasm. After PbgA transportation of CL, 
there should be an OM receptor that may receive CL. We still need to perform more 
biochemistry studies to identify PbgA related proteins. PbgA seems not to be able to 
work independently to transport CL from IM to OM. Identifying the full CL 
transportation path may facilitate the PbgA transportation mechanism.  
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Appendices 
Selenomethionine (SeMet) labelling related medium/solution recipe: 
10 L M9 medium Dissolve 64 g Na2HPO4-7H2O, 15 g KH2PO4, 2.5 g NaCl and 
5.0 g NH4Cl in 2L ddH2O and dilute into 10L then autoclave 
the medium. 
20×Selenomethionine 
Medium Nutrient Mix  
Dissolve 102 g powder in 1L sterile water and filter sterilized 
at last, (Molecular Dimensions Cat# MD12-502) 
50×Additional solution Dissolve 200g D-Glucose 12.5g MgSO4 (1 M), 0.02g thiamine 
in 1 L ddH2O and sterilized with filter at last. 
100×Selenomethionine 
inhibitor amino acid 
solution 
Dissolve 5g Lysine, 5g Phenylalanine, 5g Threonine, 2.5g 
Isoleucine, 2.5g Leucine and 2.5g Valine in 500ml sterile water 
and filter sterilized at last. 
1000×Selenomethionine 
solution 
Dissolve 1g Selenomethionine in 10ml sterile water. 
Appendix 1 Selenomethionine (SeMet) labelling related medium/solution recipe (274) 
This is the selenomethinone incorporated protein production solution recipie. 
Some of the solutions in the recipie can be omitted in some cases. The most 
essential component is the 10 L M9 medium, 20×Selenomethionine Medium 
Nutrient Mix, 100×Selenomethionine inhibitor amino acid solution and 
1000×Selenomethionine solution 
Appendix tables 
Crystallization screen kits Supplier company 
MemGold Molecular Dimensions 
MemGold2 Molecular Dimensions 
MemStart Molecular Dimensions 
Memsys Molecular Dimensions 
MemMeso Molecular Dimensions 
MemPlus Molecular Dimensions 
MIDAS Molecular Dimensions 
Morpheus Molecular Dimensions 
Morpheus II Molecular Dimensions 
MultiXtal Molecular Dimensions 
ProPlex Molecular Dimensions 
SG1 Screen Molecular Dimensions 
3D structure Screen Molecular Dimensions 
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JCSG-plus Molecular Dimensions 
MemAdvantage Molecular Dimensions 
PEG/ION Hampton Research 
Index Hampton Research 
Crystal screen Cryo Hampton Research 
Crystal Screen 2 Cryo  Hampton Research 
MembFcac Hampton Research 
Table 10 Commercial crytallizaion screening conditon kits used in all chapters 
These crystallization screening kits were bought in the 96×10ml form and 
divided into deep well blocks (1ml 96well) by hands. The deep well blocks 
containing each screens can be applied on Gryphon Robot directly. 
 
 
Ecoli_LapB_24_F ATATCCATGGCGCAACAAAACAAGCAAGATGAAG 
Ecoli_lapB_24_R ATATAAGCTTTTACAGGCCATCAAGACCGCG 
Sal_LapB_24_F ATATCCATGGCGCAACAAACAAAACAGGATGAAG 
Sal_lapB_24_R ATATAAGCTTCTACTGCCCATCAAGTCCGC 
Shi_lptCAB_F_EcoRI ATATGAATTCGAAGCCAAAGGGCAATCGATATG 
Shi_lptCAB_R_KpnI_8HIS ATATGGTACCTCAGTGATGGTGATGGTGATGGTGATGGAGTCTGAAGTCT
TCCCCAAGG 
Shi_lptFG_F_KpnI ATATGGTACCtttttacgggcgtatttaaaGTGATAATC 
Shi_lptFG_R_XbaI ATATTCTAGATTACGATTTTCTCATTAACAGCCACAG 
Shi_delet_1-76C_F TGGTTTACGCAGCCGGTACTTAC 
Shi_delet_1-76C_R CGGCTGCGTAAACCACATatcgattgccctttggcttc 
Neisseria_lpt82CAB_F_EcoRI ATATGAATTCgctttgaacgggtacatcaaATGGATTCGCCGCATCTCGTGTTCTTC 
Neisseira_lpt82CAB_R_KpnI_8HIS ATATGGTACCTTAGTGATGGTGATGGTGATGGTGATGATATTTGAAGTTCT
CGCCCAAATAGACGG 
Neisseria_lptFG_F_KpnI ATATGGTACCGCCCCCCTGACCGCGATTTTATG 
Neisseria_lptFG_R_XbaI ATATTCTAGATTAACGTTTTTCCTGTTTGCGTATCAGCC 
LT2_lpt76CAB_F_EcoRI ATATGAATTCgaggccaaagggcaatcgatATGTGGTTTACGCAACCGGTATTAAC 
LT2_lpt76CAB_R_KpnI_8HIS ATATGGTACCTTAGTGATGGTGATGGTGATGGTGATGGAGTCTGAAGTCT
TCCCCAAG 
LT2_lptFG_F_KpnI ATATGGTACCTTTTTACGGGCGTATTTAAAGTGATAATCATAAG 
LT2_lptFG_R_XbaI ATATTCTAGATTACGACTTACGCAGCATTAGCCAG 
Klebsiella_lpt76CAB_F_EcoRI ATATGAATTCgaggccaaagggcaatcaatATGTGGTTTACCAAGCCGGTGATG 
Klebsiella_lpt76CAB_R_KpnI_8HIS ATATGGTACCTTAGTGATGGTGATGGTGATGGTGATGGAGTCTGAAGTCT
TCCCCAAG 
Klebsiella_lptFG_F_KpnI ATATGGTACCTTTTTACGGGCGTATTTATAGTGATAATCATAAGATATCTGG
TTCG 
Klebsiella_lptFG_R_XbaI ATATTCTAGATTAGGCCTTGCGCATCATCAGCC 
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Legionella_lpt78CAB_F_EcoRI ATATGAATTCatcacaggctatttaaaacaATGCTTAAAAACCCCCATATTATTATTAA
GCAAG 
Legionella_lpt78CAB_R_KpnI_8HIS ATATGGTACCTTAGTGATGGTGATGGTGATGGTGATGCAAAGCAAATTCT
TCACCCAAATAAAC 
Legionella_lptFG_F_KpnI ATATGGTACCGTCCTCTGTAGGGTATTGTAGTGATTATTTTTC 
Legionella_lptFG_R_XbaI ATATTCTAGATTATCTGACTCTTCGCATTAAATAAATTCCAATTAAAG 
Klebsiella_lptCAB_F_EcoRI ATATGAATTCGAGGCCAAAGGGCAATCAATATG 
Klebsiella_lptCAB_R_KpnI_8HIS ATATGGTACCTTAGTGATGGTGATGGTGATGGTGATGGAGTCTGAAGTCT
TCCCCAAG 
K12_CAB_sm_F GAAGCCAAAGGGCAATCGATATGAGTAAAGCC 
K12_CAB_HIS_sm_R aattaGTGATGGTGATGGTGATGGTGATGGAGTCTGAAGTCTTCCCCAAGGT
ATACACG 
K12_FG_sm_F CACCATCACCATCACtaatttttacgggcgtatttaaaGTGATAATCATAAGATATCTG 
K12_FG_sm_R TTACGATTTTCTCATTAACAGCCACAGGC 
pTRC99a_sm_F TGTTAATGAGAAAATCGTAACGGGGATCCTCTAGAGTCGACC 
pTRC99a_sm_R ATCGATTGCCCTTTGGCTTCCATGGTCTGTTTCCTGTGTGAAATTGTTATC
CG 
Kan_SalI_F tatagtcgacATACAAGGGGTGTTATGAGCCATATTCAAC 
Kan_HindIII_R tataaagcttttagaaaaactcatcgagcatcaaatgaaactgc 
Sm_AmpKan_ptrc99a_F TGCTCGATGAGTTTTTCTAACTGTCAGACCAAGTTTACTCATATATACTTT
AGATTG 
Sm_AmpKan_ptrc99a_R CCCGTTGAATATGGCTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTA
TCAGG 
AcinetobacterLptB-FNcoI CATGCCATGGAGCAAGCTCTTCAACAACCGC 
AcinetobacterLptB-REcoRI ATCGGAATTCTTAATGATGATGATGATGATGAACTGTGAAATCATCACCTA
AATAGACT 
AcinetobacterLptC-FNcoI CATGCCATGGTTAATGAGACAATGAAGCATCAGTTT 
AcinetobacterLptC-RHindⅢ TCGCAAGCTTCACTTTGTAGAGAGTAAGCCGCCTTG 
AcinetobacterLptF-FNdeI GGAATTCCATATGATTATTCGGCGTTATCTCGTCAAGCAAGT 
AcinetobacterLptG-NXhoⅠ TATACTCGAGTTAACGGGCCCGATAAAGCAAATAACTTCC 
citrobacterLptB-FNcoI CATGCCATGGCAACATTAACTGCAAAGAACCTTGC 
citrobacterLptB-RBamHI ATCGGGATCCTTAATGATGATGATGATGATGCTCGAGTCTGAAGTCTTCCC
CAAGG 
citrobacterLptC-FNcoI CATGCCATGGGCAAAACCAGACGTTGGGTTATC 
citrobacterLptC-RHindⅢ TCGCAAGCTTAAGGCTGAGTTTGTTTGTTTTGGATTTC 
citrobacterLptF-FNdeI GGAATTCCATATGATAATCATAAGATATCTGGTTCGGGAAACG 
citrobacterLptG-NXhoⅠ TATACTCGAGTTACGATTTACGCAGCATCAGCCACAGG 
VibriocholeraLptB-FNcoI CATGCCATGGCCATCTTAAAAGCACAGCATTTAGC 
LptB-REcoRI ATCGGAATTCTTAATGATGATGATGATGATGTCTGAGACGGAATTGTTCGC
CGAGATAC 
LptC-FNcoI CATGCCATGGGTTTGTCGCGCATTGTTTACGTTCTGC 
LptC-RHindⅢ TCGCAAGCTTAAGGTGTGAGCGTTTCATATCTACCTTG 
LptF-FNdeI GGAATTCCATATGATTATTGTTAGATATTTGATCCGAGAAACAAT 
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LptG-NXhoⅠ TATACTCGAGTTATAGCTTTCTACCCAATAGCCCTAAC 
K12_G144_myc_F GAACAAAAACTCATCTCAGAAGAGGATCTGTTGCTCTCTACCCAGCAAG
GCTTATGG 
K12_G144_myc_R CCTCTTCTGAGATGAGTTTTTGTTCCGAGCCGCCGTACATCGCC 
K12_G228_myc_F GAACAAAAACTCATCTCAGAAGAGGATCTGACCTGGAAAACCAACCTC
ACGCC 
K12_G228_myc_R CCTCTTCTGAGATGAGTTTTTGTTCGCCGCTCACCGTCTGCGAAC 
K12_F230_flag_F GATTACAAAGATGACGACGATAAACAGGCGATCATTGGTCACCAGGC 
K12_F230_flag_R TTTATCGTCGTCATCTTTGTAATCATAATCCTGGAAGTCCGTAATGCGGAA
ATCACG 
K12_F138_flag_F GATTACAAAGATGACGACGATAAACCTGGCATGGCGGCGCTG 
K12_F138_flag_R TTTATCGTCGTCATCTTTGTAATCGTTCGCTTTCGCTTCTGCTAACACTTC
ATCCTG 
Mutagenesis  
01_F_S318C_F CCTGAAATGTAACGGCGGTAAAGGTAAGCTGGACCCGACG 
01_F_S318C_R CGCCGTTACATTTCAGGGAGGTCTGGATCAGGAAGAAAAGTAGATACAG
C 
01_G_K40C_F CAGCTGTGTAAAGCCGGGCAGGGGAGTTACGACGCGTTAG 
01_G_K40C_R CCGGCTTTACACAGCTGATCGACAAACTTGATAATGCCCGACAGCG 
02_F_L311C_F CTTTTCTTCTGTATCCAGACCTCCCTGAAATCGAACGGCGGTAAAGG 
02_F_L311C_R GAGGTCTGGATACAGAAGAAAAGTAGATACAGCAGCATGGCTGGC 
02_G_V36C_F attatcaagtttTGTgatcagctgaaAAAAGCCGGGCAGGGGAGTTAC 
02_G_V36C_R ttcagctgatcACAaaacttgataatGCCCGACAGCGACACCAGC 
03_F_S315C_F ATCCAGACCTGTCTGAAATCGAACGGCGGTAAAGGTAAGCTGGAC 
03_F_S315C_R CGATTTCAGACAGGTCTGGATCAGGAAGAAAAGTAGATACAGCAGCATG
GC 
03_G_L39C_F gatcagTGTaaaaaagccggGCAGGGGAGTTACGACGCGTTAG 
03_G_L39C_R ccggcttttttACActgatcGACAAACTTGATAATGCCCGACAGCG 
04_F_G36C_F CTCTGTGCAGCGGTTGACGGCGATATTCCGGCGAATCTG 
04_F_G36C_R AACCGCTGCACAGAGGATCCTCACTAACTTTTGACAGAAGAAGATCAAA
AGC 
04_G_Q324C_F ACTGGACTGTATCTTCGGCCCGCTGACGTTGGTTTATGGCATC 
04_G_Q324C_R CCGAAGATACAGTCCAGTACGTAGAAGACAAAACCGAAACTGATACCGG 
05_F_L35C_F TGAGGATCTGTGGCGCAGCGGTTGACGGCGATATTCCG 
05_F_L35C_R GCGCCACAGATCCTCACTAACTTTTGACAGAAGAAGATCAAAAGCAAGA
TGAAGAG 
05_G_I325C_F TGGACCAGTGTTTCGGCCCGCTGACGTTGGTTTATGGCATCC 
05_G_I325C_R GCCGAAACACTGGTCCAGTACGTAGAAGACAAAACCGAAACTGATACC
GG 
06_F_D42C_F TTGACGGCTGTATTCCGGCGAATCTGGTGCTCTCCCTTCTCG 
06_F_D42C_R CCGGAATACAGCCGTCAACCGCTGCGCCGAGGATC 
06_G_Q266C_F TTGTGATGCCGGACGTTatcagctcaacatgtggagcaaaatcttccag 
06_G_Q266C_R AACGTCCGGCATCACAACCGCTCGACTTCAGATACTTCACATAGTTGTG 
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07_F_T153C_F CAAGCGTGTAATGGCAGCTCGGTGCTGTTCATCGAAAGCGTTG 
07_F_T153C_R GCTGCCATTACACGCTTGCTGGAATTGCCCTTGCGCCAG 
07_F_T246C_F CGAACGATTGTGACCAGATGGACATGCGCACATTGTGGAACACTGAC 
07_F_T246C_R CATCTGGTCACAATCGTTCGGGTCGAGCGCCACCGCC 
08_F_D229P_Q231P_F AGCCGTATCCGGCGATCATTGGTCACCAGGCGGTGG 
08_F_D229P_Q231P_R CGCCGGATACGGCTGGAAGTCCGTAATGCGGAAATCACGTAAC 
09_F_R223PT225P_F TTTCCCGATTCCGGACTTCCAGGATTATCAGGCGATCATTGGTCACCAG 
09_F_R223PT225P_R GAAGTCCGGAATCGGGAAATCACGTAACAATGCAGTGCCTTCGAAG 
10_G_K40E_K41E_F ATCAGCTGGAAGAAGCCGGGCAGGGGAGTTACGACGCG 
10_G_K40E_K41E_R CGGCTTCTTCCAGCTGATCGACAAACTTGATAATGCCCGACAGCG 
11_G_S223P_T225P_F GTCCGCAGCCGGTGAGCGGCACCTGGAAAACCAACCTCAC 
11_G_S223P_T225P_R CTCACCGGCTGCGGACCGGTAATCTGTTTCGGATTGGTCAGATCAGATTC 
12_G_G228P_W230P_F AGCCCGACCCCGAAAACCAACCTCACGCCGGACAAAC 
12_G_G228P_W230P_R TTTTCGGGGTCGGGCTCACCGTCTGCGAACCGGTAATCTG 
13_G_L234C_F AAACCAACTGTACGCCGGACAAACTGGGCGTGGTGGC 
13_G_L234C_R CGGCGTACAGTTGGTTTTCCAGGTGCCGCTCACCG 
13_G_D156C_F GAAATGTGGCAACAACTTCGTCTACATTGAGCGGGTTAAAGGTGACGAA
G 
13_G_D156C_R GAAGTTGTTGCCACATTTCGCCCATAAGCCTTGCTGGGTAGAGAG 
14_F_F26D_F CTTTTGATCGATTTCTGTCAAAAGTTAGTGAGGATCCTCGGCGCAGC 
14_F_F26D_R ACTTTTGACAGAAATCGATCAAAAGCAAGATGAAGAGTATCGCCAGCTG
GC 
14_F_L62D_F AAATGGCGCAGGATATCCTGCCATTAAGCCTGTTCCTCGGG 
14_F_L62D_R AGGATATCCTGCGCCATTTCCGGCACGCCCAACCC 
15_F_R295E_F AGGGAGAAGTACTGTCGATGCTGCCAGCCATGCTG 
15_F_R295E_R TCGACAGTACTTCTCCCTGACGTGGGTTAACCACGCTCAG 
15_F_K13E_F ACGCTCGAAAGCCAGCTGGCGATACTCTTCATCTTGCTTTTGATCTTCTTC
TG 
15_F_K13E_R CAGCTGGCTTTCGAGCGTCTCCCGCACCAGATATCTTATGATTATCAC 
16_F_R295E_F AGGGAGAAGTACTGTCGATGCTGCCAGCCATGCTG 
16_F_R295E_R TCGACAGTACTTCTCCCTGACGTGGGTTAACCACGCTCAG 
16_F_K78E_F CTGGGCGAACTGTATACCGAAAGTGAAATTACGGTAATGCATGCCTG 
16_F_K78E_R GTATACAGTTCGCCCAGCGTCATCAGCAGCCCGAGG 
17_F_R269E_F TGAACTGGGAAATCACGTTGGTATTCACCGTGTTTATGATGGCAC 
17_F_R269E_R ACGTGATTTCCCAGTTCAGTTCTGCGCGAGCACGATC 
17_F_K317E_F: CTCCCTGGAATCGAACGGCGGTAAAGGTAAGCTGGACC 
17_F_K317E_R GTTCGATTCCAGGGAGGTCTGGATCAGGAAGAAAAGTAGATACAGC 
18_F_R269E_F TGAACTGGGAAATCACGTTGGTATTCACCGTGTTTATGATGGCAC 
18_F_R269E_R ACGTGATTTCCCAGTTCAGTTCTGCGCGAGCACGATC 
18_F_R126E_F TCATCGGAACATCAGGATGAAGTGTTAGCAGAAGCGAAAGCGAAC 
18_F_R126E_R ATCCTGATGTTCCGATGACCACGGTCCCGCCCACATC 
19_F_E10A_F GGGCGACGCTCAAAAGCCAGCTGGCGATACTCTTCATC 
19_F_E10A_R TTTGAGCGTCGCCCGCACCAGATATCTTATGATTATCACTTTAAATACGCC
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C 
19_F_E84A_F GAAAGTGCGATTACGGTAATGCATGCCTGCGGCCTGAG 
19_F_E84A_R ATTACCGTAATCGCACTTTCGGTATACAGTTTGCCCAGCGTCATC 
20_F_E58A_F GCGATGGCGCAGCTTATCCTGCCATTAAGCCTGTTCC 
20_F_E58A_R GCTGCGCCATCGCCGGCACGCCCAACCCGAGAAG 
20_F_E265A_F CGCAGCGCTGAACTGGCGTATCACGTTGGTATTCACCG 
20_F_E265A_R GCTGCGCCATCGCCGGCACGCCCAACCCGAGAAG 
20_F_E265A_F CGCAGCGCTGAACTGGCGTATCACGTTGGTATTCACCG 
20_F_E265A_R AGTTCAGCGCTGCGCGAGCACGATCGGTGTCAGTG 
21_F_D129A_F ATCAGGCGGAAGTGTTAGCAGAAGCGAAAGCGAACCCTG 
21_F_D129A_R TAACACTTCCGCCTGATGACGCGATGACCACGGTCC 
21_F_E265A_F CGCAGCGCTGAACTGGCGTATCACGTTGGTATTCACCG 
21_F_E265A_R AGTTCAGCGCTGCGCGAGCACGATCGGTGTCAGTG 
22_F_I18D_F TGGCGGATCTCTTCATCTTGCTTTTGATCTTCTTCTGTCAAAAGTTAGTGA
G 
22_F_I18D_R GATGAAGAGATCCGCCAGCTGGCTTTTGAGCGTCTCC 
22_F_M74D_F TGCTGGATACGCTGGGCaaaCTGTATACCGAAAGTgaaATTACGGTAATGC 
22_F_M74D_R CCAGCGTATCCAGCAGCCCGAGGAACAGGCTTAATGG 
23_F_M74D_F TGCTGGATACGCTGGGCaaaCTGTATACCGAAAGTgaaATTACGGTAATGC 
23_F_M74D_R CCAGCGTATCCAGCAGCCCGAGGAACAGGCTTAATGG 
23_F_M299D_F TACTGTCGGATCTGCCAGCCATGCTGCTGTATCTACTTTTCTTCC 
23_F_M299D_R TGGCAGATCCGACAGTACGCGTCCCTGACGTGGG 
24_F_L66D_F CTGCCAGATAGCCTGTTCCTCGGGCTGCTGATGACG 
24_F_L66D_R AACAGGCTATCTGGCAGGATAAGCTGCGCCATTTCCGGC 
24_F_Y306D_F GCTGCTGGATCTACTTTTCTTCCTGATCCAGACCTCCCTGAAATC 
24_F_Y306D_R GAAAAGTAGATCCAGCAGCATGGCTGGCAGCATCGACAG 
25_F_W268E_F AACTGAACGAACGTATCACGTTGGTATTCACCGTGTTTATGATGGCACTT
ATG 
25_F_W268E_R CGTGATACGTTCGTTCAGTTCTGCGCGAGCACGATCGG 
25_F_F310E_F CTACTTTTCGAACTGATCCAGACCTCCCTGAAATCGAACGGCG 
25_F_F310E_R CTGGATCAGTTCGAAAAGTAGATACAGCAGCATGGCTGGCAG 
26_F_R212E_F AGGGAACGGAATTCGAAGGCACTGCATTGTTACGTGATTTCC 
26_F_R212E_R TTCGAATTCCGTTCCCTGGTTGAGAGTGACGACCTGGG 
26_F_Y230E_F CAGGATGAACAGGCGATCATTGGTCACCAGGCGGTGG 
26_F_Y230E_R ATCGCCTGTTCATCCTGGAAGTCCGTAATGCGGAAATCACGTAAC 
27_F_F149D_F AAGGGCAAGATCAGCAAGCGACTAATGGCAGCTCGGTG 
27_F_F149D_R TTGCTGATCTTGCCCTTGCGCCAGCGCCGCCATGCC 
27_F_P139D_F AAAGCGAACGATGGCATGGCGGCGCTGGCGCAAGG 
27_F_P139D_R ATGCCATCGTTCGCTTTCGCTTCTGCTAACACTTCATCCTGATGACGC 
28_G_K13E_F CGCTATATCGGTGAAACTATTTTCACCACCATCATGATGACACTGTTCATG
C 
28_G_K13E_R GAAAATAGTTTCACCGATATAGCGGTCAAGTACGCCAAAAGGTTGCAT 
28_G_R86E_F GCGCAGGAAAGCGAACTGGTGGTGATGCAGGCTTCTG 
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28_G_R86E_R TCGCTTTCCTGCGCCAGCATCCCAAGACCAAGCAACG 
29_G_R86E_F GCGCAGGAAAGCGAACTGGTGGTGATGCAGGCTTCTG 
29_G_R86E_R TCGCTTTCCTGCGCCAGCATCCCAAGACCAAGCAACG 
29_G_R301E_F CACTGGAAAGCGTACCGATGGGCGTGCGTGTGG 
29_G_R301E_R GGTACGCTTTCCAGTGGGCCAAAGATGAACGACAGCGC 
30_G_R301E_R308E_Fsm GAAAGCGTACCGATGGGCGTGGAAGTGGTCACCGGTATCAGTTTCGGTT
TTG 
30_G_R301E_R308E_Rsm TTCCACGCCCATCGGTACGCTTTCCAGTGGGCCAAAGATGAACGACAGC 
31_G_K34E_F GGCATTATCGAATTTGTCGATCAGCTGAAAAAAGCCGGGCAGG 
31_G_K34E_R ATCGACAAATTCGATAATGCCCGACAGCGACACCAGCATGAAC 
31_G_R136E_F GTAACTACGAAGCGCAGGCGATGTACGGCGGCTCG 
31_G_R136E_R CTGCGCTTCGTAGTTACGCGCCATCTGCTCGCC 
32_G_K34E_F GGCATTATCGAATTTGTCGATCAGCTGAAAAAAGCCGGGCAGG 
32_G_K34E_R ATCGACAAATTCGATAATGCCCGACAGCGACACCAGCATGAAC 
32_G_K62E_F CCGGAAGATGTGCAGATCTTCTTCCCGATGGCGGCTC 
32_G_K62E_R TCTGCACATCTTCCGGCACGCTCAGCAAGGTATACATTCCTGC 
33_G_R133E_R136E_F CGGAAAACTACGAAGCGCAGGCGATGTACGGCGGC 
33_G_R133E_R136E_R CGCTTCGTAGTTTTCCGCCATCTGCTCGCCCTGCG 
34_G_R270E_R278E_Fsm GAATATCAGCTCAACATGTGGAGCGAAATCTTCCAGCCGCTATCTGTGGC 
34_G_R270E_R278E_Rsm TTCGCTCCACATGTTGAGCTGATATTCTCCGGCATCCTGACCGCTC 
35_G_K40E_F GATCAGCTGGAAAAAGCCGGGCAGGGGAGTTACGACG 
35_G_K40E_R GGCTTTTTCCAGCTGATCGACAAACTTGATAATGCCCGACAGCGAC 
35_G_R136E_F GTAACTACGAAGCGCAGGCGATGTACGGCGGCTCG 
35_G_R136E_R CTGCGCTTCGTAGTTACGCGCCATCTGCTCGCC 
36_G_T18D_F TTTCACCGATATCATGATGACACTGTTCATGCTGGTGTCGCTGTC 
36_G_T18D_R TGTCATCATGATATCGGTGAAAATAGTTTTACCGATATAGCGGTCAAGTAC
GCCAAAAG 
36_G_L78D_F GCGTTGGATGGTCTTGGGATGCTGGCGCAGCGCAG 
36_G_L78D_R CAAGACCATCCAACGCCCCAAGCAGAGCCGCCATCG 
37_G_V309D_F CGTGATGTCACCGGTATCAGTTTCGGTTTTGTCTTCTACGTACTGGACC 
37_G_V309D_R TACCGGTGACATCACGCACGCCCATCGGTACGCTACG 
37_G_L78D_F GCGTTGGATGGTCTTGGGATGCTGGCGCAGCGCAG 
37_G_L78D_R CAAGACCATCCAACGCCCCAAGCAGAGCCGCCATCG 
38_G_L26E_F TTCATGGAAGTGTCGCTGTCGGGCATTATCAAGTTTGTCGATCAGC 
38_G_L26E_R AGCGACACTTCCATGAACAGTGTCATCATGATGGTGGTGAAAATAGTTTT
ACC 
38_G_M70E_F TTCTTCCCGGAAGCGGCTCTGCTTGGGGCGTTGC 
38_G_M70E_R CGCTTCCGGGAAGAAGATCTGCACATCTTTCGGCACGC 
39_G_F67E_F GCAGATCGAATTCCCGATGGCGGCTCTGCTTGGGGC 
39_G_F67E_R ATCGGGAATTCGATCTGCACATCTTTCGGCACGCTCAGCAAG 
39_G_Y320E_F TTGTCTTCGAAGTACTGGACCAGATCTTCGGCCCGCTGACG 
39_G_Y320E_R GTCCAGTACTTCGAAGACAAAACCGAAACTGATACCGGTGACCAC 
40_G_W204D_F CATAAAGTCGATCGTCTGTCGCAGGTTGATGAATCTGATCTGACCAATCC 
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40_G_W204D_R GACAGACGATCGACTTTATGTTCCGGGTCAAACTTCGCAGTAGC 
40_G_I163D_F TTCGTCTACGATGAGCGGGTTAAAGGTGACGAAGAGTTAGGTGGC 
40_G_I163D_R CGCTCATCGTAGACGAAGTTGTTGCCATCTTTCGCCCATAAGC 
41_G_L206D_V209D_F TGATTCGCAGGATGATGAATCTGATCTGACCAATCCGAAACAGATTACCG 
41_G_L206D_V209D_R TCATCATCCTGCGAATCACGCCAGACTTTATGTTCCGGGTCAAAC 
42_G_Y257E_Y271E_Fsm AAGTCGAGCGGTCAGGATGCCGGAcgtGAACAGCTCAACATGTGGAGCA
AAATCTTCC 
42_G_Y257E_Y271E_Rsm CTGACCGCTCGACTTCAGATACTTCACTTCGTTGTGCAAACCGCTGATAG
AGAGTG 
WaaB_V186A_F ttctctatGCGgggcgtcttaaatttgaagggcagaaaagagttaaag 
WaaB_V186A_R gcccCGCatagagaaATACAGCGGGTTTATCGCGC 
WaaB_Q194A_F gaagggGCGaaaagagTTAAAGATTTATTTGATGGCTTAGCTCGTACG 
WaaB_Q194A_R ctcttttCGCcccttcaaatttaagacgcccTACatagagaaatacag 
WaaB_K195A_F agggCAGGCGagagTTAAAGATTTATTTGATGGCTTAGCTCGTACG 
WaaB_K195A ctctCGCCTGcccttcaaatttaagacgcccTACatagagaaatac 
WaaB_I216A atattGCGggtgatggCTCAGATTTTGAAAAGTGCCAGGC 
WaaB_I216A_R ccatcaccCGCaatatGTAGCTGCCATTCCCCTGTC 
WaaB_W243A_F atggtGCGcaaagcgcgccgtggcaagtcgtac 
WaaB_W243A_R gctttgCGCaccatACCAGATCACACGCTGCTCAATACC 
WaaB_E268A_F gcatttGCGggatttcCTATGACCCTGCTGGAAGCAATG 
WaaB_E268A_R gaaatccCGCaaatgcAGAGGTAAGTAGTAACGCGGTGAC 
WaaB_T273A_F ctatgGCGctgctgGAAGCAATGTCATATGGAATTCCGTG 
WaaB_T273A_R cagcagCGCcatagGAAATCCCTCAAATGCAGAGGTAAG 
WaaB_E276A_F gctgGCGgcaatgtcatatggaattccgtgtattagttctgattg 
WaaB_E276A_R cattgcCGCcagcAGGGTCATAGGAAATCCCTCAAATG 
Table 11 Primers used in this thesis 
The related primers used for molecular cloning and mutagenesis are listed 
here. The Tm temperatures are calculated using NEB Q5 TM CALCULATOR 
(https://tmcalculator.neb.com/). The annealing temperatures may vary from the 
Tm calculated for the websites and can be adjusted by cases. 
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Table 12 Plasmids information in this thesis 
The three main plasmids used in the thesis are pHISTEV, pLOU3, pTRC99a. 
pHISTEV (KanR) is derived from pET28 (Novagen) with a 6-histeine-TEV 
cleavage sequence inserted in front of the MCS, resulting in a plasmid that 
expresses the protein in an easy-tag-removal manner. pHISTEV uses T7 and 
IPTG inducible promoter. pLOU3 (AmpR) is modified from pMalE plasmid 
(NEB). By inserting a 6-histeine in front of MBP and a TEV cleavage site 
between MBP and MCS, the pLOU3 is generated and can express the target 
protein in a MBP fusion mode and the removal of MBP and 6-His tag is also 
simple. MBP fusion method is a widely used method which can help improve 
the protein folding and can increase soluble expression level of some specific 
insoluble proteins, especially the proteins that form inclusion bodies during 
expression. pMalE uses tac IPTG inducible promoter. pTRC99a (AmpR) is a 
high copy vector with strong IPTG inducible promoter trc. The high copy and 
the strong promoter properties of pTRC99a can maximize the protein 
expression level. The backbone of pTRC99a is quite simple even without RBS, 
PTRC99a 
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which allows the target gene insertion to be freer. This vector is most helpful 
when expression protein complexes in polycistron.  
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